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Currently 22% of the UK population die in care homes, mostly within 18 months of 
admission, yet there is little research about the nature of symptoms at the end of life in 
this population. The limited evidence suggests that the dying trajectory may be 
different to other populations.  
Aim 
To describe the presence and intensity of physical symptoms of residents during the 
dying phase and explore common characteristics that occur over time. 
Methods 
This prospective cohort study used the Modified Edmonton Symptom Assessment 
Scale (ESAS) to collate demographic and symptom characteristics from 157 residents 
during the final days of life in 11 care homes. Descriptive statistics were used to 
present demographic and clinical characteristics. The presence and intensity of both 
symptom load and individual symptoms was tested for significance with either 
ANOVA or Cochran’s Q and post-hoc comparisons performed. Finally, an inferential 
analysis was performed to test for associations between presence and intensity and key 
characteristics. 
Results 
The five most common symptoms nearest to death were drowsiness, fatigue, anorexia, 
unable to respond and shortness of breath with a significant increase in both presence 
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and intensity of these symptoms towards the time of death. Only a small number of 
associations between demographics, diagnoses and symptoms were observed. 
Discussion 
The main symptoms occurring in residents relate to a general deteriorative condition 
suggesting that dying in care homes is characterised by a gradual decline, with an 
increased presence and intensity of symptoms towards the time of death. Symptoms 
can be classified as ‘silent’ or ‘strident’, resulting in a typology that has not been 
previously identified in symptom research in this population. The limited associations 
between co-variables indicate that despite differences in age, gender, number of 
diagnoses and length of stay, this cohort is a homogenous group during the last few 
days of life.   
Conclusion 
The research findings have implications for end of life care of residents, education and 
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Chapter 1 – Introduction 
 
1.1 An ageing population  
The global population is ageing rapidly. In 2012 there were 810 million people aged 
60 years or over in the world, 178 million more than in 2002 and, by 2050, it is 
estimated that 22% of the global population will be 60 or over, amounting to over 2 
billion people (United-Nations, 2012). A significant feature of the ageing population 
is the progressive ageing of the older population itself. It is estimated that there will be 
425 million people aged 80 years or over by 2050, a 3.5-fold increase (World Health 
Organization, 2017). Within the UK, there will be an estimated increase in those aged 
85 or over, from 1.3 million in 2008 to 8 million in 2050 (Office for National Statistics, 
2017) 
 
The increase in the ageing population will bring challenges on many levels from 
personal to socio-economic due to an increasingly smaller working population having 
to provide for a non-working older group, both financially and as care providers 
(Doyle, 2009). The Office for National Statistics (ONS) predict a fall in the 
demographic support ratio from 3.3 people of working age for every person of 
pensionable age to 2.9 by 2050 (Office for National Statistics, 2015). This is already 
evident in Germany which has the third largest oldest population in the world and is 
facing a ‘war of generations’, where younger people are required to pay additional 
taxes for older people’s care (Powell, 2012). With people living for longer periods and 




1.2 Facing illness in old age 
As people live longer and older, they are facing longer periods of good health leading 
to a shorter period of ill health, with increasing needs and more dependency in their 
final years (Harper, 2017). The numbers of deaths worldwide are set to rise from 57 
million in 2015 to 70 million in the next 15 years (Bone et al., 2018). There is a 
relationship between the number of older people and the number of deaths, as most 
deaths occur in people over the age of 65 years or older (Costantini & Lunder, 2012), 
and most will die as a result of serious chronic diseases. In the future, although older 
people in general are likely to stay healthier for longer (Doyle, 2009), the proportion 
of people with a long-term limiting illness or disability will increase with age (ONS, 
2012); additionally, the last years of life will be accompanied by an increase of illness 
and disability (Lunenfeld, 2008). This will lead to those who require care within a 
Long Term Care setting becoming more frail, with higher numbers of co-morbidities 
and more considerable dependency than those previously cared for (Hallberg, 2006b; 
Koller & Rockwood, 2013; Murray, Boyd, Hockley, & Sheikh, 2008).  
 
Within the UK, Lievesley, Crosby, and Bowman (2011) established that the average 
length of stay in care homes in one provider organisation (BUPA) is decreasing. They 
forecasted that by 2015 the median length of stay for frail older residents would be 265 
days; for residents receiving ‘dementia care’, it would be 367 days. They also 
highlighted a similar pattern in a decreasing rate of length of stay across Australia, 
Spain and New Zealand (Lievesley et al., 2011). The World Health Organization has 
also affirmed that the number of older people dying in care homes is almost certain to 
increase worldwide (WHO, 2011). This will result in care homes having a higher 
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turnover of residents who have a shorter length of stay from admission to death, 
resulting in an increased number of deaths in care homes.  
 
1.3 Care homes in the UK 
Within England and Wales, in 2011, 3.2% of the population aged 65 or above live in 
a care home (with or without nursing care) (Office for National Statistics, 2013). One 
of the main findings of the ONS report was that the care home population for those 
aged 65 and over has remained virtually stable since the previous 2001 survey, 
showing an increase of only 0.3%, despite an increase of 11.0% in the total population 
of the same age. However, it shows that there has been a change in the age 
demographic. The numbers of those aged 75 - 84 has decreased while the populations 
aged 65 - 74 and those of 85 years and over have both increased. This may be an 
indication of health improvements in the population, which is why there has been an 
increase in those aged 85 and over but does not explain why the number of those aged  
65 – 74 has increased. One key influence on the relative stability of the population 
within the care home population is likely to be due to an increase of unpaid carers. 
There were an additional 600,000 unpaid carers in 2011 compared to 2001 (Office for 
National Statistics, 2013). As this is increasing faster than the population growth, it is 
helping to prevent care home admissions with more people being cared for in either 
their own home or a family member’s home. 
 
Historically, care homes have always had a higher proportion of females to males, but 
the gender gap in the care home population is narrowing.  In 1983 there were 155 
women aged 65 and over for every 100 men of the same age, compared to the current 
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sex ratio of 130 women for every 100 men for this age group. By 2033 it is projected 
that the 65 and over sex ratio will have fallen still further to 117 women for every 100 
men (Office for National Statistics, 2013). This does differ from provider to provider: 
for example, The Methodist Homes Association reported that just under a quarter of 
their care home residents were male, and this proportion was increasing annually 
(Methodist Homes Association, 2015). The fall in numbers of women entering care is 
likely to be due to the increase in unpaid carers as previously mentioned on page 3, 
and particularly to the increase in longevity of men, who are providing support and 
care for women who had previously lived longer than their spouses and were usually 
the recipient of care rather than the provider. 
 
Although the number of people who are living in care homes at any one time has not 
changed significantly over the last 10 years, there are higher numbers of people dying 
in care homes than ever before. In England, deaths in care homes have increased from 
80,000 to 111,000 per annum in the last five years (Public Health England, 2017). This 
can be explained by the reduction in residents’ length of stay. It has been difficult to 
estimate the average length of stay in care homes as this information has not been a 
statutory monitoring requirement; however, in 2011, it was reported that the median 
period from admission to the care home to death was 462 days or 15 months (Forder 
& Fernandez, 2011). Yet, ten years earlier a study by Bebbington, Darton, and Netten 
(2001) reported a median length of stay of 19.6 months. From their origins of being 
long stay residences, care homes are rapidly becoming an important place for end of 
life care (Public Health England, 2017b) along with an increase in temporary residents1 
                                                          
1 A temporary resident is defined as a person whose need to stay in a care home is intended to last for a 
limited period of time and where there is a plan to return home 
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who are dying in the care homes. End of life care has become a core and vital 
component of the work of care homes. 
 
1.4 Palliative and end of life care 
The term ‘palliative care’ has been used from around the beginning of the 19th Century, 
although it has only been employed in its broader sense for the last 25 – 30 years. 
Traditionally, palliative care was mostly offered to patients with cancer. In 2001, the 
World Health Organization closely aligned palliative care with cancer and discussed 
the need to provide it in conjunction with other therapies intended to prolong life, such 
as chemotherapy or radiation therapy. Although the definition was broadened to 
embrace life-threatening illness (World Health Organization, 2004), the initial cancer 
focus still has an impact upon current practice around palliative care. 
 
Palliative care has been defined by the World Health Organization as “an approach 
that improves the quality of life of patients (adults and children) and their families 
who are facing problems associated with life-threatening illness. It prevents and 
relieves suffering through the early identification, correct assessment and 
treatment of pain and other problems, whether physical, psychosocial or spiritual” 
(World Health Organization, 2018b) 
 
In the UK, the term ‘palliative care’ was largely replaced by the term ‘end of life care’ 
in 2008, following the publication of the End of Life Care Strategy (Department of 
Health, 2008). It was identified that people did not fully understand the word 
‘palliative’ and felt the alternative ‘terminal care’ focussed too much on the final few 
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hours of life. The concept of end of life care was believed to be broader and was 
intended to include the last hours, days, weeks, months, and even years.  Like the term 
‘palliative care’, it was meant to be inclusive of any illness that was considered life 
threatening (Department of Health, 2008).  Globally, the term ‘palliative care’ is still 
commonly in use: Australia (Department of Health, 2018): Canada (Morrison, 2017): 
USA (Hawley, 2017). Within Europe, there is a similar situation; the European 
Association for Palliative Care has produced a resource of National Guidelines 
(European Association for Palliative Care, 2017) which shows that the Netherlands, 
Germany, Switzerland, the Republic of Ireland and other UK countries such as 
Northern Ireland and Scotland have guidelines referencing ‘palliative care’. This thesis 
will use the term ‘end of life care’ as this is now accepted as the main term within 
England; however, palliative care will still be referred to when appropriate such as for 
historical references, international discussion or when referring to certain services 
within the UK. For example, hospices2 talk about providing ‘specialist palliative care’ 
and many Macmillan teams3 refer to their service as a ‘specialist palliative care’ 
speciality. 
 
Three key elements that strongly emerge from the World Health Organization 
definition (page 5) are the terms ‘quality of life’, ‘life-threatening illness’ and the 
‘early identification, correct assessment and treatment of pain and other problems’.  
 
                                                          
2 Hospice care seeks to improve the quality of life and wellbeing of adults and children with a life-
limiting or terminal illness, helping them live as fully as they can.  
3 A Specialist Team that is made up of health professionals who provide support and advice to 
individuals affected by cancer or other advanced incurable illnesses, and their carers. 
7 
 
The first element, quality of life is an often quoted principle of end of life care, yet is 
accepted to be uniquely subjective to the person experiencing it. However, there is 
evidence to suggest that there are core factors that are important to many patients and 
families at the end of life which will enhance quality of life (Steinhauser et al., 2000). 
These include pain and symptom management, preparation for end of life and 
promoting relationships between patients, families and health care professionals. 
Quality of life in end of life care is closely related to quality of death. Regardless of 
when a person dies or the cause of their death, most people, when asked, want to have 
a ‘good death’ (Kelly, 2014; Meier et al., 2016). The End of Life Care Strategy 
(Department of Health, 2008) highlighted the principles of a good death, and these 
included being treated as an individual, being free from pain and other symptoms, 
being in familiar surroundings and being in the company of close family and/or friends. 
Preparation for end of life was identified as something that can improve quality of life 
at the end of life. This can be illuminated through two different approaches, both 
wholly applicable to end of life care:  
1. Meeting the patient’s needs, wishes and preferences by shared decision 
making. This can only happen if there is honesty and willingness to discuss 
future plans on the part of patients, staff and families (Mullick, Martin, & 
Sallnow, 2013) and to open up discussions early on in the course of the illness.  
2. The need to recognise that end of life is approaching. This is a very challenging 
situation to undertake (Glare et al., 2008), but without timely identification and 
subsequent communication, opportunities can be lost for the person and their 
family to say their goodbyes. A report from the Care Quality Commission 
(2016) identified that people who could benefit from end of life care are not 
being identified in a timely manner. If it is not recognised that end of life is 
8 
 
approaching, it can lead to inappropriate hospital admissions and an increased 
risk of dying in hospital. This may not have been that person’s choice, given 
that people in the last year of life will experience 2.28 hospital admissions with 
an increasing likelihood of emergency admissions in the last 2 weeks of life 
(Robinson, Gott, Frey, & Ingleton, 2018). 
 
The second element, the early identification, correct assessment and treatment of 
pain and other problems, has become a foundation in the provision of end of life 
care. Providing relief from symptoms has been long identified as an essential 
component for end of life care (Wilkie & Ezenwa, 2012). Knowledge of the prevalence 
of symptoms, together with assessment and management, has become a necessary 
requirement for the care of all patients (Potter, Hami, Bryan, & Quigley, 2003). This 
knowledge is not just required of medical staff, but of nursing staff, allied health 
professionals and, to a lesser degree, of auxiliary care workers and requires a 
supportive educational approach to promote it. Good symptom control has been 
associated by those at the end of life with the wish that they do not want to die in pain 
or distress, rating it as a higher priority than being at home or being with loved ones  
(Demos, 2013). To be able to treat symptoms effectively, they first need to be 
recognised (as a symptom) and correctly assessed. While symptom management 
maintains a high profile in palliative and end of life care, the recognition and 
assessment of symptoms have a lesser emphasis (although pain does have a higher 
profile than many other symptoms). To do this effectively, appropriate assessment 
methods (or instruments) need to also be considered. There is a lack of instruments 
generally to measure symptoms in an elderly population who are receiving palliative 
care. (Browner and Smith (2013) reviewed 21 instruments in their study involving an 
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older palliative population and noted that none of the instruments had been validated 
for use with geriatrics (elderly population), although they had been used within these 
populations. 
 
The third element, ‘life-threatening illness’, refers to the extension of palliative care 
to a wider group of diseases/illnesses that would benefit from this type of approach. 
Initially, palliative care largely pertained to cancer care; however, in 2004, the World 
Health Organization recognised the need to expand this definition to include the needs 
of people living with different serious chronic illnesses who had similar concerns and 
needs (World Health Organization, 2004). 
 
1.5 End of life care in care homes  
The definition of end of life care as discussed above is applicable to care homes with 
the three elements having the same impact upon residents within care homes as it does 
to the population in general. This section will consider the place of end of life care in 
relation to current policy which will be developed further in chapter two: background 
and context. 
 
Residents living in care homes are some of the most vulnerable people in society, 
usually presenting with multiple co-morbidities. Residents are likely to have very 
complex needs. The number of residents with types of dementia, such as Alzheimer’s 
disease, is increasing with nearly two thirds of residents dying with dementia (Public 
Health England, 2017a). Multiple services may provide care and treatment and 
decision making involves managing inherent uncertainties. One of those uncertainties 
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is around the recognition of the end of life phase, both at the earlier stages and later 
on, when the resident is entering the final days or hours of life. Yet, this uncertainty 
can reduce the opportunity for the resident and their family to be able to make informed 
decisions about their care. There is currently a drive to reduce ‘avoidable’ hospital 
admissions from care homes thus reducing the number of deaths in hospital (Krueger, 
2016). This is seen as a positive move to enhance quality, lower costs and meet 
people’s preferences (Hunter & Orlovic, 2018). NHS Trusts and Clinical 
Commissioning Groups (CCGs) have been tasked with reducing deaths in hospitals 
(National Quality Board, 2017) and anecdotally some CCGs, including local Cheshire 
ones, have identified ‘high flyers’, that is care homes with the highest hospital 
admission and death in hospital rates. However, given the increasing ageing 
population, increasing number of deaths and the wish to prevent hospital admissions, 
the demand for end of life care provision within care homes is only likely to increase.  
 
1.6 Reflection on the background for this research study 
The motivation for this research probably started many years ago. I was an A-level 
student planning to study home economics when my Mother who was a nurse asked if 
I would help out in the care of the elderly hospital (as they were known at that time) 
during my school holidays. I loved it from the first day, so much that I decided to apply 
for my nurse training. My Mother was not particularly happy at what she had 
inadvertently set off, and proceeded to include me in all manner of nursing tasks 
(including my nemesis, cleaning false teeth) but I knew it was what I wanted to do. 
This foundation gave me my interest in working with older people, something that has 
remained throughout my nursing career.   
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After qualifying, I worked in general medical wards and then a hospice, and it felt a 
very natural progression to work with people, especially older people, at the end of 
life. After several years working at the hospice, I was given an opportunity to move 
into an educational post in palliative care. Within my role as an educator/facilitator, I 
was responsible for a number of initiatives to support nursing homes in delivering end 
of life care. Many of these allowed me to be able to work directly with nursing home 
staff, enabling me to start to understand the work that takes place and appreciate both 
the highlights and the challenges. I was able to use the knowledge that I had built up 
working within specialist end of life care to support my nursing home colleagues to 
enhance their own end of life care practices. I could see their frustrations about not 
always being able to support residents to die in the nursing home and could see the 
impact that this had upon residents and families. One particular aspect that had started 
to bother me was in relation to the use of the (now obsolete) Liverpool Care Pathway4. 
The tick-box approach that the LCP was advocating did not seem to fit in with the 
needs of the nursing home resident. Staff often spent a lot of time requesting drugs to 
be prescribed for core symptoms and then having to obtain them, yet did not use them. 
I spent many hours teaching staff how to set up a syringe pump, only for staff to not 
use one for several months. I felt passionately enough about this to write an article 
about the use of the Liverpool Care Pathway in nursing homes (Partington, 2006). This 
was the start of my journey and I was able to secure support to carry out a ‘project’ to 
understand this better. I wanted to know more about the end of life symptoms that 
occur in nursing home residents in order to gain more knowledge to reflect upon and 
                                                          
4 The LCP was an Integrated Care Pathway intended to provide a method of recording and measuring 
outcomes of end of life care (Ellershaw et al, 2001) 
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influence practice, as I felt that this was an unaddressed issue within the literature that 
I had read.  
 
I did not start out aiming to be a ‘researcher’, but I knew that I wanted to be able to do 
something that would have a positive impact upon the care of residents at the end of 
life. I also did not set out intending to conduct a positivist research study, but to answer 
the questions that I was asking, as I appreciated that this was the only viable approach. 
It is from this background and from my desire to make a difference that I present this 
research. I will conduct and present the research within a positivist paradigm, along 
with the rigour and reliability that provides. While I can, and do, accept that knowledge 
is ‘out there’, I would also like to explore the possibility of viewing the research 
through another lens: that of a conceptual model to help to frame the research and 
make sense of the findings and also help locate it for any potential future researchers 
to use if they so wish. 
 
The purpose of this research is to determine the presence and intensity of physical 
symptoms of residents in the dying phase in care homes and explore whether there are 
changes in symptoms over time and how they relate to specific demographics and other 
characteristics. It is presented in seven chapters. The aims and objectives of the 






1.7 A synopsis of Chapters 2 – 6  
1.7.1 Chapter 2 – Background and context 
This chapter builds on the introduction chapter and continues to set the scene about an 
ageing population, both internationally and in the UK. Long Term Care/Care home 
care is introduced within an international perspective and then within the UK. This 
leads to considering dying in Long Term Care/Care homes and identifies many of the 
challenges that are currently being faced in this sector. From the care homes, the 
components of good end of life care are considered and the relationship between 
symptoms and end of life care is reviewed. This leads into a discussion around 
symptoms at the end of life for residents in care homes and the role of symptom 
research from a practical application and a conceptual model. 
 
1.7.2 Chapter 3 – Literature review 
By using the PICO framework5, the literature review seeks to question the prevalence 
of physical symptoms in residents living in care homes at the end of life. The search 
strategy is described and the results of the review are presented, followed by a 
discussion of the literature that was included in the review. The chapter concludes by 




                                                          
5 The PICO framework is a mnemonic used to frame and answer a clinical or health care related question 
and is described in chapter 3. 
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1.7.3 Chapter 4 – Methodology and methods 
This chapter begins by setting out the aim and objectives of this study and addresses 
the study’s underlying epistemology and ontology. The research study design is 
presented which leads into detail about the processes that were followed. Data 
collection is discussed followed by the data analysis plan and the selection of an 
appropriate instrument. Due to the nature of the study being conducted with 
participants at the end of life, there is a detailed ethical issues section and concludes 
with discussions about reliability and validity. 
 
1.7.4 Chapter 5 – Results 
This chapter presents the results from the analysis of the data. The objectives of the 
research are presented, which link into a set of hypotheses to test the objectives. Within 
the results, an overview of the data sets the scene and provides detail on the complexity 
of the data. This is followed by a descriptive analysis which describes the presence 
and intensity of both total symptom load and individual symptom presence and 
intensity. Testing for significance is followed by pairwise comparisons across three 
different time points. The next section focusses on an inferential analysis and the 
associations between presence and intensity of both total load and individual 
symptoms, and a number of demographic and clinical characteristics. Finally, an 
overview of the results are provided in the conclusion. 
 
1.7.5 Chapter 6 – Discussion 
This chapter begins with presenting the characteristics of the symptoms and leads into 
a discussion of a typology of symptoms associated with the dying phase. The 
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discussion broadens and takes into account the changes in symptoms over time and 
recognition of the dying phase. The strengths and limitations of the study are addressed 
and conclude with the implications for practice, policy and research. 
 
1.7.6 Chapter 7 – Conclusion 
This final chapter summarises the findings from the research by considering the 
importance of the research. It considers what it has contributed by presenting five key 
findings. The chapter concludes by providing recommendations for future practice, 











Chapter 2 – Background and Context 
 
2.1 Introduction 
An ageing population is affecting when and where older people live and die on a global 
level, leading to challenges for the future provision of health and social care (Bone et 
al., 2018). Over the next 15 years, the numbers of deaths worldwide are set to rise from 
57 million in 2015 to 70 million (World Health Organization, 2014).  In the UK, (Bone 
et al., 2018) it has been projected that if current trends continue, the next 25 years will 
see an increase for the need for end of life care, particularly at home and in care homes. 
As the demographics change, family structures alter, and people are living longer, with 
a reduced workforce to care for them, there is a risk in not understanding the needs of 
the population, which in turn will add more pressure onto already overstretched 
services. A group of particular interest, due to an increase in prevalence, are people 
with dementia. Worldwide, the number of people is estimated to double to 65.7 million 
by 2030 and triple to 115.4 million by 2050 (Wortmann, 2012), while in the UK there 
are currently around 835,000 people living with dementia which is estimated to 
increase to over two million by 2050 (Alzheimers Association, 2012). This is because 
the greatest risk factor for developing dementia is increasing age (Prince et al., 2014). 
In addition, an increasing number of older adults are living with multiple chronic 
health conditions. Hung, Ross, Boockvar, and Siu (2011) reported that between 1998 
and 2008, the proportion of adults with one or more chronic diseases increased from 
86.9% to 92.2% revealing a connection between increasing age and co-morbidities. 
 
Given the increase in older frail people and people with dementia, care homes have 
increasingly become a place where people are living and dying, meaning that an 
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understanding of care homes and the care home population is essential to meet both 
current and future health needs and to support the services providing this care. This 
chapter will begin with the concept of Long Term Care/care homes/nursing homes and 
defining the terminology, and by building upon the overview provided in chapter one 
will consider the development and role of end of life care within care homes. Good 
end of life care is synonymous with quality of life and this is closely linked with the 
quality of a person’s dying, so the relationship to these concepts will be explored. One 
key attribute is that of a ‘good death’, and that has been related to being free of 
burdensome symptoms. However, to manage symptoms, they firstly need to be 
identified and quantified, so this aspect will be discussed. This will lead to an 
examination of the concept of symptoms, what they are, and how they are measured. 
Finally, the symptoms experienced by older people living in a care home at the end of 
life will be considered. 
 
2.2 Long Term Care – The international perspective 
Long Term Care covers a very broad range of settings and not just care homes; these 
included facility-based long-term care, continuing care retirement communities, 
assisted living, adult day service programs, meal programmes, senior centres, home 
healthcare aides, and transportation services (Technavio, 2017). During a World 
Health Assembly in 2016, 194 countries agreed that all countries should have a system 
(World Health Organization, 2018a). However, it was identified that few countries 
have systems that can effectively meet the care needs of their populations. Despite this, 
Technavio (2017) predict a global growth of 6.5% for the need for Long Term Care 
during the period of 2017-2023 highlighting a high level of inequity in the provision 
of Long Term Care internationally. Institutional care for older people is more common 
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in developed countries having primarily evolved due to a lack of informal care within 
families (Seale, 2000). In western countries, the trend in service development is that 
only older people with significant needs receive institutionalised care (Brazil, Brink, 
Kaasalainen, Kelly, & McAiney, 2012; Eun-Young, Cho, & June, 2006; Hasson & 
Arnetz, 2009; McCann, O'Reilly, & Cardwell, 2009; Raikkonen, Perala, & Kahanpaa, 
2007).  
 
Increasing numbers of older people are living and dying in care homes and other long-
term care settings (Froggatt & Reitinger, 2013), yet the organisation and structure of 
Long Term Care vary greatly both within Europe and worldwide. To address this, a 
European Association of Palliative Care (EAPC) taskforce was established in 2010 to 
review the ways in which palliative care is developing in Long Term Care settings and 
adopted the following definition of Long Term Care settings: “….collective 
institutional settings where care is provided for older people who live there and care is 
provided for 24 hours a day, 7 days a week for an undefined period of time” (Froggatt 
& Reitinger, 2013):p.6).  
 
To provide further clarity, the International Association of Gerontology and Geriatrics 
and The Foundation for Post-Acute and Long Term Care Medicine (Sanford et al., 
2015) developed a survey to assist with an international consensus on the definition of 
a nursing home and provided a similar definition to that of the EAPC taskforce: “A 
nursing home is a facility with a domestic-styled environment that provides 24-hour 
functional support and care for persons who require assistance with ADLs and who 
often have complex health needs and increased vulnerability” (Sanford et al., 
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2015):p183). The main difference is the reference to complex health needs, however, 
this could be explained by the difference between the broader Long Term Care setting 
definition and that of a nursing home. 
 
On a wider international basis the systems of long-term care are very diverse across 
different countries and these are likely to strongly influence the care provided (Albers 
et al., 2012).  In the Netherlands and Norway, Long Term Care is well established, 
while in South Europe, care is developing with family carers giving much of the care. 
Further afield, Australia, the USA and Canada have well established systems, but with 
very different funding arrangements. In an attempt to understand international 
differences around the approaches to the Long Term Care of older people, 
McCormack, Roberts, Meyer, Morgan, and Boscart (2012) set out to explore different 
models of care. The authors found a wide variation of approaches, from an institutional 
model of care, to one that recognises and celebrates the older ‘person’ (as a unique 
individual), and although they conclude that recognising the concept of personhood is 
crucial to continuing to improving and developing Long Term Care, there is a wide 
difference of approaches around the world.  
 
Internationally, there are many examples of initiatives to increase knowledge around 
the needs of older people in care homes. In the US, the National Care Home Study is 
a continuing series of nationally representative sample surveys of US care homes, 
including their services, staff, and residents. The last full study was undertaken in 
2004, but aspects of care have been reviewed and updated with the most recent 
occurring in 2011 (CDC, 2013). Other European countries have also identified issues. 
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In Norway, Selbaek et al. (2007) questioned the increasing practice of prescribing of 
psychotropic drugs with residents but concluded that it reflected the needs of people 
with dementia in nursing homes.  In the Netherlands, Zuidema et al. (2007) examined 
symptom clusters of nursing home residents with dementia reporting a prevalence of 
at least one symptom in 85% of residents. This concurs with the findings from Shah et 
al. (2010) UK study that residents are likely to have high clinical needs across 
international settings, so the focus will now move to consider the situation in the UK.  
 
2.3 Long Term Care - Care homes in the UK 
Within the UK, the majority of care homes provide services for older people, but a few 
offer services to children and to people with mental or sensory impairments. This study 
will be considering care homes for older people only. Using the definition from the 
EAPC taskforce, above, care homes for older people in the UK are divided between 
two categories:  
1. The first offers personal care only and is called a ‘care home’ (although 
formerly would have been referred to as a residential home). This type of care 
home is run by staff who are trained to support residents, but are usually not 
Registered Nurses.  
2. The second type of care home was traditionally called a nursing home, but are 
now referred to as a ‘care home with nursing’. These have Registered Nurses 
on duty 24 hours per day and they are supported by Health Care Workers.  
 
Within the UK, care homes are run by voluntary organisations, local councils, health 
authorities and private agencies. All care homes must be individually registered, 
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inspected and listed by a relevant authority, which in England and Wales is the Care 
Quality Commission (CQC). There are currently 11,300 care homes in the UK 
providing care for around 410,000 residents with 95% of beds being provided by the 
independent sector (Competition and Markets Authority, 2017). This study uses the 
generic term of ‘care home’ throughout unless referring to historic literature where the 
terms ‘nursing home’ and ‘residential home’ will be utilised. 
 
While care homes would have always cared for older frail people, there is a change in 
dependency of residents. On average older men towards the end of life now have 2.4 
years with substantial care needs and women 3.0 years, and although most will live in 
the community, it is anticipated that if dependency and care home proportions remain 
static in the future, a further 71,215 places will be needed by 2015 (Kingston et al., 
2017).  There is another group of people that are also requiring additional care: it is 
estimated that 70% of people in care homes have dementia or severe memory problems 
(www.alzheimers.org.uk, 2017), the number of which is increasing and will have an 
effect on the number of care home places that are required. As a result, projections of 
future demand in relation to providing care for those with dementia indicate that the 
current number of care home places will need to increase by 82% between 2010 and 
2030 to cope with the extra demand (Jagger et al., 2011). 
 
2.4 The importance of understanding care homes and residents  
There is a lack of robust information on residents in care homes in terms of their 
diseases and progression of illness. The last major study that was carried out regarding 
individual residents across a broad number of care homes was in 2000, when the focus 
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of the survey was on the health of older people and “provided a general overview of 
the characteristics of care homes in England and of the socio-demographic and health 
profiles and social participation of care home residents aged 65 and over” (Health 
Survey for England, 2000): p.8). This survey involved 544 care homes and interviews 
with 2,493 residents, although 51% were interviewed in proxy involving either 
families or care home staff. Through the knowledge of the demographic status of those 
living in care homes, it has was identified that older people living in the care homes 
had high levels of physical dependence and health care use (Bajekal, 2002). Yet, 
according to Shah et al. (2010), there was limited information regarding the clinical 
characteristics of this population, meaning that despite growing numbers, there are not 
any consistent sources of data to support future planning or organisation of care needs. 
In an attempt to resolve this lack of information about care home residents, Shah et al. 
(2010) identified older care home residents through a national cross sectional analysis 
of a primary care database. They found high clinical need, especially with dementia 
and stroke prevalence, but incomplete recording of other expected diseases suggesting 
inequity of care for care home residents compared to their counterparts living in their 
own homes, with the latter group more likely to be on GP frailty or vulnerability 
registers. Shah et al. (2010) also reported little difference between the clinical needs 
of residents living in care homes compared to those living in their own home, which 







2.5 Death and dying in care homes 
2.5.1 Dying in care homes – The international perspective 
The role of palliative care within Long Term Care was specifically identified as being 
a requirement to meet the needs of older people during the 2016 World Health 
Assembly (World Health Organization, 2018a) yet as described, Long Term Care in 
many countries is minimal. Within other countries, however, Long Term Care has been 
a constant with palliative care being a stable feature. A significant proportion of people 
die in Long Term Care settings: ranging from 13% in Austria, 20% in England to 39% 
in Canada (Hall, Kolliakou, Petkova, Froggatt, & Higginson, 2011).  
 
New Zealand has advocated a palliative care approach for a number of years and 
Nolan, Featherston, and Nolan (2003) reinforced the benefits of applying palliative 
care principles to develop end of life care in care homes. Within Sweden, there were 
reservations indicating that more research is required to adapt this care for older people 
(Hallberg, 2006a). The domain of specialist palliative care had taken the initiative to 
try and improve end of life care within care homes. At this time, extensive work was 
also being carried out in Australia (Parker, Grbich, et al., 2005) and Canada 
(Goodridge, Bond, Cameron, & McKean, 2005) and the USA (Reynolds, Henderson, 
Schulman, & Hanson, 2002). 
 
A number of developments in the provision of end of life care took place in Long Term 
Care settings at international level, so to describe the level and type of interventions 
occurring Froggatt et al. (2006) undertook a literature review between 2000 and 2004. 
The review found that the development of end of life care was clearly being addressed 
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in published literature with its strength lying in the extent to which researchers and 
practitioners were attempting to engage with the complexity that surrounds this area 
of care. However, it was found that the nature and form of developments tended to be 
descriptive, small scale and limited. It was recommended that there was a need to 
engage in further developments, particularly around interventions that attempt to 
address the complexity of care in Long Term Care settings. This review shared 
comparable conclusions to a similar review carried out by Cartwright (2002) between 
1990 and 2000, who also found that interventions were mainly descriptive in nature 
and that there was a lack of evidence-based strategies for recognising common 
symptoms at end of life with staff often lacking knowledge about how to assess and 
manage symptoms. 
 
2.5.2 Dying in care homes – The UK perspective 
Care homes, both care and care with nursing, play a crucial and growing role in the 
delivery of care towards the end of life for older people. In the UK in 1990, 
approximately 13% of people died in nursing or residential homes (Field & Cassel, 
1997). By 2005, this was 16% (76,977 people) increasing to 22% (101,203) in 2014 
(Centre, 2017). An even higher proportion will receive part of their care in a care home 
before their death as approximately one third of people (28,892) living in care homes 
die elsewhere, predominantly in hospital. There is significant variation by Clinical 
Commissioning Group (CCG) in the proportion of people aged 75 years and older who 
die in care homes in England, varying from 10% to 43% (Centre, 2017). If the recent 
decline that has been experienced in hospital deaths is sustained, the annual numbers 
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of people dying at home and in care homes is estimated to almost double by 2040 and 
care homes will become the most common place of death (Bone et al., 2018). 
 
Prior to 1995, palliative care was not seen as a requirement within the care home 
setting, as it was frequently regarded as a type of care that was given to people dying 
with cancer. It was also viewed as care that needed to be given in hospices. As already 
noted, people spent longer living in care homes, there were fewer deaths and when 
death occurred it was often viewed as something that just happened and there was an 
acceptance that death was a natural event. This view of death being incidental is 
supported by the observation that there were no research studies carried out in care 
homes around death and dying until after the mid-1990s. The Calman-Hine Report 
(1995) promoted the provision of a palliative care approach that could be offered in all 
care settings and this appeared to coincide with the acknowledgement of palliative care 
in care homes. However, initially the notion that end of life care could be offered in 
care homes was slow to establish and this is reflected in the increasing number of 
deaths that now occur within care homes and a more widely accepting attitude towards 
them.  
 
The first large UK study of dying in care homes was undertaken in 1997, when Sidell, 
Katz, and Komaromy (1997) studied the way that death and dying were dealt with in 
different types of care homes in England. Their research indicated that the palliative 
care concept was not very widely understood in care homes, and they often failed to 
recognise the need for end of life care at the end of life. Most homes reported feeling 
isolated and unsupported when caring for dying residents. Furthermore, care home 
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managers often identified pain as a major cause of suffering, but without any 
appreciation of other symptoms. This may be linked to palliative care having strong 
associations with cancer care and the emphasis on pain management. Following the 
publication of the Sidell et al. (1997) study, other UK studies subsequently emerged 
which studied the definition and practice of end of life care in care homes. The findings 
from these studies continued to reveal that end of life care was often not seen a priority 
in care homes. These early studies also started to recognise that those who support the 
development of end of life care in care homes needed to understand the nature of care 
in care homes and the different ways in which older people die (Froggatt, 2000; Katz, 
Komaromy, & Sidell, 1999b).  
 
The profile of end of life care in care homes increased and although there were pockets 
of recognising the need to develop end of life care, many were initiated by external 
sectors, particularly specialist palliative care. This was confirmed by an European 
Association for Palliative Care taskforce report (Froggatt & Reitinger, 2013) when 
they mapped exemplars of good end of life care initiatives across different countries, 
including the UK, but noted that the drivers came externally rather than from the care 
homes themselves, for example, Froggatt’s study looking at palliative care education 
in care homes found that education was provided for the care homes rather than by the 
care homes (Froggatt, 2000). Subsequently, Froggatt put forward the explanation that 
palliative care may operate from a different paradigm from care home philosophy and 
that the care homes may have their own ‘successful’ ways of accommodating dying 
residents’ needs (Froggatt, 2001). It may have also been due to residents having 
different needs when dying which were not visible, especially to specialist palliative 
care with their cancer focus. While outside bodies such as the hospice movement 
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recognised the growth of palliative care, the care home sector itself and its regulatory 
body, The Commission for Social Care Inspection (CSCI6), appeared to be progressing 
the development of end of life care much more slowly. It is possible that a more 
enquiring approach as to why care homes did not feel the need to adopt this practice 
would have achieved a better understanding.  
 
In 2005, a Social Care Institute for Excellence (SCIE) briefing paper identified a lack 
of detailed standards governing the provision of terminal care to older people in care 
homes, especially for conditions other than cancer (SCIE, 2005). Despite the 
acknowledged need to improve end of life care within care homes, there was little 
support for homes to do this and SCIE reported that the principal source of documents 
containing practice recommendations came from The National Council for Hospice 
and Specialist Palliative Care Services (NCHSPCS) and (SCIE, 2005) – a body set up 
to provide support and advice to hospices and other specialist palliative care services 
and but not to care homes.  
 
More recently, there has been a greater investment to enable care home residents to 
stay in the care home up to the point of death, particularly in relation to the support of 
staff and the provision of additional education and training. In the North West of 
England, the ‘Six Steps’ end of life care programme for care homes has been developed 
and demonstrated improved quality of end of life care outcomes (Brien et al., 2014; 
                                                          
6 Commission for Social Care Inspection (CSCI) began operating on 1 April 2001, to be replaced by the 
Care Quality Commission (CQC) in October 2009. 
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Martin & Martin, 2018). A further programme review is currently underway to 
continue to support care home staff to care for residents (www.sixsteps.net)7.  
 
Increased investment has taken place for a number of reasons: an increase in the 
autonomy and choice of individuals and the right to make decisions around their own 
care which recognises that most people wish to die in their ‘usual place of residence’, 
i.e., the care home. It has also been found that residents do not fare well in acute care 
facilities (Wowchuk, McClement, & Bond Jr, 2007) increasing the need to prevent 
hospitalisation. Given the financial climate in health care, it could also be considered 
a cost effective investment. Within the UK, there has been a drive to reduce the number 
of hospital deaths generally, and specifically, in the case of care home residents, 
inappropriate hospital deaths (National Quality Board, 2017). 
 
This impetus to facilitate more residents to die in the care home means that evidence-
based end of life care, which has been slow to be established, must advance to ensure 
that the resident has the best possible death, but also prevents last-minute hospital 
admissions due to ineffective care or care failure. There may be a number of potential 
barriers or aspects of care that impede the delivery of good end of life care and these 
must be addressed to prevent poor experiences around death and dying for residents 
and their families. However, external support provided to care homes may be at odds 
with the support they actually require as much of the support is based on a model of 
care required for the ‘cancer trajectory’ (Seymour, Kumar, & Froggatt, 2010). The 
                                                          
7 The Six Steps programme is a North West initiative based on the NHS Improving Quality Route to 
Success and aims to enhance end of life care through facilitating organisational change and supporting 
staff to develop their roles around end of life care. 
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cancer trajectory, originally defined by Lynn and Adamson (2003) involves a deep and 
rapid decline towards death. An alternative trajectory identified by Lynn and Adamson 
which would be more appropriate for this group is the ‘frailty decline’. This is a slow 
low level decline leading to death. The cancer trajectory is often more familiar to those 
who provide support to care homes, such as Macmillan Teams, because it is one they 
associate with the type of death they are more familiar with. 
 
The End of Life Care Strategy (Department of Health, 2008) was a key driver in 
changing the focus of end of life care delivery and research in the UK and has been 
described as the “publication which significantly changed the focus of EoL care 
delivery and research in the UK” (Spacey, Scammell, Board, & Porter, 2018): p182). 
While this is accurate in many ways, reviewing the literature shows that things did 
start to change prior to that. Although the Calman-Hine Report (NHS Executive, 1995) 
had a focus on cancer services, it brought palliative care to the fore and established the 
ground for much of the work that was done with care homes after that. However, by 
reviewing the most current literature, it can also been seen that there is still much room 
for improvement (Forbat, Chapman, Lovell, Liu, & Johnston, 2017; Martin & Martin, 
2018; Spacey et al., 2018), so the next section will consider what makes good end of 
life care in general and then within care homes.  
 
2.6 The components of good end of life care 
The End of Life Care Strategy (Department of Health, 2008) was a change agent in 
many ways as it opened up discussions around end of life care, many of these with the 
general public as well as health and social care professionals. Despite the strategy 
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promoting good quality end of life care, it also underlined that this was not happening 
for everyone. As a result, there was an intense engagement process with the general 
public and ‘What’s important to me. A Review of Choice in End of Life Care’ was 
published (The Choice in End of Life Care Programme Board, 2015). This review 
brought public views together and presented seven key themes about what people 
want:  
“Many people told us that they wanted choice over their place of care and 
death; others told us that they wanted choices over other aspects of their care, 
such as pain control and involvement of family and those close to them” (The 
Choice in End of Life Care Programme Board, 2015):p.3) 
 
End of life care has been attributed with ensuring that death is not just treated as a 
medicalised event, but considers a broad range of aspects in addition to the physical 
ones (Lloyd, White, & Sutton, 2011), yet while the authors highlighted six 
characteristics of a good death, the second most important one was ‘the control of pain 
and other symptoms’ which suggested that despite not wanting a medicalised death, 
physical comfort is a high priority for many people. The End of Life Care Strategy 
(Department of Health, 2008) put forward a comparable version consisting of five 
domains that are particularly pertinent to the last phase of life, with the first reported 
element being ‘preferences for care and treatment’ (p.5) 
 
When considering the characteristics of older people’s choices around end of life care, 
they wish to have a similar experience and do not request to ‘give up’ or receive less 
care than their younger counterparts. Although a prolonged dying trajectory can make 
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it difficult to determine whether they are living with or dying from a disease (Gott, 
Small, Barnes, Payne, & Seamark, 2008). Lloyd-Williams and Payne (2002) and 
Mathie et al. (2012) found that older people’s views of dying remained similar to those 
of the wider population with concerns regarding end of life issues such as how they 
would die. Meier et al. (2016) reported similar findings when they compared patient 
perspective articles which included an equal representation from individuals over the 
age of 60 years with those under 60. 
 
There is a relationship between what people want at the end of life in relation to their 
quality of dying and what has been termed as a ‘good death’ and a ‘bad death’. The 
‘What’s important to me’ report very clearly stated that: 
“Patients are so often afraid of a ‘bad death’ - pain, nausea, fear and other 
symptoms - they need reassurance and promises they will receive help with 
these.” (The Choice in End of Life Care Programme Board, 2015):p.23)   
 
Much has been written about the notion of a ‘good death’ (Granda-Cameron & 
Houldin, 2012; Kelly, 2014; Lloyd et al., 2011; Meier et al., 2016; Sherwen, 2014; 
Steinberg, 2012), and it has been identified as the ultimate goal of palliative care 
although given people’s lack of desire to talk about death and dying, it may be that a 
‘good death’ is implied rather than an explicit statement. Scarre (2012) argued that a 
‘good death’ is an oxymoron and since a death is always the loss of a human life, the 
claim can only be a philosophical one, and patients can only die “as well as possible” 
(p.1084). Since dying cannot be avoided, Scarre suggested that a person would be best 
to assure themselves a ‘peaceful’ death. Steinhauser et al. (2000) may be more 
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insightful when they observed that there is no single definition of a good death 
commenting that quality end of life care is a dynamic process that is collaborated 
between patients, families, and health care professionals. As an example of this, 
Saunders, Ross, and Riley (2003) described a young man who died following an 
accident and was perceived to have died an awful death by healthcare professionals, 
but contended that he himself may have considered it to have been good, as he died 
fighting for his life. This emphasises the individuality of the interpretation of what a 
good or bad death entails. 
 
Steinhauser et al. (2000) carried out a study with patients, families, and health care 
practitioners and found that the key issue was freedom from pain and good symptom 
management. As with the example given above, a ‘good death’ can be seen as different 
things by different people making it crucial to understand it from the point of view of 
the person who is dying, although this may not always be possible if someone is unable 
to communicate through poor condition or lack of capacity due to dementia. Within 
the provision of end of life care, this can impact upon the measurement of symptoms, 
especially when others need to report by proxy. It can also influence families’ 
experiences, which can affect the way that they may report symptoms post death, 
during an interview, for example. A literature review by Meier et al. (2016) set out to 
define a good death. They worked with three stakeholder groups (patients, families 
and health care professionals) and identified 11 core themes of what a good death 
looked like. The most common three themes from across all of the groups were 
preferences for a specific dying process, i.e. choice of place of death (94%), pain-free 
status (81%), and emotional well-being (64%), highlighting again the importance of 
symptom measurement leading to symptom control for people at the end of life. 
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There are challenges in supporting a person to have a good death but care homes need 
to ensure they are equipped to do so, as do the external organisations that are 
championing them. Current evidence suggests that practice in care homes can be 
unsystematic (SCIE, 2005), which results in disorganised care. The quality of death 
cannot be separated from care practices given within end of life care (Brazil et al., 
2004; Chapman & Ellershaw, 2011), so these must be attended to. Staff working in 
care homes would have a better understanding of patients’ physical needs at the end 
of life to be able to optimise quality care if symptoms were more effectively 
characterised (Hui, Santos, Chisholm, & Bruera, 2015). In a study with patients in the 
terminal phase of dementia, it was identified that quality of life and comfort were 
enhanced by good symptom assessment and management (Lloyd-Williams & Payne, 
2002). This was further supported by findings by Munn et al. (2008) who identified 
physical and psychological symptom management as one of the components of a good 
death. The importance and value of symptom assessment and management in 
promoting a good death has been clearly indicated and its role within end of life care 
will be expanded upon in the next section. 
 
2.7 The meaning of symptoms in end of life care 
As identified in the introduction chapter and the previous section, the relationship 
between good end of life care and the management of symptoms has been identified, 
To manage a symptom firstly requires its’ recognition which is closely linked to 
symptom assessment and this will be considered in more detail in section 2.13. 
However a further dichotomy will be considered, which is the meaning and use of 
signs and symptoms. This needs to be discussed as current clinical practice favours an 
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interchangeable use of the terms ‘symptom’ and ‘sign’ reflecting an unclear 
understanding held by practitioners and researchers. The clarity of this definition is 
central to the positioning of the research question within a positivist epistemology. The 
evidence regarding symptoms is constantly being revised, with new knowledge being 
built upon. In the following section the role of signs and symptoms in a good death 
will be explored. 
 
Derived from the Greek word, sumptÕma, symptoms are defined as subjective health 
related experiences (Cook, Sousa, Matthews, Meek, & Kwong, 2010) or the subjective 
evidence of disease or physical disturbance (Sheppard et al., 2013). Symptoms were 
initially distinguished from signs in the 1800s, where a symptom was identified as an 
alteration determined by the sense of the person, and a sign is a change in the function 
of the affected parts (Armstrong, 2003).  
 
A symptom is the “subjective evidence of disease or physical disturbance observed by 
the patient” (Merriam Webster, 2015)www.merriam-webster.com/ dictionary/ 
symptom). However, if this definition of symptom is applied, it is a subjective 
experience which in turn is a construct that requires methods of appraisal (Fayers, 
Hand, Bjordal, & Groenvold, 1997; Wilkie & Ezenwa, 2012). Within this definition, 
there is a firm emphasis on “subjective experience”, which could be argued to sit more 
resolutely within an interpretivist paradigm (Trochim, 2008). A subjective experience 
would require the person who has the symptom to be able to report on their experience, 
yet this will present challenges in end of life care research with participants who are 
unable to self-report due to the nature of dying. As such, according to definitions, what 
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are being measured within this research study are not symptoms, but signs. A sign 
comes from a different aetiological perspective and defined as an indication of a 
condition which is directly observable and measured objectively (Merriam Webster, 
2015)www.merriam-webster.com/dictionary/sign). This definition aligns more 
closely with a positivist paradigm and will lead onto a discussion about the objective 
measurement of a sign. Despite these conceptual differences, many studies have been 
carried out retrospectively and thus rely on a researcher who translated a third party’s 
notes and/or records (Forbes et al., 2011; Hendriks, Snmalbrugge, Hertogh, & van der 
steen, 2014; Steindal, Ranhoff, Bredal, Sorbye, & Lerdal, 2012). These studies are not 
gaining a subjective experience (nor do they purport to) yet they use the term symptom 
and it is this term that is most commonly utilised throughout studies and has gained 
common acceptance in the sense of language, particularly for health care professionals. 
It is not common for a person who is in the dying phase to be able to self-report, so the 
observer is relied upon to measure the occurrence, incidence and prevalence of a ‘sign’ 
rather than a ‘symptom’, which becomes an objective reality aligning more closely 
with a positivist approach. However, this study has elected to adopt the term symptom 
as it reflects its universal acceptance and its common use in practice, even though it 
would have been technically more precise to have used the term sign. The linguist 
Ferdinand de Saussure argued that language and labelling is not neutral and identified 
that the names of things and the labels that are used to form knowledge are a product 
of culture (Joseph, 2012). This philosophy has a parallel to the use of the term 
symptom, which has developed to encompass a range of meanings for the medical 




At the end of life when a person is no longer able to communicate, it does not mean 
that symptoms are no longer present, so to ensure good quality care, there becomes a 
need to rely on the observation of possible signs. Signs would be observed versions of 
symptoms yet there are some symptoms that are strongly classified as subjective 
experiences, such as pain or fatigue. Another boundary between symptoms and signs 
may be the ‘value’ that is placed on a sign. If a sign is the existence of an undesirable 
situation, a sign that would reasonably be expected at the end of life, such as 
drowsiness, be considered too unpleasant so it is not observed for or measured.  
 
If good pain and symptom management can be so closely identified with the concept 
of promoting a good death, more clarity of what a symptom is within the literature 
would be expected due to the level of importance placed on them, yet this remains a 
relatively under-stated area.  A better understanding of what symptoms are needs to be 
explored, prior to the consideration of recognition and measurement which impacts 
upon the subsequent ability to provide symptom management. 
 
2.8 Multiple symptoms 
The assessment and interpretation of symptom clusters has become more widespread 
over the recent years with increasing literature featuring multiple symptoms or 
symptom clusters (Kim, McDermott, & Barsevick, 2014; Linder et al., 2015; Moens, 
Siegert, Taylor, Namisango, & Harding, 2015). Furthermore, it was contended that 
symptom cluster research should be theoretically led (Laird et al., 2011; Molassiotis, 
Farrell, Bourne, Brearley, & Pilling, 2012) so in other words, having a structure or a 
framework helps to make sense of what is happening for both multiple and cluster 
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symptom research but also for single symptom research, an issue that will be 
considered later in this chapter. 
 
Although not clearly defined systematically, a symptom cluster relates to an aggregate 
of symptoms that are related to each other in a predictable manner, although Dodd et 
al. (2000) argue whether they share a common aetiology. Understanding how 
symptoms present in relation to each other will help increase awareness of the impact 
upon the person, particularly the older person with co-morbidities. However, before 
moving to a conceptual view, symptoms at end of life in care home residents will be 
considered. Single symptoms have been a subject of some research studies and many 
of these within a single disease group, such as cancer, Chronic Obstructive Pulmonary 
Disease (COPD) or heart failure. Viewing symptoms as a singular entity imposes a 
reductionist line, which supposes that the relationships between symptoms can be 
understood by looking at each one individually and restricts understanding and limits 
the development of practice (Aktas & Walsh, 2010).  
 
People with multiple conditions often experience a complex range of symptoms  
(National Institute for Health and Care Excellence, 2015a). When patients’ conditions 
become complicated due to multiple diseases, they are often excluded from research 
due to complexities of measuring and portraying symptoms (Mercer, Smith, Wyke, 
Dowd, & Watt, 2009), yet these are likely to be the patients that have the greatest 
symptom burden and would benefit the most from input. Furthermore, research that 
focussed on older persons is scarce, with older people often excluded from studies 
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because it has not always been an area of interest and, even now, remains relatively 
under researched (Van Lancker et al., 2013). 
 
2.9 Symptoms at the very end of life for residents in care homes 
As discussed, care homes have not always been seen as a place for dying and it was 
not until the mid-1990s that literature about end of life care, and particularly related 
symptoms, became more widespread. In the USA, a study by Ferrell (1995) on pain 
evaluation and management in care homes in the USA only briefly mentioned the 
applicability to those near the end of life. End of life care in care homes in the UK 
achieved more prominence when Avis, Greening Jacson, Cox, and Miskella (1999) 
piloted a project to improve end of life care in nursing homes with the goal of  
“extending hospice standards of end of life care…to people with a terminal illness” 
(p.33), emphasising the application of general end of life care approaches. Avis et al. 
discussed end of life symptom management, but made the assumption that knowledge 
gained from other end of life specialties, such as cancer care, was applicable to 
residents in the care home setting. The focus of other studies conducted around the 
same time took a strong focus on pain management, with less attention given to other 
symptoms (Katz, Komaromy, & Sidell, 1999a; Parker & De Bellis, 1999).  Katz et al. 
(1999a) made a broad reference to the use of syringe drivers being a necessary part of 
symptom management in care homes, which has been more recently challenged by 
Kinley and Hockley (2010) when they argued that symptoms frequently did not require 
the use of a syringe pump8 due to the late presentation and transient nature of the 
presence of symptoms. 
                                                          
8 Syringe drivers are now called syringe pumps since the old type ‘driver’ was replaced by a ‘pump’ 
device for safety reasons in 2007  
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By the mid-2000s several articles had been published considering symptom prevalence 
and management in care homes. This literature had started to focus on a wider range 
of symptoms, although there was a great diversity across the literature (Brandt et al., 
2005; Brandt, Ooms, Deliens, van der Wal, & Ribbe, 2006; Brechtl, Murshed, Homel, 
& Bookbinder, 2006; Brookfield, 2002; Caprio et al., 2008; Cartwright, Hickman, 
Perrin, & Tilden, 2005; Goodridge et al., 2005; Hanson et al., 2008; Koopmans, van 
der Sterren, & van der Steen, 2007; Reynolds et al., 2002; Solloway, LaFrance, 
Bakitas, & Gerken, 2005). Care homes have now become more widely recognised as 
the final place of life for the people who live there, and coupled with government 
directives impelling that people are able to die in their usual place of residence, 
(Department of Health, 2008), the significance of understanding what experiences take 
place have been seen as important. In general, research has vastly increased knowledge 
of symptoms and their impact, especially ones associated with cancer. However, these 
are more typically involving younger people, which has not been helpful to develop 
clinical practice and an evidence base, especially for older people. The manifestation 
of symptoms usually distinguish a shift in health status (Henly, Kallas, Klatt, & 
Swenson, 2003) and, in the instance of end of life care, this can coincide with the onset 
of the dying phase. As symptoms are unpleasant sensations which have a severe impact 
upon a person’s quality of life and places a great burden on families (Karabulu, Erci, 
Ozer, & Ozdemir, 2010; Pautex, Berger, Chatelain, Herrmann, & Zulian, 2003), it is 
crucial for professionals to understand both singular and multiple symptom presence 





2.10 Identifying symptoms 
The recognition and identification of symptoms can be further complicated as care 
home residents have a number of reasons that make it challenging for care 
professionals to ensure that death and dying is well planned for, and to ensure that the 
resident is able to die in the care home. Most residents now living in care homes are in 
their 80s and 90s and will have multiple co-morbidities. There is around a 70% 
possibility of residents having dementia, with those with dementia having the shortest 
life expectancy (Agüero-Torres, Fratiglioni, Guo, Viitanen, & Winblad, 1999). Death 
is not easily ‘predictable’, with a slow decline masking the residents approaching death 
(Froggatt, 2001) meaning staff have to work with the ‘uncertainty’ while still 
providing care (Goodman, Froggatt, Amador, Mathie, & Mayrhofer, 2015).  
Prognostication is a challenge for care professionals: despite most residents estimated 
to have a life expectancy of 15 months following admission  (Forder & Fernandez, 
2011), they are often not identified as being at the end of their lives. Hov, Hedelin, and 
Athlin (2013) recognise that identification of approaching death is a complex process 
due to the vague prognostic signs that could signal either recovery or death. As a result, 
there is a lack of meaning placed on end of life symptoms, partly because of the lack 
of recognition of the resident being in the terminal stages, and partly because the most 
commonly observed symptoms, such as pain, nausea, agitation, and shortness of breath 
(from an end of life cancer focussed evidence base) may not actually present in 
residents dying in care homes. It is also important to consider that although many end 
of life symptoms are termed physical symptoms, they may allude to broader 




2.11 Symptom presence in care home residents  
The symptoms that are most commonly looked for in care homes have been identified 
in studies that have been carried out in more disparate care settings such as hospices 
or hospitals (Brandt et al., 2006), although Hui, Dev, and Bruera (2015) contest that 
there have been insufficient studies carried out on symptom prevalence during the last 
few days of life in the general population either. Estabrooks et al. (2015) subsequently 
state that there are few published studies that describe end of life symptom burden in 
older adults in nursing homes. This has led to much of the knowledge about symptoms 
being based upon previous research from other settings, despite the lack of applicable 
evidence to the care home setting.  For example, syringe pump training is normally 
seen as a core part of education for Registered Nurses working within care homes 
(Mukoreka & Sisay, 2015), yet Kinley and Hockley (2010) found that syringe pumps 
were rarely used in care homes and when used, only required for less than 1.5 days 
prior to death. This suggests two things: there are fewer symptoms present than in 
other populations and importantly, that when symptoms do occur, they are present for 
a restricted amount of time. It also suggests that this education may not be appropriate, 
given the limited time that staff have for training, and that there could be more 
appropriate education provided which is more appropriate to resident care and making 
better use of staff time. In a study by Gorlen, Gorlen, and Neergaard (2013) staff 
participants reported problems with administering medications, yet this study used the 
guidance from the Liverpool Care Pathway, which identified an expectation that a 
syringe driver will be required rather than testing out whether there was a need. As 
well as medication issues, there has also been reported a lack of evidence-based 
strategies for recognising common symptoms at end of life in care homes (Cartwright, 
2002; Eicher et al., 2016; Hallberg, 2006a; Parker-Oliver, Porock, Zweig, Rantz, & 
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Petroski, 2003; Van Lancker et al., 2013; Wowchuk, McClement, & Bond Jr, 2006), 
with care staff lacking knowledge on the assessment and management of symptoms 
(Katz, 2003), resulting in poor symptom control (Seymour et al., 2010). 
 
2.12 Symptom research in end of life care 
End of life care research has been described as slow, expensive and often failing to 
produce useful results (Department of Health, 2008) with Higginson et al. (2013) 
observing that treatments in end of life care are hampered by poor research.   
 
Symptom research will require a quantification of the symptoms, however symptom 
research has been described as being, in the majority, cross-sectional and descriptive 
(Brant, Beck, & Miaskowski, 2010). As already noted, end of life care research 
requires future development and to do this, two areas will be considered: 1) the 
measurement of symptoms and 2) the location of the research within a conceptual 
framework. 
 
2.13 Measuring or assessing symptoms 
Measurement and assessment are different constructs, although they are often used 
interchangeably. Surprisingly, there is little in health related literature to differentiate 
between the two with some literature using assessment measures. An example of this 
can be observed in a paper by McColl (2004): the title of the paper is best practice in 
symptom ‘assessment’ but this quickly progresses to ‘measuring’ symptoms with no 
intervening discussion. However, there does appear to be a distinction even if it is not 
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made explicit. To explore this further, adopting terminology that is defined in the 
educational field can add some clarity. ‘Assessment is the process of gathering 
information to observe progress and make decisions if required’ while ‘Measurement 
relates to the process to which the attributes or dimensions of an object are determined’ 
(Zemlyаnskaya, 2016). 
 
Despite their differences, there are also associations between the two with an 
assessment being necessary to produce a measurement, or as identified by Ajayi 
(2018), again from science education, measurement provides a technique to capture 
changes through the assessment process in a two-step process. By taking this a step 
further, it may be applied to health science as something that translates the phenomena, 
from the gathering of information (assessment), into a representative set of numerical 
variables (measurement). Within health science, tools are used to assess and measure 
using the two-step process, but with the ultimate goal of producing a representative set 
of information. This process is not mutually exclusive to either using the information 
for clinical means (e.g., as part of a needs assessment) or for research purposes, but for 
both, it has the end goal of presenting reliable and valid results. 
 
It is the intention to use the term ‘measurement’ within this study as it aligns with the 
research question to reflect the positivist paradigm in which it sits and to reflect the 






2.13.1 The measurement of symptoms 
The MORECare statement (Higginson et al., 2013) stated that outcome measures 
require similar properties for both clinical practice and research, in that they should be 
short, responsive to change and used in both areas. A crucial part of measuring 
symptoms, for either research or clinical practice in carrying out symptom research is 
the measurement of a symptom. This is important because symptoms directly affect a 
person’s distress and quality of life. Measurement is a prelude to successful symptom 
treatment, however it is complex because of the evolving nature of disease, and 
interrelationship between the person’s phase of life and symptoms.  
 
Depending upon the research question, symptom research can be conducted with 
quantitative or qualitative methods, and sometimes a combination of both. The 
MORECare statement identified five areas of contention to consult upon. ‘Outcomes’ 
was one of these areas which was subsequently reported by Evans et al. (2013), who 
identified the importance of 1) robust measures, 2) data collection time points and 3) 
proxy reporting guidelines. These findings concurred with work by Armstrong (2014b) 
who recommended that factors such as the severity, distress and rate of change of 
symptoms over time needed to be taken into consideration when conducting symptom 
research. 
 
Symptom measurement has become more complex, or it could be that there has been 
a new recognition that symptoms are not single entities that occur at a single point of 
time. For the measurement of symptoms to be meaningful given that studies are now 
including multiple concurrent symptoms and temporal aspects, locating symptoms 
45 
 
within a conceptual model or framework will not only strengthen the research process 
by offering more clarity, but help to make the research and its processes more 
transparent for other researchers. The terms model and framework are often used 
synonymously in general literature, but this cross-over in definition and purpose also 
demonstrates why they are used interchangeably as elements of both can be required 
in any research study. They can both used to describe processes, however a framework 
provides a big picture overview of various descriptive categories and how they may 
relate to one another, while a model is commonly used to describe the process of 
translating research into practice (Crockett, 2017), making it more appropriate for the 
purpose of this study. A further advantage of the use of a model is that it can help to 
inform choices of instruments that align with this clearer and more transparent vision. 
As discussed in the introduction, it was not the intention to use a model or framework 
for the research study, but to apply it retrospectively to help to frame the research and 
make sense of the findings. 
 
2.14 The use of a conceptual model 
It is often difficult to tell if a particular piece of symptom research has utilised a 
conceptual model as it is often not reported explicitly within the literature. Because a 
model provides a way of thinking and organising a subject or an area, a lack of a 
defined model can result in a lack of structure, and reduce consistency within the 
bigger picture of symptom research with studies becoming unconnected, thus 
potentially reducing opportunities for transferability and for meta-analysis studies. 
Furthermore, the location of symptom research within a positivist paradigm may allow 
the lack of a conceptual model to go unchallenged due to a universal (but unspoken) 
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acceptance of this positivist worldview. While this may be a well-founded decision, it 
raises the possibility that symptom research could be enhanced by the use of a model, 
or a framework, to make sense of the findings and that allows itself to be refined for 
use in future symptom research. 
 
To investigate the use of a conceptual model, it was noted that within positivist studies 
there were a lack of either symptom research models or frameworks. As this study 
intended to take a positivist approach, a conceptual model that could be applied to 
review the study and the findings, but in a balanced way, was required. Given a lack 
of appropriate models for positivist symptom research, both models and frameworks 
that were allied to symptom research were reviewed. During the review of these 
publications it became apparent that many of them did not present either a model or a 
framework, but rather comprised of a set of recommendations for symptom 
management research.  Following the review, six symptom management models and 
frameworks were located (Brant et al., 2010; Brant, Dudley, Beck, & Miaskowski, 
2016; Cashion & Grady, 2015; Corwin, Meek, Cook, Lowe, & Sousa, 2012; Finnegan, 
Shaver, Zenk, Wilkie, & Ferrans, 2010; Parker, Kimble, Dunbar, & Clark, 2005; Teel, 
Meek, McNamara, & Watson, 1997). Table 2.1 summarises each of the publications 








Table 2.1 A summary of research management models and frameworks 
Author(s) and date 
 
Summary 
Brant et al, 2010 A model that aims to incorporate symptom clusters and 
symptom interactions to allow researchers to have an 
expansive view of the multitude of symptom related 
variables. 
Cashion et al, 2015 The model is an investigative sequence involving 
description of complex symptoms, phenotypic 
characterisation, biomarker discovery and clinical 
application. 
Corwin et al, 2014 The model embraces the use of common measures, 
symptom trajectories. Advocates a registry of CDEs 
(common data elements) and sophisticated analytic 
techniques.  
Finnegan et al, 
2010 
A framework for guiding symptom research around 
symptom cluster experience and are based on five cardinal 
symptoms 
Parker et al, 2005 A framework to provide a conceptual perspective to 
understand the underlying mechanisms of symptom pairs 
and clusters. Plans to help to translate research findings into 
practice rather than inform symptom research. 
Teel et al, 1997 Introduces the symptom interpretation model, which is 
based on an illness representation model. Aims to 
understand the individual nature of symptoms in a 
behavioural context. 
 
The focus of all of the models and frameworks were initially intended for use with 
symptom management research; however, this may not be appropriate for all types of 
symptom research, so further deliberation took place. Brant et al. (2010) identified that 
new developments need new models. While this was largely in reference to a 
paradigmatic shift within other studies such as work emerging on symptom clusters, 
temporal studies and patient outcome measures (reported or proxy), many of these 
involved using the findings for symptom management. However, there are other 
changes in practice that may require different approaches to gain new understanding 
and knowledge. Rather than always extending knowledge within new practices, it is 
also recognising that changes taking place can lead to gaps that are appearing in current 
knowledge. One such change is in place of death. As a shift is occurring to support 
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people to die in their usual place of residence, it means that populations are dying in 
different places than previously and new knowledge about symptom experience in this 
population and setting is required. While the scope of symptom research management 
models needs further development, knowledge around symptom presence also needs 
to be kept up to date and this will require different models and frameworks to capture 
it.  
 
Ultimately, Brant’s model was the only model to address the requirements for 
symptom research. Their own system, ‘the components and criteria of the 
characteristics of an ideal model or theory for symptom management research’ (see 
Appendix i) proved a useful tool to review the content of all of the models and 
frameworks, but it did show that others were limited in relation to their focus (i.e. 
symptom clusters), their representation (behavioural aspects), or their application 
(chemical changes in symptoms) so using the review criteria by Brant et al. did not 
give them an unfair advantage but merely emphasised the inappropriateness of other 
models.  
 
Brant et al. (2010) developed their New Symptom Management Model as the result of 
a comparison and contrasting exercise of four existing models or theories which 
ultimately led to proposing their own model. In 2016, it was renamed the Dynamic 
Symptoms Model as it had been used beyond the sphere of symptom management 
(Brant et al., 2016). Since 2010, the model has been used in a number of ways such as 
addressing the complex nature of symptoms, co-occurring symptoms and longitudinal 
changes of symptoms over time (Brant et al., 2016). It was broad enough to meet a 
number of different uses, but also it has been used with different disease groups which 
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have included cancer but other chronic diseases as well. Figure 2.1 shows the New 


















Figure 2.1 The New Symptom Management Model (Brant et al., 2010) 
(Reproduced with kind permission by Jeannine Brant) 
 
The model by Brant et al (Brant et al., 2010 has a focus on symptom management but 
has utility to be applied to other aspects because of its comprehensive overview. It 
shows the potential chain reaction of symptom events, starting on the left hand side of 
the diagram, moving towards the right. On the left hand side, are the antecedents; these 
are factors that influence symptoms, both in the way that they present, i.e., through 
different characteristics and demographics, or the way in which the individual 
experience may influence them. These can affect the symptom intercept (when 
symptoms may occur together) or the symptom slope (the level or intensity of the 
symptom). These are influenced by temporal factors (the symptom trajectory over 
time). Interventions are carried out (at the right hand side of the diagram), leading to 
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consequences in terms of quality of life, survival, function and adjustment which go 
full circle and lead back to the symptom being managed or not. The application of the 
model will be further discussed in relation to this study and its findings within the 
discussion chapter. The New Symptom Management Model also highlights the 
challenges of differentiating between a model and a framework as discussed in section 
2.13.1. As a model it does facilitate the description of a process (of symptoms) to help 
translate research into practice (through the breakdown and explanation of the different 
elements), however it also, in parts, meets the requirements for a framework in that it 
describes categories and their relation to one another. 
 
2.15 Conclusion 
Care homes are increasingly caring for a population that is becoming older and frailer, 
with multiple comorbidities and who are living for shorter periods of time in the care 
home before they die. As the length of stay shortens and place of death shifts from 
hospital to care homes, they are delivering end of life care much more frequently. 
Quality of life is strongly linked to knowing that a good death will happen and one 
core element of a good death that is important to people is the control of symptoms. 
However, to be able to provide symptom control, there needs to be an understanding 
of the type and nature of symptoms that this population will be affected by. 
 
As identified by the introduction in chapter one and reinforced by this chapter, there is 
a need for research in this area, not only to improve the dying experience for residents 
in care homes, but to provide an evidence base to support staff to be able to deliver 
good end of life care and to add new knowledge to influence practice and policy. There 
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has been work done in this area, but in order to look for gaps in knowledge and 
methods, a systematic literature review was carried out to understand the nature and 





















Chapter 3 – Literature Review 
 
3.1 Introduction 
Providing relief from symptoms has been long identified as an essential component 
for end of life care  (Wilkie & Ezenwa, 2012). End of life care practice and research 
in residents in care homes has identified an interest in symptoms from measurement 
to management, and knowledge of the prevalence of symptoms is necessary for the 
care of all patients (Potter et al., 2003). As discussed in the previous 
background/context chapter, there is an increasing ageing population with chronic 
diseases, with associated symptoms requiring appropriate measurement and 
management. (Chang, Hwang, Thaler, Kasimis, & Portenoy, 2004). Good symptom 
control has been identified by people at the end of life with the wish that they do not 
want to die in pain or distress, rating it higher than being at home or being with loved 
ones. (Demos, 2013). Little is known about symptoms at the end of life in the care 
home population, in terms of which symptoms occur and the presence and frequency 
of those symptoms. This review seeks to survey current and previous literature and to 
identify areas for future development in relation to current knowledge around end of 
life symptoms for residents in the final days of life, in the care home setting. A 
narrative or traditional literature review is a comprehensive, critical and objective 
analysis of the contemporary knowledge on a topic and helps to establish a theoretical 
context of the research (Onwuegbuzie, 2016). Onwuegbuzie (2016) define four 
common types of narrative reviews and this review will take the form of a general 
literature review, which is further defined as: 
“A review of the most important and critical aspects of the current knowledge 
of the topic. This general literature review forms the introduction to a thesis or 
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dissertation and must be defined by the research objective, underlying 
hypothesis or problem or the reviewer's argumentative thesis (Onwuegbuzie, 
2016, p.24-25).  
 
This type of systematic approach to reviewing has been widely discussed in other 
literature (Booth, Papaioannou, & Sutton, 2012; Hawker, Payne, Kerr, Hardey, & 
Powell, 2002; Khan, Kunz, Kleijnen, & Antes, 2003). The specific data extraction and 
evaluation methods presented by Hawker et al (2002) that are intended to aid 
researchers who are planning to undertake a systematic review of disparate material 
was adopted. This method was selected because, although the traditional method of 
systematic review is well accepted in health-related research, this method has the 
capacity to reduce large quantities of data into palatable pieces for digestion, 
particularly if there is qualitative research incorporated in the review (Dixon-Woods 
& Fitzpatrick, 2001).  While the general approach to a systematic review identified by 
Booth et al (2012) was utilised to support the overall process, a step wise approach, 
using five steps identified by Khan et al. (2003) was incorporated as this provided an 
explicit and comprehensive framework. 
Step 1 - Framing questions for a review  
Step 2 - Identifying relevant work 
Step 3 - Assessing the quality of studies 
Step 4: Synthesising the evidence 




3.2 Framing the research question 
To construct the search strategy, the PICO Framework (Huang, Lin, & Demner-
Fushman, 2006) was used to articulate the research question (P - patient, problem or 
population; I - intervention; C - comparison, control or comparator; O – outcome), 
which supports an improved query formulation and better search. Although there can 
be a risk of losing the subtle relationships between concepts with this method, the use 
of PICO may be given a broader application by combining the most relevant items. 
Table 3.1 highlights the use of PICO to formulate the research question. 
 
 




P - patient, problem or population End of life care for older residents in care 
homes in the final days of life 
I – intervention Observation 
C - comparison, control or 
comparator 
None 
O – outcome Knowledge of symptom prevalence in 
terms of presence and intensity 
 
As a result, the research question was developed – ‘What is the presence and frequency 
of symptoms in residents dying in care homes during the final days of life?’  
 
3.3 The search and search strategy 
3.3.1 Search methods 
The electronic databases searched from January 1990 to April 2014 were PubMed, 
CINAHL (Cumulative Index to Nursing and Allied Health), BNI (British Nursing 
Index), AMED (The Allied and Complementary Medicine Database), EMBASE, Web 
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of Science and the NHS Evidence database. An updated search was conducted in 
January 2018. A three-part search strategy was established based on headings from the 
Medical Subject Headings (MeSH) of the National Library of Medicine and identified 
key words (Table 3.2). 
 
Table 3.2 - Search strategy keywords 
Search term part 1 ((“Assisted Living Facilities” [MeSH term] OR “Nursing 
Homes” [MeSH term] OR “Residential Aged Care” 
[MeSH term] OR “Homes for the Aged” [MeSH term]) OR 
“Long Term Care” [MeSH term]) OR (“Care Home*” 
[Key word] OR “Nursing Home*” [Key word] OR “Long 
Term Care*” [Key word] OR “Long Term Care Facilit*” 
[Key word])) 
 AND 
Search term part 2 ((“Palliative Care” [MeSH term] OR “Terminal Care” 
[MeSH term] OR “Hospice Care” [MeSH term] OR 
(“Advanced” [Keyword] OR “Life Limiting” [Key word] 
OR “Hospice” [Key word] OR “Palliative” [Key word] OR 
“Supportive” [Key word] OR “End Stage” [Key word] OR 
“Severe” [Key word] OR “Terminal” [Key word] OR 
“Death” [Key word] OR “Dying” [Key word])) 
 AND 
Search term part 3 ((“Outcome Assessment” [MeSH term] OR 
“Measurement” OR “Assessment” [MeSH term] OR 
“Symptom” [Key word] OR “Symptoms” [Key word])) 
 
The search was supplemented by reviewing the reference list of the identified studies 
for any further relevant citations not obtained from the electronic databases. A cited 
literature search was completed using Web of Science on the final articles that were 
included in the review. Finally, a grey literature search was performed through a search 
of conference abstracts, dissertations and theses and appropriate websites. All 
references were saved to EndNote®. The titles and abstracts of the studies were 
reviewed against inclusion and exclusion criteria (Table 3.3) and studies excluded that 
were not relevant. If there was doubt about the content of a study due to an incomplete 
or unclear abstract, the full study was obtained and reviewed. Finally, the full text of 
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studies were obtained and reviewed on the basis of their relevance to the inclusion 
criteria. The reasons for excluding any studies were recorded for the sake of 
transparency and subsequent reporting. The review was carried out by the researcher 
(LP). 
 
3.3.2 Inclusion and exclusion criteria 
The inclusion and exclusion criteria were established to identify studies involving the 
reporting/observation of symptoms in residents in the final days of life in nursing/care 
homes (Table 3.3). The nature of the study around end of life presented a particular 
challenge and the inclusion/exclusion criteria needed to be sensitive enough to 
represent this. A difficulty when studying end of life is that end of life can only be 
identified after it has occurred, so has to also identify aspects that could lead to end of 
life. This is a similar issue when trying to identify end of life symptoms, however, it 
is possible to include symptoms that did not result in death, i.e., preventable events 
that did not lead to the person dying.   
 




Language - English 
Care/Nursing Homes 
Age ≥ 65 




January 1990 – to date 
Language - Non-English 
Acute/Hospital, Primary Care, Hospice 
Age < 65 
Symptoms7 during events not resulting in 
death, such as urinary tract infections, or 
falls 
Review articles 
                                                          
9 A symptom was not pre-defined for the literature review in order to capture the potential breadth and 
range of different symptoms. Had certain symptoms been named and searched for specifically, there 
was a risk that some symptoms may have not been captured. Any paper which included symptoms (as 





3.3.3 Study characteristics 
The database searches, along with hand searching and grey literature yielded 1685 
potentially relevant articles after duplicates were removed. This resulted in 25 articles 
being included in the review. See PRISMA flow diagram (Figure 3.1) and Table 3.4 
































































































Articles assessed (titles and abstracts) 
(n = 96) 
Articles excluded not relevant 
based on title (n = 1594) 
Full-text articles assessed for eligibility  
(n = 45) 
Articles excluded not relevant 
based on abstract (n = 51) 
Articles included in literature review  
(n = 25) 
 
Duplicates removed (n = 247) 
Articles excluded - not relevant       
(n = 20) 
Articles identified in databases (n= 1937) 
- Medline (n = 868) 
- Cinahl (n = 298) 
- EMBASE (n = 170) 
- Web of Science (n = 553) 
- British Nursing Index (n = 21) 
- Citation searching (n = 17) 
- Additional articles identified through other   
sources (n = 10) 
 
Articles after duplicates removed  
(n = 1690) 
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3.4 Assessing the quality of the studies 
The 25 final selected studies were reviewed to ensure that they met the research 
question and the selection criteria. The selection criteria included the minimum 
acceptable level of design (empirical studies). The studies were then subjected to a 
quality assessment, using the Hawker et al (2002) review framework. This framework 
permits the appraisal of either qualitative or quantitative studies, or specifically, a 
combination of both, as it was anticipated that dual type articles were likely to be 
found. Additionally the quality appraisal enabled consideration of heterogeneity across 
the studies and whether a meta-analysis would be possible. It also helped to identify 
the strength of the studies to understand their value when making recommendations 
for future research.   
 
During data extraction each study was reviewed using the appraisal tool by Hawker et 
al. (2002) (see Appendix ii). This was utilised to support a consistent approach to the 
review of the evidence. This also included a scoring protocol (see Appendix iii). The 
latter was applied to calculate a total score for each article.  There were a total of nine 
questions with marks to be allocated as 10 (very poor), 20 (poor), 30 (fair) to 40 (good), 
which would result in each article being allocated a total out of 360 marks. The scores 
for the studies within this literature review ranged from 160-340 the scores can be 
found in Table 3.4.  
 
3.5 Synthesising the evidence 
Narrative reviews have a wide scope and non-standardised methodology, therefore 
their breadth, depth and time range will vary and do not follow an established 
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procedure. To enable transparency, the process undertaken to synthesise the evidence 
will be described here before moving on to present an overview of the findings prior 
to the discussion.  
 
The final selected studies were read in full several times for familiarisation. Once this 
had been completed, each articles was scrutinised further, and notes were made about 
each study within an Excel spreadsheet. These notes were also able to incorporate the 
notes that had been made during the quality review. This enabled common themes to 
be observed, recorded and compared across the different articles/studies. The themes 
had to be revised several times and articles had to be revisited and revised to assess 
how they fit in with any new emerging themes. An early observation of the evidence 
showed a lack of homogeneity within the literature, which consisted of both clinical 
and methodological diversity leading to statistical heterogeneity meaning that a meta-
analysis could not be carried out (Eysenck, 1995; Russo, 2007). A meta-synthesis 
approach was also considered as this would enable qualitative methods to synthesise 
existing qualitative studies to create meaning through an interpretative process (Erwin, 
Brotherson, & Summers, 2011). However, the lack of consistency between qualitative 
and quantitative methods within the literature also prevented this. As a result, rather 
than presenting a meta-analysis or a meta-synthesis, each study was analysed and 
presented individually to investigate how the clinical and methodological aspects of 
studies related to the research question (Higgins et al., 2019). Thus the common 
elements of the studies were presented as themes and are listed below and will be 
presented in the following section: 
 Geography and demographics 
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 Care contexts 
 Nature and type of studies 
 Data collection time period and time points 
 Data collection instruments/methods 
 Data sources 
 Type and prevalence of symptoms 
 Influence of associated diagnoses 
 
The 25 articles resulting from the literature review can be found within a summary 
table (Table 3.4). This table provides an overview of the literature including author, 
year, country of origin, setting, study size, type of respondent, overview, aim of study, 
study design, the number of symptoms reported on, and the overall score derived from 
Hawker et al. (2002) critical appraisal tool. 
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Brandt et al 
(2005) 
The Netherlands 
Nursing Homes 516 Nursing Home 
Physicians 
To identify resident 
characteristics, symptoms, 
direct causes and incidence of 




1 time point within 6 
weeks of death 
26 (plus one 
open) 
310 
Brandt et al 
(2006)  
The Netherlands 
Nursing Homes  463 Nursing Home 
Physicians 
To identify the direct causes 
of death and to evaluate the 
presence of burdensome 
symptoms in last 2 days of life 
Prospective 
observational study 
2 time points within 2 
days of death (0 - 24hrs 
and 24 - 48hrs) 
15 330 






325 Family and staff 
care givers 
To evaluate the relationship 
between pain, dyspnoea (sic) 
and family perceptions 
Retrospective 
interviews 
1 time point within 1 
month of death 
2 300 








To identify EoL symptom 
experience of residents 
After death in person 
interviews 
1 time point within 1 
week of death 
11 260 








To describe if people with 
dementia die peacefully and 





1 time point. Unspecified 
period of time 
9 330 





141 Clinical and 
nursing records 
To describe the last month of 
life and clinical decisions in 




1 time point within 1 
month of death 
12 320 
Estabrooks et al 
(2015) 
Canada 
Nursing Homes 3647 Minimum Data 
Set information 
Compare symptoms at EoL 
for those with and without 
dementia and look at care 




Up to 4 time points 
within 12 months of life. 
The final time point was 
within 3 months of death 
6 310 










To examine perspectives of 





1 time point within 3 
days of death 
3 250 




185  Nursing records To focus on the last 48 hours 
of life of residents 
A retrospective chart 
audit 
1 time point within 2 









674 Staff and family To describe EoL symptoms of 




1 time point within 1 
month of death 
4 300 
Hendriks et al 
(2014) 
The Netherlands 
Nursing Home 330 Physicians To look at prevalence and 
course of pain, agitation and 




1 time point within 1 
week of death 
3 330 
Hermans et al 
(2017) 
Belgium 
Nursing Home 109 Nurses and 
nursing 
assistants 
To describe palliative care 
needs and symptoms and 




1 time point with 12 










55 Physicians To explore characteristics 




Up to 6 time points 
within 6 months of death 
(1 time point within 1 





Nursing Homes 117  Residents, staff 
and family 
Investigate process of 
providing EoLC to residents 




Unknown 1 250 
Klapwijk et al 
(2014) 
The Netherlands 
Long Term Care 
Facilities 
24 Elderly Care 
Physicians 
Describe symptoms and 
treatments when death is 




Up to 4.3 time points 
within 5 days of death 
23 300 




263 Nursing staff  Audited the use of an EoL 
Integrated Care Pathway 
Retrospective pre-
audit and post-audit 
1 time point within “few 












Describe and Compare EoL 




1 time point within 120 
days of death 
12 340 





45  Registered 
Nurses 
To describe profile of dying 
resident 
Retrospective case 
note review with staff 
who had completed 
them 
2 time points (a varied 
‘initial’ assessment and 
‘final’ assessment, no 
specific times given) 
5 240 






125  Families To assess symptom prevalence 
of chronically ill 
Retrospective random 
cross sectional survey 
1 time point within 2 













To describe the pall care needs 
of dying NH residents 
Retrospective 
structured interviews 
1 time point within 3 
months of death 
9 300 
Rodiguez et al 
(2010) 
United States 
Nursing home  303  National 
Nursing Home 
Survey (NNHS) 
To evaluate prevalence of 
under-treatment of non-pain 




1 time point within day 
of death 
5 330 
Sandvik et al 
(2016) 
Norway 




To determine signs of 
imminent dying and change in 




2 time points (last year 








581  Nursing staff 
and families 
To understand the experiences 
and potential unmet need 
After death 
interviews 
1 time point within 1 
month of death 
5 300 





48  Dyads of nurses 
and staff 






1 time point within 3 







102  Medical and 
nursing records 
and nurses 
To measure the burden of 






1 time point within 3 




3.5.1 The geography and demographics of the different studies 
There were 25 articles included in the review, and the majority of these were carried 
out in the United States (n = 8) and the Netherlands (n = 7). Apart from Canada (n = 
3), and Norway (n = 2), all other countries (Belgium, Italy, Germany and South 
Australia) only had one published study each.  The only study published in the UK 
was carried out in South Wales. The studies were published between 1999 and 2017: 
there were no studies published between 2017 and January 2018, when the search was 
updated. There was a cluster of studies published between 2002 and 2010 (n = 18) 
equating to 70% of the total; however, from 2010 to the updated review in January 
2018, there have only been a further seven published studies despite the comparable 
time periods. In relation to the location of publication, 11 studies were published in 
journals with a gerontological focus, nine were published in those with a palliative care 
focus, and the remaining five in general publications (for example, general medicine 
and cancer care). Although 18 of the publications were in internationally orientated 
journals, half of those (n = 9) were in American publications, possibly reflecting the 
higher proportion of American studies included in the literature review. 
 
The range of ages within the study populations were 76.8 - 88 years with the mean 
across all studies was 83.5 years. The proportion of females outweighed males in every 
study except one (Veerbeek, van Zuylen, Swart, van der Maas, & van der Heide, 2007) 
with a median percentage of 66.5% (range 45 - 81%). 
 
The length of time spent in the care home was only reported explicitly in eight studies 
and ranged from 1.2 years to 4 years (mean 2.79 years). 
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3.5.2 Mixed care contexts 
Three studies (Cartwright et al., 2005; Pinzon, Claus, Zepf, Fischbeck, & Weber, 2012; 
Veerbeek et al., 2007) present comparison studies and identified a mixed population 
from a number of different settings. These were included as the care home results were 
reported on separately from the other settings, enabling the care home data to be 
extrapolated from the wider results. 
 
3.5.3 Nature and type of the studies 
All studies focussed on the observation of symptoms although this was not always the 
primary purpose that the study had set out to achieve. For example, one study was an 
ethnography to observe end of life care in nursing homes (Kayser-Jones, 2002) while 
another was investigating the possibility of being able to determine imminent dying 
(Sandvik, Selbaek, Bergh, Aarsland, & Husebo, 2016). As a result, they can be 
classified broadly into three types of approaches:  
1. Primary measurement/observation of symptoms for the purpose of the study 
2. Where the measurement/observation took place within a broader context, so 
that the purpose of the study was not primarily concerning symptoms, but still 
included a direct observation 
3. Indirectly collected data that used data to provide information about symptoms 
 
This links closely to whether the data in the studies were collected prospectively (at 
the same time as the resident was dying) (n = 7) or retrospectively (following the death) 
(n = 17). One study (De Roo et al., 2014) included both retrospective and prospective 
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data collection, with physicians collecting information both before and after death, 
although families were sent questionnaires to complete only after the death occurred. 
 
In the eight studies that collected data prospectively (although one of these studies 
collected both retrospectively and prospectively), there were processes set up to 
systematically collect data about residents in the final period of life, and track them 
until death. Six studies utilised a direct reporting system (Brandt et al., 2005; Brandt 
et al., 2006; De Roo et al., 2014; Klapwijk, Caljouw, van Soest-Poortvliet, van Der 
Steen, & Achterberg, 2014; Sandvik et al., 2016) with physicians completing agreed 
protocols for data collection. Kayser-Jones (2002) used an ethnographic approach, and 
reported on one observed symptom from the fieldwork (pain). Jordhoy et al. (2003) 
extrapolated data from a study that prospectively recorded symptoms using the 
EORTC QLQ-C30 questionnaire, and Estabrooks et al. (2015) used a Minimum Data 
Set with prospectively recorded data. There appears to be a trend in the mode of data 
collection as five of the most recent six studies have used prospective data while the 
older studies mainly use retrospective data. 
 
Eighteen studies presented data that had been collected retrospectively (as mentioned, 
one included retrospective and prospective data). Eight of these used interviews with 
staff or family members as a method of data collection, five used case notes or medical 
records reviews, and five interrogated existing data sets for their information. Two 
mixed-methods studies were conducted, with van der Steen, Gijsberts, Knol, Deliens, 
and Muller (2009) utilising questionnaires for families and interviews for nurses and 
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Veerbeek et al. (2007) presenting a case note review which incorporated a 
questionnaire for nurses to ask for their recall on the symptoms. 
 
3.5.4 Proxy data collection 
All studies were informed by data collected from proxies who were either 
professionals or families, or through established data sets, such as Minimum Data Sets 
or case notes. No study was devised specifically to collect symptoms on residents at 
the end of life. 
 
3.5.5 Data collection instruments/methods  
Across the 25 studies, eleven studies reported that they had used existing instruments 
to collect data, and 14 had developed alternative approaches. These alternative 
approaches included producing a list of symptoms, adapting an existing instrument by 
adding questions or undertaking interviews (Table 3.5). Of those who had used 
existing instruments (Table 3.6), their psychometric properties were mentioned in nine 
of the ten studies; however, this was very brief and usually limited to one or two lines. 
The focus of the instruments varied: some were concerned with measuring symptom 
experience through symptom assessment (ESAS: Brandt et al. (2006)) whilst others 
(QOD-LTC: De Roo et al. (2014), EORTC QLQ-C30: Veerbeek et al. (2007)), 
collected symptoms as a method of measuring quality of life. This may contribute to a 
variation within the results from the studies. Some studies overstate the properties of 
the instrument, such as reports of the instrument being ‘reliable and valid’ despite the 
instrument not having been validated in care home settings (Brandt et al., 2006; 
Cartwright et al., 2005; Jordhoy et al., 2003; Sandvik et al., 2016). However it should 
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be acknowledged that word limitations in a journal may have prevented any detailed 
discussion.  
 




Brandt et al (2005) List of 25 symptoms developed for study plus one ‘open’ symptom 
Di Giulio et al (2008) Collected from records when recorded 
Estabrooks et al (2015) Collected from records when recorded 
Goodridge et al (2005) Semi-structured interviews – thematic analysis 
Hall et al (2002) Audit tool developed for study 
Hanson et al (2008) Interview that included a question about four identified symptoms 
Hendriks et al (2015) Physician assessments 
Kayser-Jones (2002) Observation, followed up with interviews 
Knight (2007)  Items from the Integrated Care Pathway (ICP) 
Mitchell (2004) Various instruments specific to MDS (symptoms are an ‘item’ on 
the MDS) 
Parker & De Bellis 
(1999) 
An assessment instrument was developed by the research team for 
study 
Reynolds et al (2002) Interview questions developed for study following a literature 
review which generated closed ended questions 
Rodiguez et al (2010) Reviewed symptoms and medications from existing data set of data 
(National Nursing Home Survey) 
Sloane (2008) Interview questions developed for study 
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Table 3.6 - Studies that used existing instruments for data collection 
Study 
 
Instrument used Discussion of psychometrics 
Brandt et al (2006)  
 
Edmonton Symptom Assessment Scale (ESAS) & Resident 
Assessment Instrument MDS – Palliative Care (RAI-MDS-PC) 
Not discussed although refers to ESAS as “validated” – not 
referenced to NH setting 
Caprio et al (2008) 
 
Quality of Dying in Long-Term Care (QOD-LTC)- a uni-
dimensional measure for psychosocial aspects of the quality of 
dying plus 2 identified symptoms (pain and dyspnoea) 
Describes QOD-LTC as a psychometrically sound for 
psychosocial aspects 
Cartwright et al 
(2005) 
28 - item guide, Family Memorial Assessment Scale-Global 
Distress Index (FMSAS-GDI) 
Describes FMSAS-GDI as reliable and validated – not 
referenced to AL setting 
De Roo (2014) 
 
Quality of Dying in Long-Term Care (QOD-LTC) – a uni-
dimensional measure for psychosocial aspects of the quality of 
dying plus Symptom Management – End of life Dementia (SM-
EOLD) 
Not discussed – not referenced to LTC  
Hermans (2017) Palliative Outcome Scale Refers to validation studies in specialist palliative care in the 
UK 
Jordhoy et al (2003) European Organization for Research and Treatment of Cancer 
Quality of Life Core Questionnaire (EORTC QLQ-C30) 
“Practical and valid in measuring quality of life in patients 
with advanced disease” 
Klapwijk et al 
(2014) 
Mini-Suffering State Examination (MSSE), End-Of-Life in 
Dementia-Comfort Assessment in Dying (EOLD-CAD), DS-DAT, 
PAINAD 
Some discussion 
Pinzon (2012)  
 
Adapted the Hospice and Palliative care Evaluation (HOPE) by 
adding symptoms 
Original instrument validated for use in evaluation of 
symptom intensity in pall care setting, however, no testing has 
been done since adaptation 
Sandvik et al (2016) Edmonton Symptom Assessment Scale (ESAS), Cognitive Staging 
Tool (CDR), Karnofsky Performance Scale (KPS), Mini-Suffering 
State Examination (MSSE), Mobilization-observation-behavior-
intensity-dementia-2 Pain Scale (MOBID-2), Physical Self-
Maintenance Scale (PSMS), Residents Assessment Instrument for 
Palliative Care (RAI-PC) 
Each item briefly discussed 
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Van der Steen et al 
(2009) 
 
End of Life in Dementia (EOLD) Scale which includes: 
Satisfaction with Care (SWC) Symptom Management (SM) and 
Comfort Assessment in Dying (CAD) 
Discusses good psychometric properties when completed by 
nurses using interviews 
Veerbeek (2007) 
 
Adapted from  European Organization for Research and Treatment 
of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30) 
– 6 symptoms, then added additional 5 “because these symptoms 
are common” 
Validity of adapted questionnaire was evaluated in face to face 
interviews with 4 nurses 
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5.5.6 Time periods and time points of data collection within the studies 
The timeliness of the data collection within the studies were seen in two different 
aspects: the time period over which the data were collected and whether the studies 
collected single or multiple episodes of symptom prevalence.  
 
All studies set out to consider symptoms towards the end of the resident’s life. As 
discussed in the background chapter, and as expected, the terminology was different 
across the studies and included “terminally ill”, “last days of life”, “dying”, “end of 
life care” and “when death is expected”. However, the period of time that was captured 
also varied from study to study with no concurrence as to what period of time 
constitutes the end of life. These time spans ranged from a few hours (Knight and 
Jordan, 2007) up to the last year of life (Estabrooks et al., 2015; Sandvik et al., 2016). 
Within four studies, the period of assessment time was unknown or unclear as the time 
frame was not specified (Kayser-Jones, 2002; Rodriguez, Hanlon, Perera, Jaffe, & 
Sevick, 2010) or the study referred to “final days” (Cartwright et al., 2005) or “end of 
life” (De Roo et al., 2014). Only four studies (Brandt et al., 2006; Estabrooks et al., 
2015; Jordhoy et al., 2003; Klapwijk et al., 2014; Parker & De Bellis, 1999; Sandvik 
et al., 2016) carried out longitudinal studies, to capture data at different points of the 
resident’s dying trajectory to compare changes over time. However, the gaps between 
data collection points were varied and few captured data consistently either over the 
final few days of life, or within the final hours of life. Klapwijk et al. (2014) was the 
only study to have collected data at multiple time points over the final days of life with 
a mean number of observations of 4.3 (SD 2.6).  Sandvik et al. (2016) took a broader 
approach and followed residents during the first year after admission and in their last 
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days of life (day perceived as dying and day of death). To emphasise this variation, 
Table 3.7 uses a timeline to show the time span where data collection occurred within 
the studies. Not all studies provided this information and within some studies, generic 
terminology such as “few hours” or “end of life” were used and these can be found at 
the end of the table. 
 
 
Table 3.7 – Time periods and time points of data collection across the studies 
Study 
 
Studies with a single time point 




















Brandt et al (2005)       x    
Caprio et al (2008)      x     
Cartwright et al (2005)     x      
Di Giulio et al (2008)      x     
Goodridge et al (2005)   x        
Hall et al (2002)  x         
Hanson et al (2008)      x     
Hendriks et al (2014)     x      
Hermans et al (2017)          x 
Mitchell (2004)         x  
Pinzon (2012)   x         
Reynolds et al (2002)        x   
Rodiguez et al (2010) x          
Sloane (2008)      x     
Van der Steen et al (2009)        x   
Veerbeek (2007)   x        
 Studies with multiple time points 
 




















Brandt et al (2006)  x x         
Estabrooks et al (2015)      x  x x x 
Jordhoy et al (2003)      x x x x  
Klapwijk et al (2014) x x x x       
Sandvik et al (2016) x         x 
 Not specified 
 
De Roo (2014) Not specified (One time point - “End of Life”) 
Kayser-Jones (2002) N/A (Ethnographic study) 
Knight (2007)  Not specified (One time point - “Few hours to 14 days”) 





3.5.7 The range of different symptoms reported within the studies 
Across the 25 studies, a total of 90 different symptoms were identified and reported 
upon. Table 3.8 presents the range of most frequently reported symptoms across all of 
the 25 studies. When a symptom was reported upon in three or more studies, it is 
included in the list in the table below. Each symptom has the reported presence from 
the study in column three and this is presented as a summarised range, i.e., the highest 
and lowest reported presence from a study to demonstrate the wide variation within 
studies. When a symptom is called by a different name, but are clearly referring to the 
same symptom, they have been grouped together, but only where there is an undoubted 
defined relationship (using NHS symptom definitions), e.g., ‘difficulty swallowing’ 
and ‘dysphagia’. If the reported symptoms were potentially different, e.g., 
‘nausea/feeling sick’ and ‘nausea/vomiting’, they have been included separately. 
Symptoms that are reported on in one or two studies have been listed in the lower 
section of the table.  
 
Table 3.8 – The most frequently reported symptoms from all studies  
 
Symptom Reported in 
no of studies 






Pain 23 9 - 80 
Dyspnoea/shortness of breath/difficulty 
breathing 
19 8.2 - 93.3 
Anorexia/loss of appetite/lack of appetite 10 10.4 - 94.8 
Anxiety 9 2.8 - 54 
Constipation 9 8.1 - 60 
Fatigue/lack of energy/tiredness 9 52 - 99 
Agitation/restlessness 8 3.2 - 71 
Depression 7 9.1 - 48.6 
Difficulty swallowing/dysphagia 6 5 - 73 
Fever 6 3.1 - 64 
Nausea 6 0.9 - 30 
Pressure ulcer/decubitus ulcer 6 3.8 - 47 
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Nausea/vomiting 5 0.9 - 38 
Drowsiness 4 19 - 97.5 
Lung aspirations/troublesome mucus production/ 
noisy breathing/respiratory tract secretions  
4 1.8 - 39 
Vomiting/emesis 4 0.9 - 18.8 
Choking 3 0.7 - 16 
Diarrhoea 3 1.9 - 30 
Symptoms only reported in two studies: Calm,  Crying, Dry mouth, Fear,  Gurgling, Little/no 
nutrition intake, Moaning, Need for help with ADLs, Peace, Problems with cleanliness, Serenity 
Symptoms only reported in one study: Bed sores, Behavioural symptoms, Bleeding, Cachexia, 
Coma, Cough, Discomfort, Decreased activity, Dehydration, Difficulty coughing, Discomfort, 
Financial impact, General weakness, Hallucinations, Incontinence, Infections, Insomnia, 
Invasive action, Irritability, Malnutrition, Medication not successful, Myoclonus, Nervousness, 
Oedema, Overburden of family, Patient gives up, Pneumonia, Problems with organization of 
care, Refusal of food, Refusal of liquid, Refusal of medication, Restiveness to care, Sadness, 
Screams, Seizures, Severe somnolence, Skin breakdown, Somnolence, Sleep disturbance, Sub-
coma, Suffering, Tension, Unstable medical condition, Weight loss, Weakness, Well-being, 
Worry 
Five studies presented an undefined category where the symptom was not named - “other 




Table 3.8 has presented the wide range of symptoms reported across the 25 studies and 
this highlights the differences within the studies. The number of symptoms within a 
single study ranged from 1 - 27, with a mean of 9.1 symptoms across all studies, 
however the mode figure was one (with 37 symptoms only being reported upon once 
and 12 symptoms reported upon twice) resulting in a mean of 2.1 symptoms across all 
studies. Furthermore, four studies reported on ‘other’ or ‘rare’ symptoms, but did not 
name the symptom, although this may have been an unknown category taken from the 
original data source. Consequently, a wide spread of symptoms were presented, yet 
with little consistency between the studies. For example, pain was represented in 23 
out of 25 studies. Despite it being considered an important symptom to include in the 
overarching majority of studies, there was no explanation as to why it was omitted in 
other two. Equally, there was little discussion in most studies as to why any of the 
symptoms were included or excluded.  
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Pain was reported as the most prevalent symptom in the studies (n = 23), and in the 
study by Kayser-Jones (2002) and Hermans, Cohen, Spruytte, Van Audenhove, and 
Declercq (2017), it was the only reported symptom, although Hermans et al. did 
include an ‘other’ category. Dyspnoea was reported under three different, but 
consistently defined terms (dyspnoea, shortness of breath, difficulty breathing) (n = 
19) and presented with a wide range of reported prevalence. Anxiety was included in 
nine studies and had the lowest variation in range of prevalence (2.8 – 54%). Anorexia 
(loss of appetite/lack of appetite) was presented in 10 studies and had the narrowest 
gaps when it was measured within the same study. Fatigue (lack of energy/tiredness) 
occurred in nine studies and was found to have the widest variation in reported 
prevalence of between 3.2 - 92%. Within the symptoms that were less frequently 
reported upon the variations in the ranges get smaller (but this is most likely due to 
there being fewer studies to report on); however, drowsiness, which was only found in 
four studies had a wide variation of prevalence of between 19 - 97.5%. 
 
When reviewing the literature, a picture of great disparities started to become apparent. 
There was a wide variation of reporting within the studies, not only within the reported 
prevalence rate but also the range of symptoms included. In addition, some studies had 
included symptoms but had not documented the rates of occurrence (De Roo et al., 
2014; Estabrooks et al., 2015; Kayser-Jones, 2002; Reynolds et al., 2002; van der Steen 
et al., 2009). To demonstrate this heterogeneity further, pain as the most frequently 
reported symptom across the studies is considered and this permitted some of the 
noteworthy differences across the studies to be identified. 
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Pain had a reported variation in prevalence of between 11.5 - 86% within the 23 studies 
that included pain as a symptom. Some studies measured at more than one time point 
leading to a count of 27 different measurements/reports of pain. In addition, to the 
range of 11.5 – 86%, the mean was 43.72, the median was 44 and the mode 58. A 
standard deviation of 19.06 shows a wide spread of prevalence. 
 
At the upper end of the range, Reynolds et al. (2002) found that 86% of residents 
experienced pain, and although they report that this is undertreated in dying residents, 
their study used retrospective data from interviews regarding residents in the last three 
months of life, meaning that pain may have been present, but does not indicate for how 
long, how frequent or how near the very end of life it occurred. Parker and De Bellis 
(1999) measured two different time points prior to death, but there was no consistency 
between residents, making a comparison even between the individuals in the study not 
possible. They reported the presence of pain in 80% of residents but they went on to 
state that the nurses reported it as ‘usually’ controlled. This makes it difficult to convey 
whether the nurses were potentially over-assessing/over-treating residents as the study 
also identified that pain was a great source of conflict between nurses and GPs. 
Towards the lower end of the reported prevalence of pain, Mitchell, Kiely, and Hamel 
(2004) found that 11.5% of residents with dementia experienced pain during the 
‘dying’ phase, again, there was no specific time-point of measurement. Knight and 
Jordan (2007) conducted an audit examining the use of an Integrated Care Pathway 
(ICP). Their pre-audit prior to use of the ICP reported 17% of residents had pain; 
however in their post implementation audit, this dropped to 9%. As their project to 
implement the ICP also involved an educational element within care homes, this 
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finding may reflect by an improved awareness and assessment of residents’ pain, or a 
more regular recording of symptoms.  
 
 
3.5.8 The influence of diagnosis 
The main diagnosis of particular interest across the studies is dementia with eight 
studies (De Roo et al., 2014; Di Giulio et al., 2008; Hendriks et al., 2014; Hermans et 
al., 2017; Klapwijk et al., 2014; Mitchell et al., 2004; Sloane, Zimmerman, Williams, 
& Hanson, 2008; van der Steen et al., 2009) having a specific focus on it. Hermans et 
al. (2017) and Sloane et al. (2008) compared residents with a dementia diagnosis 
against those without and both found no differences between those who died in terms 
of pain; Sloane et al. (2008) reported less shortness of breath but an increased need for 
sedative use, while Hermans et al. (2017) reported fewer physical (unspecified) 
symptoms. Diagnosis alone does not impact upon the diversity of findings as both 
Sloane et al. (2008) and Mitchell et al. (2004) reviewed residents with dementia, yet 
presented different findings for shortness of breath/dyspnoea (50.2 v. 8.2%). 
 
The diagnosis of cancer is incorporated into several studies, although only one study 
(Jordhoy et al., 2003) specifically focuses on it. This study compared those with cancer 
in a nursing home with other care settings, but found symptom prevalence similar to 
other end of life care home studies, including those that did not specifically identify 
cancer. This is supported by Veerbeek et al. (2007), who showed little difference in 





3.6 Discussion - Interpreting the findings 
This literature review identified 25 studies and despite being very specific with 
inclusion and exclusion criteria, located a very diverse group of studies. There are a 
number of reasons that are liable for this finding. These are variations in the definition 
of symptoms; different time periods and time points of data collection; different data 
sources; different instruments used for data collection; variations in the nature and type 
of symptoms included in the studies, and different countries of origin of the research. 
The following section will explore these reasons while discussing the articles that have 
been reviewed.  
 
 3.6.1 Data points within the data collection period 
Symptom prevalence over a time period needs to be a consideration in addition to one-
off incidents, to help understand the process of dying in the older person rather than 
viewing it as a one point measurement. Any changes or fluctuations in symptoms are 
as important as the incidence and the patterns can help establish trends to assist with 
symptom management. Some will be recorded from notes, ‘as it happened’; others will 
have only considered if a symptom was present at the time of completing a quarterly 
report (for example, when using Minimum Data Sets). This could result in a resident 
experiencing a symptom constantly for a month, but if they were symptom-free at the 
time of reporting, it would have been missed. Conversely, a resident may have 
experienced a symptom on a single occasion, but has been assumed as ‘present’ for 




Knowing when to commence data collection requires the interpretation of when end 
of life care commences. Again, this review highlighted a wide range of data collection 
points. This varied from a single point in 19 studies to six studies that had between two 
and six data points. Even when reviewing the studies with multiple data points there 
was a wide variation in relation to the time before death that these were collected, 
ranging from within the final 24 hours to within the last 12 months of life. Notably, 
there appears to be a changing trend to conduct studies with time point data with three 
out of the four most recent studies (Estabrooks et al., 2015; Klapwijk et al., 2014; 
Sandvik et al., 2016) taking this approach. Time point data collection, especially when 
aiming to collect data within the very final few days of life, adds an additional 
difficulty around recognising the point at which to start data collection. This is more 
evident in frail older residents whose dying trajectory may be a slower decline over a 
period of weeks and months or sometimes longer in residents with dementia. The 
difficulty in prognostication may be one reason why it is difficult to collect regular 
data on symptoms. The review included studies focussing on the last period of life 
which has ‘cut off’ residents at earlier points of life where greater differences may 
have been found. It is also likely to be a reason why prospective data collection is more 
difficult and why fewer studies employed this approach.  
 
Retrospective data collection methods were used in 18 studies (one study used both). 
This can reflect the challenges of collecting information prospectively, but the 
challenge then becomes how the symptoms are identified after the event. Retrospective 
data collection relies on impeccable measurement at the time, and well-documented 
notes from which to be able to extrapolate the information afterwards. In the case of 
interviews, a reliable memory of events is needed when interviews are carried out up 
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to several weeks or months after a death. This results in secondary data, with a further 
level of interpretation by the researchers. Fewer prospective studies are carried out, yet 
these can avoid certain potential bias.  
 
3.6.2 Different types of data sources 
Across the studies, there was a variety of different data sources which utilised either 
data collected directly from respondents or derived from records, with one study 
(Veerbeek et al., 2007) using both. Six studies used data from records, these included 
Minimum Data Sets (Estabrooks et al., 2015; Mitchell et al., 2004), National Nursing 
Home Survey (Rodriguez et al., 2010) and the others accessing nursing and/or medical 
records for information. The majority of studies used healthcare professionals within 
either prospective or retrospective data collection. The most common way of gaining 
this information was from interviews for retrospective data and direct observation for 
prospective data. The studies that involved families all used retrospective data, which 
apart from one study (Pinzon et al., 2012) involved interviews with invited 
participants. When family members are asked to opt-in for research purposes, there is 
potentially an element of self-recruitment of people who have experienced more 
emotive situations; for example, those who perceived that their family member died in 
distress or in pain may be more likely to participate and add bias to the overall results. 
 
All studies used proxy reporting - with no study using self-reporting methods. This is 
less surprising given the timing of the research at end of life even though symptom 
experience has a high level of subjectivity. However it is unclear whether some of the 
data from data sets may have been self-reported, especially in the studies that were 
 82 
 
collecting data several months prior to death. Proxy reporters were either professionals 
or families. Although families can contribute as a reliable proxy for the resident, 
professionals can provide consistent assessments especially for the measurement of 
physical symptoms. 
 
Another difference across the studies was the method of measurement of the 
symptoms. Eleven studies used validated instruments (although not validated with a 
care home population) and 14 used other measures. Of the 11 studies using 
instruments, four used between two and seven different instruments (with seven using 
just one). Furthermore many of the instruments had been modified for the purpose of 
the study: as an example, Caprio et al. (2008) and De Roo et al. (2014) both used the 
QOD-LTC (Quality of Dying in Long-Term Care) instrument, but while Caprio et al. 
(2008) added two symptoms, De Roo et al. (2014) added six symptoms. This has an 
impact upon any validation of instruments; however, as identified earlier, the 
psychometric properties of instruments were not discussed in detail within the 
literature. It can be noted, though, that care home research has few high quality 
instruments to improve comprehensive assessment of symptoms (Ellis-Smith, 
Higginson, Daveson, Henson, & Evans, 2018; Etkind et al., 2015) resulting in the 
reliance on instruments validated with other populations, if and when these are used.  
The most recent study of the review, Hermans et al. (2017), used the Palliative care 
Outcome Scale (POS) (Cicely Saunders Institute, 2018). The POS was originally 
validated in 1999 (Hearn & Higginson, 1999) and has been used extensively and 
validated in many settings, disease groups and languages. Although Hermans et al. 
(2017) identified that it is suitable for evaluating palliative care needs and symptoms 
of people with and without dementia, it was not validated in a care home population 
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even though up to 75% of residents are likely to have dementia in care homes (Public 
Health England, 2017a). The POS is also available in a version to be completed by 
staff, although this was not used by Hermans et al. (2017), which may have been an 
appropriate approach given the population and lack of ability of residents to self-
report. Sandvik et al. (2016) in the second most recent study, used the Edmonton 
Symptom Assessment Scale (ESAS) (Bruera, Kuehn, Miller, Selmser, & Macmillan, 
1991) which was also used by Brandt et al. (2006). The ESAS had been used and 
validated for proxy-rating but had not been used with dying patients with dementia 
(Murray, Sachs, Stocking, & Shega, 2012) despite its use in their study. 
 
3.6.3 Variations in the definition of a symptom  
Within the literature review, 90 different symptoms were identified across the 25 
studies, although with many of them occurring only once or twice. There appeared to 
be a lack of consensus to what constitutes a symptom, which in turn leads to a wide 
number of potential symptoms included in studies resulting in a lack of harmony in 
measuring and reporting methods. Furthermore, it means that a meta-analysis of 
studies becomes unfeasible due to these variations. All studies included symptoms 
individually but did not look at overall symptom load. If this approach had been 
utilised in studies, it may have facilitated a type of meta-analysis or an assimilation of 
findings to have been carried out.  
 
Symptoms when considered individually and in their broadest sense, may be physical, 
psychological, spiritual and social and many studies addressed a core set of physical 
symptoms, but a range of other symptoms were included that often did not seem to fit 
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the usual expectations. Reviewing the list in Table 3.4, some examples of these 
symptoms include overburden of family, problems with organisation of care, patient 
gives up, need help with ADLs (Activities of Daily Living). As well as this broad 
interpretation of a symptom, some items that appeared to be more concept-like were 
included, such as peace and serenity. Certain symptoms do have a universal 
application, such as pain, although ‘discomfort’ could be considered a variation of 
pain. Others such as shortness of breath, may have obviously allied medical 
terminology i.e., dyspnoea. Some symptoms are much less apparent in their meaning, 
such as wellbeing, tension and serenity. There are particular challenges in assessing 
some of these concepts and even more so in reaching a consensus. Even when 
symptoms were consistent in their presence across studies, there was no consensus 
over the frequency and intensity. For example, pain was included in most studies, yet 
had one of the widest reported ranges. As a result, defining the symptoms alone is not 
enough and requires agreement about the application of the definitions as well. 
 
The range of symptoms reported did not appear to be related to the study design nor 
the size of the study population. Potentially, a larger number of symptoms may have 
had to be collected when reviewing notes retrospectively due to the need to broadly 
interpret notes or records, but this has not ensued as prospective studies presented with 
a range of symptoms from 1 - 26, while retrospective studies offered a range of 
symptoms from 3 to 16. Prospective studies faced with real life decisions may have 
found it harder to categorise the symptoms, hence the increased range of symptoms. 
There is a link between the symptoms and the instrument used for the study and this 
will be addressed later. Despite the wide range of symptoms that were addressed, the 
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majority of symptoms reported upon did have a physical focus and these will be 
discussed in the next section.  
 
3.6.4 Variations in the type and nature of symptoms 
The most commonly reported upon symptoms were predominantly physical ones. Pain 
was included in 23 studies and dyspnoea was reported in 19 studies. There was a big 
gap between the next group of symptoms with anorexia included in ten studies and 
anxiety, constipation and fatigue found in nine. Another influence on the type of 
symptoms may have been due to the profession of the person conducting the data 
collection. Most measurements were conducted or supported by medical personnel and 
physical symptoms may have been viewed as a priority, but may also be considered 
easier to measure, given that residents were at the end of life, and usually unable to 
self-report. Physical symptoms may also have been measured more frequently as 
management pathways are viewed as clearer and the response to the management can 
be monitored more readily.  
 
The types of symptoms that are assessed are often based on those that may be 
commonly expected to be seen in acutely ill residents. This could be because cancer 
care has had a high profile within recent years and as a result, many symptom 
assessment instruments have their origins in cancer care. These symptoms, such as 
pain, have a very high profile and a high emotional value, which often places it in the 
forefront of the mind of the professional (and the public). This is supported by Kirkova, 
Rybicki, Walsh, and Aktas (2012) who report that pain is well studied and 
characterised, and that a better understanding of other symptoms is required.  This can 
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be further highlighted by considering the four symptoms that were identified in the 
Liverpool Care Pathway (LCP) specifically for end of life care. Although the LCP is 
no longer in use, three of the four symptoms that were included other than pain, i.e., 
nausea, agitation and secretions have not had a high presence reported within the 
studies in this literature review. The symptoms within the LCP, although there is no 
literature to discuss why these symptoms were included, were likely to have been 
influenced by its introduction into palliative care through hospice care, so had a strong 
cancer diagnosis emphasis. 
 
3.6.5 Effect of country of origin of the study 
The system of Long Term Care in different countries can influence the provision of 
care within care homes/Long Term Care facilities and have a potential impact upon 
the studies that emerge. The largest number of studies were carried out in the USA (n 
= 8), followed by the Netherlands (n = 7) and the demographic profiles of residents 
reported across the studies have a great deal of similarities, suggesting that there is 
parity between residents from different countries despite the studies having a fairly 
broad international spread. One explanation for the greater numbers of studies coming 
from the USA and the Netherlands could be a higher presence of medical 
staff/physicians as many of the articles that originate from there are authored by 
physicians. The Netherlands is the only country to have nursing home medicine as a 
specialty and the USA has a level of care that is closer to hospital provision with in-




As with several other countries there was noted to be a paucity of literature that 
emerged from the UK with only one study authored by nurses (Knight & Jordan, 2007) 
being included in the review. Care homes in the UK have a less well integrated service 
and are supported by GPs with considerable input from nursing professionals. This is 
reflected by findings from Goodman et al. (2016) whose literature review from the UK 
showed less published research about medical management than most other topics. 
 
3.7 Limitations 
This review was carried out in a systematic way to ensure that no studies were missed. 
Only studies published in the English language were included, which potentially 
excluded other relevant studies. There was a specific focus on care homes, so other 
studies that involved older people at the end of life were excluded. The literature 
review was conducted by a single researcher (LP) and although an additional reviewer 
is not mandated, working with a second reviewer may have added additional rigour to 
the process.  
 
3.8 Conclusion 
Due to the lack of homogeneity in inclusion criteria, study design, use of instrument, 
sample size and characteristics of the participants across the studies, the studies 
included within the literature review did not meet the criteria for a meta-analysis 
(Eysenck, 1995; Russo, 2007). However, it was possible to examine the relationships 





This literature review has identified five gaps in the research in symptom prevalence 
in care home residents at the end of life: 
 
1) Many studies have adopted a retrospective approach, although prospectively 
collected data are seen as the gold standard. There are challenges in recognising 
the start of the dying process for prospective studies, which makes 
retrospective data collection easier to manage. However, this relies on data 
collection after the occurrence of symptoms, sometimes by many months, and 
routinely uses notes recorded by a third party.   
 
2) The data are typically collected without using any form of instrument or data 
collection tool, or if instruments are used, they are frequently generic and 
unvalidated and are not specific to the purpose of assessing end of life 
symptoms in this population.  
 
3) There is a wide variation in which end of life symptoms are included across the 
different studies, resulting in inconsistent knowledge about the symptoms. 
Studies need to be able to capture the end of life symptoms that are most 
relevant for the care home population, yet there is little agreement as to what 
those are.  The main two symptoms that are reported upon in the majority of 
studies are pain and shortness of breath/dyspnoea. While these are important 
symptoms, there are a number of others that are commonly associated with end 
of life, such as consciousness, delirium, anorexia, fatigue and tiredness that are 
frequently unaddressed. In addition to the variation of symptoms that are 
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addressed within the literature, symptoms are only measured singularly and no 
studies attempted to consider overall symptom load or burden. 
 
4) The temporal aspects of symptom prevalence have received little attention in 
all but six studies, and even those do not have a wide span of time points. It is 
important to understand what happens with symptoms over time leading up to 
the time of death, including how often the symptoms occur, the levels of 
symptoms, and any changes in the levels over time.  
 
 
5) Finally, only one study was carried out in the UK (Knight & Jordan, 2007), 
which highlights a gap in UK-based research around symptoms in the care 
home population at the end of life. 
 
Symptoms are subjective experiences and there are many challenges to be faced in 
measuring symptom prevalence. However, the number of older people dying in care 
homes is increasing and there is a need to be able to understand the symptom 
experience to support the care at the end of life for residents, to offer evidence-based 
practice development for the staff caring for them and to consider the broader 
implications for practice and policy. There is a need to understand more about the care 
home population at the end of life in relation to the prevalence; that is the presence and 
intensity of  physical symptoms, not only at the very end of life but at the time leading 
up to death. The following chapter will lead with the aim and objectives for this study 









4.1.1 Aims and Objectives 
Aim  
The aim of this research study is to describe the presence and intensity of physical 
symptoms of residents in the dying phase in care homes, and explore whether there are 
common characteristics that present over time. 
 
Objectives 
1. To measure the presence, intensity and associations between physical 
symptoms during the dying phase of people who are resident in a care home. 
2. To identify the longitudinal changes in, and intensity of, the most commonly 
presenting physical symptoms during the dying phase. 
3. To propose a typology of symptoms associated with the dying phase derived 
from the population characteristics and the longitudinal changes over time. 
 
The purpose of this study is to describe the presence and intensity of symptoms in the 
final days of life in residents dying in care homes. By increasing knowledge of what 
the symptoms are and how and when they occur through time will lead to a greater 
understanding for professionals who are caring for these residents. This ultimately will 
aim to increase the quality of life and hence the quality of dying for residents 
(Miyashita et al., 2010). Chapter three identified five gaps as a result of the literature 
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review regarding research on symptom prevalence in care home residents at the end of 
life. Firstly, there was a lack of consensus over the types of symptom being measured, 
concluding in a consistent lack of knowledge about symptom prevalence. All studies 
looked at symptoms singularly, and did not consider overall symptom load.  Secondly, 
temporal aspects of symptoms received little attention, both in terms of frequency of 
prevalence and in changes in intensity over time. Thirdly, most of the studies collected 
data retrospectively, increasing the risk of bias through either recall bias or second 
hand data reporting. Fourthly, many studies collected data without using purposeful 
instruments so were unable to measure end of life symptoms in this specific 
population. Finally, there has only been one UK-based study that has researched 
symptoms at the end of life in the care home population. 
 
Epistemologically, this research study adopts a positivist approach which will be 
introduced and rationalised in the first section of this chapter. Next will follow a critical 
examination of the benefits and limitations of adopting a positivist stance in relation 
to the study of end of life symptoms. This section will lead into a discussion of the 
measurement process and the process of choosing a standardised measurement 
instrument. The final part of the chapter focuses on the research methods including 
population, recruitment, data collection, data analysis and ethical issues. 
 
4.2 Underlying epistemology  
The study aims to describe presence, intensity and associations between physical 
symptoms during the dying phase of people who are resident in a care home. This 
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presents a number of aspects to be considered when selecting the epistemological focus 
of the research.  
 
Positivism is referred to as a scientific method and is viewed as a rationalist, empiricist 
philosophy which indicates that causes determine effects or outcomes (Luchins, 2012; 
Mackenzie & Knipe, 2006). This signifies that there is firstly an objective truth/reality 
and this reality can be identified, observed and measured (Bruce, Pope, & Stanistreet, 
2008) and that secondly, the researcher’s findings are absolute and verifiable 
(Rosenthal & Rubin, 2013). The positivist philosophy encompasses a set of principles 
that will identify prediction and control (Leary, 2009) to discover the patterns of cause 
and effect. If the cause and effect can be ascertained they can be predicted, and if they 
can be predicted, they can be controlled, leading to a greater understanding of the 
reality or truth. Another concept regards observations and/or measurements as reliable 
to provide accurate information to understand the truth (Hammond, 2013). Finally, 
there is the belief that an objective understanding is achieved provided that a rigorous 
protocol is adhered to (Cohen, Leviton, Isaacson, Tallia, & Crabtree, 2006). Much of 
health and social science research has been influenced by positivism and the most 
important characteristic of positivism is empiricism (Parahoo, 2006) where empiricism 
is deemed to consist of that which can only be observed by human senses. To be able 
to link these key characteristics of positivist research to practice, observation and 





There are critics of positivism who have challenged the idea of an objective reality and 
reason that knowledge is built by accumulatively piecing together different types of 
theories and observations; however, this can be argued as lacking structure and being 
too flexible (Silverman, 2013). While phenomena such as personal meaning and 
experiences are considered as being outside of the scope of positivism (Denzin & 
Lincoln, 2011), being able to investigate natural order is necessary to make sense of 
certain features of natural laws. 
 
The debate between philosophers will continue (Trochim, 2008), but primarily the 
choice of the most appropriate epistemology should depend upon on what is being 
examined which in turn will lead to the most appropriate approach to apply (Silverman, 
2013; Trochim, 2008). 
 
4.2.1 Using a positivist paradigm in relation to end of life symptoms 
When attempting research in a field with a dominant paradigm, it may have been easier 
for the researcher to unquestioningly adopt the same approach even though those 
within positivist research may not always engage with the ontological and 
epistemological underpinnings. In addition, where a dominant discourse is regularly 
employed, the reception and acceptance of the research may ultimately depend on the 
use of similar approaches to be acknowledged within the field. Despite this, a clear 
rationale is required as to why a positivist philosophy is judged the most appropriate 
for this research and this is closely linked with the measurement of symptoms, but 




The study sets out to report the presence and intensity of symptoms in residents at the 
end of life. Positivism requires approaches that employ empirical methods to use 
quantitative analysis  (Al-Habil, 2011), and during the measurement of a symptom, 
including those at the end of life, the methods utilised are mainly positivist in nature, 
i.e. they use instruments. Instruments are frequently employed within health and social 
care as an attempt to standardise measurement. In this study, this is particularly 
important because the participants will be at the end of life, so highly likely to be 
unable to self-report which will necessitate an assessment by proxy. 
 
The first ontological assumption of positivism is that there is an objective reality and 
that it can be measured (Bruce et al., 2008). The reality in the practice of the 
measurement of end of life symptoms is that they are viewed as absolute i.e., a person 
has pain or he/she does not have pain. If the person has pain, they may have varying 
levels of pain; however, this still sits with the belief of an absolute truth, because they 
are measured as pain being present or absent. If pain is present, however, it can be 
present in varying degrees, but a person cannot maybe have pain. The presence of this 
symptom, pain, will become a variable and orders the dynamics into patterns (Schrag, 
1992). This enables the elements of the research question – presence and intensity to 
be captured in a uniform manner. Equally the conditions in which it can occur (e.g. 
prevalence with a particular diagnosis) can also be specified and through testing, 
correlations and causal explanations can be established or rejected. 
 
One of the key characteristics of positivism is that the researcher positions themselves 
objectively so the findings are unaffected by emotion or personal bias (Davey, 2001). 
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This necessitates the need to minimise the risk of biased reporting of the researcher (or 
the observer) demonstrating the relationship between a positivist philosophy and 
methodology. Portraying these entities can pose problems: Boudreau, Gefen, and 
Straub (2001) argue that the concept is straightforward when the appropriate choice of 
a valid measure is made. However, the use of valid measures within end of life 
symptom research, as seen in chapter three, are particularly challenging with many of 
the studies either not using a validated instrument or using no instrument at all. This 
was particularly evident as many of the studies considered used retrospective data, 
which had not been collected in a uniform format. The most appropriate instrument 
would facilitate an impartial and objective measurement that allows for repeatability 
over time to reliably capture the dynamic nature of symptoms, something that has 
lacked in previous studies (Brant et al., 2010). 
 
The second ontological assumption of positivism is that the researcher’s findings can 
be absolute and verifiable. This means that not only do the phenomena have an 
objective reality, but that this reality can be captured in an accurate and representative 
way. To be absolute and verifiable brings into consideration the position of detachment 
that is required between the researcher and that which is being measured. One way in 
which this is achieved is by the use of a validated measure to support this approach, 
which in turn prevents the researcher’s role shaping the inquiry. Positivists are required 
to keep a distance from their subjects under inquiry or at least neutral observations 
(Al-Habil, 2011). Although critiques of positivism assert that a pluralist approach, 
using mixed methods, are more able to ascertain an objective reality (Denzin & 
Lincoln, 2011), it can be counter-argued that merging different paradigms, such as 
within post-positivism, makes neither functional and weakens both (Phoenix et al., 
 96 
 
2012). If what is to be measured is determined by qualitative methods, it will conflict 
with the very strength of using instruments to measure objective realities. 
 
4.3 Methods 
This section aims to provide a documented process of the research design, population, 
recruitment, data collection, data analysis and ethical issues of the study. 
 
4.3.1 The research study design 
The study design is a strategy to control and influence variables to provide an answer 
to the research question that is underpinned by a set of hypotheses. This research seeks 
to report the presence and intensity over time (point and period prevalence) in dying 
residents in nursing care homes. The study design selected was a prospective cohort 
study. A prospective cohort study is appropriate because it enables a more complete 
set of data to be collected even though it is considered a less easy option than a 
retrospective data collection obtained from notes or records (Ghei, 1995). It is less 
prone to differential measurement error (Antal, Grasela, & Smith, 1989; Sedgwick, 
2013) and reduces measurement bias due to poor recall (White, Hunt, & Casso, 1998). 
A challenge for prospective data collection is that it may suffer from seasonal 
variations if a study period is a relatively short one (Ghei, 1995). The study was 
designed to collect data measurements through time as a sequence of data points. This 
enables variables from the data to be compared at different points in time conveying 
the dynamic nature of symptoms. The data collection took place over a staggered 12 




Given the nature of the data, an outcome measure was required and the clinical setting 
for data collection by the care staff meant that the measure had to be relatively 
undemanding and straightforward to administer. To ensure all factors are considered, 
the ‘five Ws (and one H)’ who/where/what/how/when was considered (Angelo, 2011) 
(Figure 4.1). Once the factors had been prioritised, a review of the available 
instruments was carried out and the factors mapped into the instruments to come up 









Figure 4.1 - The requirements of an instrument 
 
4.4 Period of data collection 
The study took place in the care homes over a twelve month period in two phases. This 
enabled data to be collected over a 12 month calendar period which avoided any 
seasonal dips or peaks. Phase one involved the recruitment of five care homes and ran 
from February 2009 – October 2009 (inclusive). Phase two recruited six care homes 
and ran from May 2009 – January 2010 (inclusive).  
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4.5 Sample size for a non-interventional study 
For interventional and non-interventional studies (NIS), an ‘adequate’ sample size is 
required. However, for non-interventional studies, it is not feasible to apply a power 
calculation, due to the lack of pre-defined clinical relevance (Schremmer, 2017). As a 
result, a justification of the sample size will be discussed here. The average number of 
deaths in care homes in the geographical recruitment area was approximately 16 - 20 
per care home per year (Partington, 2008). It was therefore anticipated that a care home 
would have approximately 13 - 17 deaths over the 9-month period that the research 
would occur. Having completed the literature review, and comparing with other 
prospective studies, it can be seen that other studies have a range of the total number 
of participants between 24 – 516: however, no other studies had a time-sequenced data 
collection along the lines of this study which increased the number of data points and 
size of the data. In order to achieve a representative proportion of resident deaths, a 
sample of eleven homes was selected to yield data on approximately 117 - 153 resident 
deaths in total. As an observational study, the goal is to collect data on the 
characteristics of the participants (Lee-Johnson, 2012), but even allowing for a small 
proportion of hospital deaths (on which data was not collected), it was with assurance 
that data on a minimum of 120 resident deaths would be achieved. The length of a so-
called confidence interval which was calculated from the data measured precision. The 
higher sample numbers led to smaller confidence intervals which corresponded to 







The population consisted of a purposive non-random sample in which participants are 
specifically sought out; that is, the total number of residents who were dying within 
the care homes during the period of the study.  
 
4.6 Participants 
The participants for the research study were residents dying in care homes. To be able 
to involve the participants, care homes had to be recruited to the study and then the 
residents from the recruited care homes were considered for participation in the study. 
The recruitment of the care homes is described and then the participants (residents). 
 
4.6.1 Recruitment of care homes 
Eleven care homes were approached to participate in the research study. The homes 
were purposively selected as a representative range of different types and sizes of care 
homes from within a geographical area. The area encompassed two Primary Care 
Trusts (which now form three Clinical Commissioning Groups or CCGs10). A meeting 
was held with each care home manager which provided details and requirements of 
the study. Each manager was provided with an information leaflet prior to the meeting 
(Appendix v).  Following the meeting a consent form was provided with the request 
for it to be completed and returned to the researcher (Appendix vi). Consenting 
managers were required to gain permission from head office (if part of a large chain) 
or the care home owner depending on the status of the home.  
                                                          
10 CCGs were formed after the passing of the Health and Social Care Act 2012, which transferred a 
range of commissioning responsibilities to CCGs from primary care trusts (PCTs). 
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4.6.2 Purposive selection of care homes with inclusion/exclusion criteria 
The following inclusion/exclusion criteria were used to recruit care homes into the 
study (Table 4.1). Each care home was required to have achieved a rating of two stars 
or more during their most recent CQC (Care Quality Commission) inspection as care 
homes with fewer stars were usually experiencing adverse issues and involving them 
in a research project was not considered to be in their best interest or would provide 
the best research site. To meet the inclusion/exclusion criteria, it was necessary for 
care homes to have a formal system in place to identify residents who were at the end 
of life. All the care homes taking part in the study were either using an Integrated Care 
Pathway/Liverpool Care Pathway (ICP/LCP) for care in the final days of life or were 
able to identify dying residents through their organisational care planning 
documentation. The ICP/LCP11 was an integrated care pathway that was used to 
improve the quality of the dying within the last hours and days of life. It was developed 
to transfer best quality for care of the dying from the hospice movement into other 
clinical areas, to provide an equitable model of care (LCP, 2010). The ICP/LCP 
incorporated a flow chart to identify if a resident is in the final days of life. Finally, at 
least one member of staff needed to have undergone additional palliative care 
education within the last 12 months. By providing education for staff helped to 










                                                          
11 In July 2013, an independent review into the Liverpool Care Pathway (LCP) highlighted several 
failings and recommended that the Government replace it with individual care plans by 14 July 2014. 
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Table 4.1 - Inclusion and exclusion criteria for selection of care homes 
Inclusion criteria Commission for Social Care Inspection (CSCI)12 star rating 
of 2 stars or above13 
 There is managerial support and/or organisational support 
(depending on care homes’ organisational structure) 
 There is current use of an Integrated Care Pathway/Liverpool 
Care Pathway or equivalent and/or means of identifying dying 
residents 
 At least one member of staff has undergone additional 
palliative care education within the last 12 months. 
Exclusion 
criteria 
CSCI star rating of less than 2 stars 
 No managerial/organisation support 
 No use of Integrated Care Pathway/Liverpool Care Pathway 
and/or ways of identifying dying residents 
 If there are no staff who have undergone additional palliative 
care education within the last 12 months. 
 
 
4.6.3 Inclusion/exclusion criteria for participants 
A clear inclusion/exclusion criteria for recruitment of participants was developed 
(Table 4.2). A resident needed to be in the final days of life to be eligible to be part of 
the research study. The trigger would be when the resident commenced an ICP/LCP 
or was identified as dying by the care home care planning documentation. If the 
resident improved in condition, they were withdrawn from the research, although they 
could be re-entered if they further deteriorated within the time period of the study. The 
death must have taken place in the care home, so the symptoms could be measured 
until the point of death. The presence of selection bias has been noted to be a potential 
problem in prospective cohort studies (Bookwala, Hussain, & Bhandari, 2011), but 
this research aimed to include all residents who were dying, which involved no specific 
                                                          
12 CSCI were an independent organisation (who were set up by the Government) to inspect and report 
on care services and councils including care homes. They ceased to exist on the 31st March 2009 to be 
replaced by the Care Quality Commission (CQC). 
13 This indicates that at the most recent inspection, care homes have received a quality rating of ‘good’ 
(2 stars) or ‘excellent’ (3 stars). 
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selection of the participant, other than the recognition of impending death, eliminating 
the risk of selection bias. 
 
 
Table 4.2 - Inclusion and exclusion criteria for selection of residents 
Inclusion Commenced on a Care Pathway (an expected death within next 
few days)  
 AND Death took place in care home 
Exclusion Care Pathway discontinued as condition had improved  
 OR Death took place in hospital 
 
4.7 Recruitment, consent, opting out and withdrawing from the study 
The following section will consider the methods used for recruitment. In this study, 
consent is closely linked with recruitment and the choice to opt out or withdraw, so 
these will be addressed in the same section. The ethical issues that could potentially 
arise as a result of some of the decisions made within the study will be later addressed 
in section 4.14.  
 
4.7.1 Recruitment 
Once a care home had been recruited to the study (section 4.6.1), and an initial period 
of induction had taken place, a start and completion date which spanned a nine month 
period of participation within the study was agreed. Once the study period was 
commenced, all residents, as identified in the inclusion and exclusion criteria for 





4.7.2 Providing information to participants 
To do this required full and open information giving, the opportunity to opt out of the 
study before the participant became involved and a method to withdraw once a resident 
was involved.   
It was very important to for all residents and families to understand that the care home 
was taking part in a research study and it was therefore essential to provide clear and 
precise information for potential participants and their families. As residents and 
families have individual ways of engaging with the care home, different mechanisms 
needed to be employed. A laminated A4 poster was displayed on all notice boards or 
common space in every care home as advocated as good practice (McMurdo et al., 
2011). (Appendix vii) The poster was phrased carefully to avoid upset to any potential 
readers, but it was also necessary to ensure that the approach and purpose of the study 
remained transparent. The study chose to use the words ‘end of life’ to avoid any 
ambiguity that other more palatable phrases used in other studies such as “becoming 
more unwell” may invite (Gibbins et al., 2012). The poster assured anonymity to 
residents and re-iterated that information would be treated with the greatest of respect. 
It provided information about the researcher and included a photograph. Families and 
residents were also informed of how to opt out of the research study on the poster. 
 
Dissemination of the study information also occurred through resident/family 
meetings. Seven care homes held these regularly and the researcher attended meetings 
in three care homes, with the managers discussing the study in the other four care home 
meetings. The remaining four care homes had regular newsletters and the poster 
information was paraphrased (for consistency across care homes) as an article within 
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the newsletters. In addition, an information leaflet was made openly available in a 
display stand within the care homes to residents and family members who wanted 
additional information about the study. (Appendix viii)  
 
During the research study period, the researcher and/or research administration 
assistant visited/contacted each care home at least once per week to support the data 
collection and increase compliance with the measures. 
 
4.7.3 Opting out of the research study 
There needed to be an opportunity for an individual resident’s data not to be included 
in the research study. If a resident or family required more information, the researcher 
would meet with any resident or relative who wished to discuss the research study 
further. (This would be offered either jointly with a staff member or individually). As 
the researcher was a qualified nurse with a wide experience of dealing with 
residents/patients and their families concerning emotive and difficult topics, the 
meeting dealt with these in an appropriate and sensitive manner. If a resident or their 
family opted out, care notes were marked with an identifying label. 
 
4.7.4 Withdrawing from the research study 
If a resident or family, whose information was in the process of being collected, 
requested to withdraw, the nursing staff destroyed the forms being completed and 
reported the code number to the researcher on a specific form (Appendix ix), so it did 
not appear as ‘missing data’ at the end of the study. Once data had been collected and 
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the forms collected by the research team, families had to be informed that it was then 
not possible to withdraw as the collected data were totally anonymous and therefore 
unable to be identified at this stage. This process was adopted to ensure and protect an 
anonymous status in this study. 
 
4.8 Data collection 
The next part of this chapter will describe the variables that were measured and how 
the measurement was achieved. There were two types of data collected by care home 
staff. The first was demographic and the second was the measurement of symptoms 
through observation. Figure 4.2 illustrates the process in a visual flow chart. A copy 
of the chart was also provided to every member of care staff working in the care home 










































Figure 4.2 - Flow chart showing data collection process 
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To interpret and understand relationships and correlations between the demographics 
and the symptoms and the changes over time required the variables to be classified as 
independent or dependent.  Within this study, the independent variables were the 
demographic elements such as age, gender, diagnosis and co-morbidities as well as a 
‘through time’ period (i.e. the period of time between the recognition of death and 
death). A prospective approach was adopted to support ‘real-time’ reporting, 
facilitating a consistent collection of maximum data and reducing recall error and bias. 
The next section explains the methods of data collection and analysis. 
 
4.8.1 Independent variables 
Data were collected on the following variables: age, gender, diagnosis, co-morbidities 
and the length spent living in the care home. The data were added to the data collection 
form on the day the resident entered the study, i.e. at the point of recognition of death. 
Information regarding age and gender were taken from the nursing notes and the 
diagnosis and co-morbidities were taken from the medical assessment form within the 
notes by the nurse commencing the form. The date that the resident entered the home 
was added to the data collection form which enabled the length of time the resident 
had lived in the care home to be calculated. No information was collected that would 
personally identify the resident, to ensure that the resident’s identity remained 
anonymous.  
 
Symptoms were measured each day at 4 hourly intervals from the time of recognition 
that the resident was dying [the point of recognition] until the time of death. Due to 
the challenge of forecasting an actual time of death, the last measurement that was 
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taken before death occurred became the last one in the series [point of death]. 
Measurements took place at 6am, 10am, 2pm, 6pm and 10pm. A 2am measurement 
was not carried out to avoid any unnecessary disturbance of the resident. 
 
4.9 The measurement of symptoms 
The model identified in chapter two was utilised to form a structure in which to 
conceptually frame the symptoms. The measurement of symptoms is a challenging 
area, as symptoms are difficult to define and consistent parameters for symptom 
measurement is hard to achieve (Chang et al., 2004). In addition, the end stage of an 
illness is highly dynamic (Nauck, 2001) and people may experience different 
symptoms than previously presented.   
 
In order to measure concepts, social scientists have created scales to increase the 
validity and reliability of measurement processes (Luchins, 2012), although the use of 
these risk losing sight of the importance of the original concept of individual 
symptoms. A number of instruments have been developed for symptom measurement 
within the end of life care setting. Some instruments have been designed to measure 
specific symptoms, while others focus on a wider range of symptoms or different 
patient groups. In addition, there are Quality of Life (QOL) instruments that are 
multidimensional constructs. QOL instruments may (and often do) include symptom 
measurement, but symptom instruments are primarily designed for the single purpose 
of measuring symptoms. As discussed in chapter four, assessment and measurement 
are closely linked, with the instrument supporting the ‘capture’ or measurement of a 
symptom. They enable the gathering of information (assessment), into a representative 
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set of numerical variables (measurement) to either allow the assessment of patient’s 
needs or the use of the data for research purposes. 
 
To develop a “gold standard” of symptom measurement, Ionova (2006) identified three 
principles, comprising of six elements, that are required to formulate an effective 
instrument (Table 4.3). Firstly, patient (self) rating is an principal feature (although 
this may not always be feasible, especially around end of life or if a person lacks 
capacity (Nekolaichuk et al., 1999)). The second requirement is that it is simple and 
brief; however, this may be too optimistic given the often dynamic nature of 
symptoms, particularly if there is a requirement to measure symptoms over a period of 
time. Thirdly, the instrument should be psychometrically validated. This is the ideal, 
and there are instruments that are validated in specific populations, but given the 
potential multiple variations between disease groups, demographic groups, and 
different cultures means that a ‘fit for purpose’ instrument does not exist for many of 
these groups. The psychometric properties of instruments are a fundamental aspect, 
but their selection also needs to meet specific clinical and research needs (Zimmerman 
et al., 2015). 
 
Table 4.3 - The “gold standard” of symptom measurement (Ionova, 2006) 
Simple 
Brief 
Easy for interpretation 
Multiple items but not necessarily multiple scales 
Psychometrically validated (published info about reliability and validity) 
Appropriate for clinical trials and clinical practice 
 
Using an appropriate instrument provides the opportunity to follow guidance to make 
the measurement. Although it relies on a measure of judgement, that judgement is of 
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the parameters of the instrument, not of the assessor. By ensuring that an appropriate 
instrument is in place and used correctly, it removes the onus of interpretation of the 
symptom and standardises the response. 
 
During a systematic review of symptom measurement tools, Kirkova et al. (2006) 
concluded that there is no ideal instrument available, due to the wide range of 
instruments that reflect different needs of symptom measurement and they 
recommended that additional research is required. Kirkova et al. (2006) also devised a 
list of considerations when looking for a suitable instrument to use which has 
similarities to the one developed by Ionova (2006). Ionova’s standards were used as a 
checklist to support the selection of instrument for this study and to ensure that it met 
the required outcomes of the study in a thorough and comprehensive manner.  
 
 
4.9.1 Measurement by proxy 
For this study, it was necessary to consider the use of proxy data collection. The 
participants in the study, due to their proximity to death, were unlikely to be in a 
position to self-report. In situations where the patient is unable to respond, such as in 
dementia care, the role of healthcare professionals and families as proxies is an area of 
considerable interest (Chang et al., 2009). In other disciplines, such as paediatrics, it 
has also been identified that objective measurement is rarely possible, with a reliance 
on parents or families to provide information (Bisgaard, Pipper, & Bønnelykke, 2011). 
 
It was not a feasible option to ask families to provide regular and frequent information 
regarding the symptoms, so in this study data were collected through the use of 
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qualified nurses as proxy raters. The frequency of monitoring needed to be approached 
with caution as Forbes et al. (2011), in their study, suggested that 12 hourly recording 
was onerous for staff working in an acute area. To overcome this issue, the rationale 
of four-hourly recording was explained to staff so they understood the purpose. Four-
hourly recording was deemed appropriate by staff because this fitted in with their usual 
pattern of observation, which meant that no addition tasks were required. To promote 
consistent recording, qualified nurses were selected as the proxy raters because they 
had the relevant clinical knowledge to carry out the assessment as well as being 
familiar with the resident, as they oversee their care on a daily basis. (Snow, Cook, 
Lin, Morgan, & Magaziner, 2005). Average nurse ratings are more likely to closely 
agree with patient ratings than medical colleagues (Nekolaichuk et al., 1999), even 
though they may still be lower than patient ratings for some symptoms. Some 
symptoms, for example, psychological symptoms such as depression, may be even 
more difficult to measure accurately by a proxy (Kutner, Kassner, & Nowels, 2001) 
and a more sensitive tool may be required. However, the more measurement methods 
used, the wider the discrepancy (Snow et al., 2005), reinforcing the use of a single 
instrument rather than multiple methods. To be suitable to assess the multiple 
symptoms experienced at the end of life, the instrument needs to include multiple items 
but not necessarily involve multiple scales (Ionova, 2006). The use of a single 
instrument is also supported by Bruera and Portenoy (2001) who identify the use of a 






4.10 Selecting an appropriate instrument 
The International Association for Hospice and Palliative Care produced a 
comprehensive list of pain and palliative care assessment and research instruments 
(IAHPC, 2008) which listed instruments broadly used for symptom measurement. This 
list was cross referenced with three other systematic reviews (Brown University, 2008; 
Kirkova et al., 2006; Medicine, 2001) to ensure that no other relevant instruments had 
been overlooked. This resulted in 22 instruments being reviewed for consideration of 
use. 
 
A two stage review process was devised to identify the most suitable instrument for 
this study. First, all instruments were scrutinised to confirm their general suitability in 
line with the identified requirements of this study based on the research outcomes, and 
the criteria identified by Ionova (2006) in Table 4.3. This process enabled unsuitable 
instruments to be appropriately filtered out, e.g., if they were aimed at different 
populations, such as care-givers or paediatrics or if they were intended to be single 
symptom only instruments. For the purposes of transparency, Table 4.4 provides an 
overview of the first stage of this process with a brief rationale to state why a particular 
instrument was included or excluded. 
 
Table 4.4 - Stage one – a review of instruments for measurement (IAHPC, 2008) 





Brief Fatigue Inventory (Cleeland & 
Ryan, 1994) 
x N/A* – Measures fatigue only 
Edmonton Functional Assessment 
Tool (EFAT) (Kaasa, Loomis, Gillis, 
Bruera, & Hanson, 1997) 
x N/A – Assesses functional 
performance in patients with advanced 
cancer 
ECOG Performance Status (Oken et 
al., 1982) 
x N/A- Assesses functional performance 
in patients with cancer 
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* N/A – Not Applicable 
From stage one, four instruments were selected: 
- Edmonton Symptom Assessment Scale (ESAS) (Bruera et al., 1991) 
- MD Anderson Symptom Assessment Scale (Cleeland et al., 2000) 
Edmonton Symptom Assessment 
System (ESAS) (Bruera et al., 1991) 
√ Assesses a range of symptoms in 
patients 
Edmonton Staging System (Bruera, 
MacMillan, Hanson, & MacDonald, 
1989) 
x N/A – A clinical staging system for 
cancer pain 
FAMCARE Scale (Kristjanson, 1993) x N/A – Scale to assess family 
satisfaction of care 
Geriatric Depression Scale (Yesavage, 
1988) 
x N/A – Measures depression only 
Grief Resolution Index (Remondet & 
Hansson, 1987) 
x N/A – Measures grief only 
Hamilton Depression Rating 
Scale (Hamilton, 1960) 
x N/A – Rating scale for depression 
Herth Hope Index (Herth, 1992) x N/A – Hope assessment scale 
Karnofsky Performance 
Scale (Karnofsky, Abelmann, Craver, 
& Burchenal, 1948) 
x N/A – Classifies patients as to their 
functional impairment 
MD Anderson Symptom Assessment 
System (Cleeland et al., 2000) 
√ 13 symptom self-assessment scale 
measures severity and interference 
McGill Quality of Life Questionnaire 
(Cohen, Mount, Strobel, & Bui, 1995)  
x N/A – Scale to measure quality of life 
at end of life 
McGill Pain Questionnaire (Melzack, 
1975)  
x N/A – Assesses pain only 
Memorial Symptom Assessment 
Scale (Portenoy et al., 1994) 
√ 24 symptom self-assessment scale 
Mini Mental State Questionnaire 
(Vertesi et al., 2001) 
x N/A – Screening instrument for 
cognitive impairment 
Palliative Outcome Scale (Hearn & 
Higginson, 1999) 
√ An outcome measure instrument to 
assess physical, psychological, 
practical and existential aspects of 
quality of life 
Palliative Performance Scale 
(Anderson, Downing, Hill, Casorso, & 
Lerch, 1996) 
x N/A – Modified Karnofsky Scale 
assessing functional impairment 
Pediatric Pain Profile (Hunt et al., 
2004) 
x N/A - Measures paediatric pain only 
Rotterdam Symptom Checklist 
(Hardy, Edmonds, Turner, Rees, & 
A'Hern, 1999) 
x N/A – Developed for cancer patients 
Support Team Assessment Schedule 
(Higginson & McCarthy, 1993) 
x N/A – Includes factors such as family 
anxiety and service needs 
Wong-Baker FACES Pain Rating 
Scale (Wong & Baker, 1988) 
x N/A – Assesses pain only 
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- Memorial Symptom Assessment Scale (MSAS) (Portenoy et al., 1994) 
- Palliative Outcome Scale (POS) (Hearn & Higginson, 1999) 
 
The second stage evaluated the four selected instruments by using the specific criteria 
identified by Ionova (2006) (Table 4.3). All instruments except the MD Anderson were 
relatively easy to use due to the length and number of questions. All instruments had 
been validated for general use and were deemed to be accurate and reliable (Bausewein 
et al., 2005; Chang et al., 2004; Okuyama et al., 2003). No instrument had been 
previously validated in the care home population, suggesting that additional studies in 
other populations are needed. (Watanabe, Nekotaichuk, Beaumont, & Mawani, 2008).  
All instruments except the POS included a variation in the number of symptoms 
included, from 11 to 32. The POS only rated pain and ‘other’ symptoms (Hearn & 
Higginson, 1999). Finally, the ESAS and the POS were the only two instruments that 
had been validated for use by proxy assessment (Nekolaichuk et al., 1999). This 
decision is supported by a review of instruments to measure symptoms in elderly 
cancer patients receiving palliative care (Browner and Smith (2013). Of the 21 
instruments reviewed, and the four finally selected, three mirrored the instruments 
reviewed by this study (ESAS, MD Anderson and MSAS) and one was a cancer 
specific outcome measure (European Organization for Research and Treatment of 
Cancer's Quality of Life Core Questionnaire: EORTC QLQ-C30. ). As with this study, 
they also noted none of the instruments had been validated for use with geriatrics 




A final decision was made to use the Edmonton Symptom Assessment Scale (ESAS) 
(Bruera et al., 1991) as it was the only instrument that fulfilled all of the six required 
criteria based on the gold standards for symptom measurement (Ionova, 2006) Table 
4.5 provides a summary of the criteria of the four instruments. 
 
 
Table 4.5 – A summary of the rationale for the use of the Edmonton Symptom 
Assessment Scale 




Simple √ √  √ 
Brief √  √ √ 
Easy for interpretation √ √ √ √ 
Multiple items but not necessarily 
multiple scales 
√ √ √ √ 
Psychometrically validated  √ √ √  
Appropriate for clinical trials and 
clinical practice, including proxy-
rater use 




4.11 The Edmonton Symptom Assessment Scale 
The Edmonton Symptom Assessment System (ESAS), although now usually referred 
to as the Edmonton Symptom Assessment Scale, was designed for the monitoring of 
patients’ symptom experience in a palliative care unit in Canada (Bruera et al., 1991). 
The original version of the ESAS used a visual analogue scale from 0 - 100mm to 
measure the intensity of each of eight symptoms (pain, activity, nausea, depression, 
anxiety, drowsiness, appetite and well-being) with 100mm being the most severe 
symptom distress. Since then, there have been a number of revised versions; different 
symptoms have been added or removed, visual analogue scales have been replaced 
with numerical rating scales, and the frequency of assessment has varied from four-
hourly to daily in in-care settings or weekly to monthly if being used in clinics or out-
patient settings. It has also been translated into over 20 languages (Bruera et al., 1991; 
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Hui & Bruera, 2017). Yet despite its widespread use, it has been recognised that the 
diversity of ESAS modifications has made cross-study comparisons difficult and 
reinforces the need for a standardised instrument and administration processes. 
Nevertheless Watanabe, Nekolaichuk, Beaumont, and Mawani (2008) defend its 
continued use as no faultless instrument exists, and the ESAS has had its use justified 
in systematic identification and monitoring of symptoms. 
 
The ESAS has been validated with several different populations primarily within 
cancer in-patients (Nekolaichuk, Watanabe, & Beaumont, 2008; Nelson et al., 2001; 
Strömgren, Groenvold, Pedersen, Olsen, & Sjogren, 2002; Yesilbalkan, Ozkutuk, 
Karadakovan, Turgut, & Kazgan, 2008), and has had significant use within nephrology 
(Davison, Jhangri, & Johnson, 2006; Flythe et al., 2015) and cardiology (Shah et al., 
2013; Udeoji, Shah, Bharadwaj, Katsiyiannis, & Schwarz, 2012).  It has also been 
found to be useful as an audit instrument for palliative symptom control (Dudgeon & 
Harlos, 1999; Rees, Hardy, Ling, Broadley, & A'Hern, 1998). Hui and Bruera (2017) 
attribute the widespread use of the ESAS due to it being a pragmatic patient-centred 
symptom assessment tool that is easy to administer, interpret, and report. It has the 
ability to assess 10 symptoms making it multi-dimensional and able to identify 
symptom clusters and concurrent symptom presence. Although it has been 
psychometrically validated by multiple groups (Hui & Bruera, 2017), it has had few 
validation studies in non-cancer populations and it has not been validated in the Long 
Term Care setting population such as nursing care homes. Brandt et al. (2006) utilised 
the ESAS, as identified in the literature review, and found it to be an effective tool for 
this population in relation to proxy data collection and for patients with non-cancer 
diagnoses.  More recently it has been used within a study into end of life symptoms in 
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Norwegian nursing homes (Sandvik et al., 2016), although post data collection of this 
study, it was reported to be the only end of life care instrument with a relevant 
symptom list to assess change in symptom intensity by a continuous scale. 
 
Due to the anticipated nature of the population in this study, a prime factor for selection 
of the ESAS is that it can be completed by the patient or by proxy if self-reporting is 
not possible Bruera et al. (1991), so while the ESAS is intended to capture the patient’s 
perspective on symptoms, in cases where the patient is unable to self-report, the source 
of information may come from a proxy (such as a carer).  There has to be a degree of 
caution with this as Garyali et al. (2006) reported errors in some types of symptom 
intensity (for sleep and appetite) when used for self-assessment against proxy 
assessment. Another challenge that arises, particularly when using proxy assessment 
rather than self-assessment, is the measurement of psychological symptoms such as 
anxiety and depression. This is considered to be methodologically challenging, 
particularly at the very end of life (Kozlov et al., 2019) and they are considered to be 
burdensome to both the patient and the care giver; however, attempts to measure and 
manage these throughout the illness trajectory are still necessary. A benefit of using 
regular staff to assess patients is that they have prior knowledge of the patients and are 
able to use that to inform their clinical assessment.  
The scales were presented horizontally which made the ESAS simple to use. However, 
the direction of the visual scale (horizontal or vertical) may have an influence on 
measurement. Other scales such as the Wong-Baker scale have reported that vertical 
scale increases validity (Wong & Baker, 1988). Other studies have reported largely 
positively when the ESAS was used by patients (Baba, Fransson, & Lindh, 2007; 
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Watanabe, Nekotaichuk, et al., 2008), although the study by Watanabe, Nekotaichuk, 
et al. (2008) found that patients found some of the medical terminology difficult to 
understand. 
 
Some of the reported limitations of the use of the ESAS have included difficulty in 
completion and its completion being time consuming (Rees et al., 1998). Although the 
ESAS has been found to be a feasible and useful instrument for palliative care nurses, 
less well qualified nurses found it more difficult to use indicating that the level of 
training of staff may influence its perceived ease of use (Watanabe, McKinnon, 
Macmillan, & Hanson, 2006), so this study purposely selected qualified nurses to 
overcome that potential issue.  
 
Taking the above into consideration, a modified version of the ESAS was selected for 
this study, and this was considered for a number of reasons: 
The modified version contains 12 items, compared to the usual 10. This gave a greater 
breadth of symptom measurement. It also omitted a symptom that had been previously 
included - ‘well-being’. This symptom had received criticism that it was only a 
surrogate marker for an overall score of symptom distress due to a lack of consensus 
of what it really meant. To balance this in a more useful way, the modified ESAS 
contains an equally weighted summation of scores that may estimate a construct of 
total symptom distress, which in turn is related to palliative goals and quality of life 
(Richardson & Jones, 2009). It has a four-hourly numerical rating scale (the previous 
version had a six-hourly scale) which was found to be simple and valid within a 
longitudinal assessment (Davison et al., 2006). Unlike other versions, there was a 
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stratification for symptom severity. This avoided staff having to assign a numeric value 
to rate the symptoms, and thus reducing the number of options available and adopted 
a rating of mild, moderate, or severe. There was an anomaly in that eight symptoms 
were assessed on an observer-rated score between 0 - 3 (0 = None, 1 = Mild, 2 = 
Moderate, 3 = Severe), but four were required to be rated as present or absent. 
 
4.12 Dependent variables 
Data were collected regarding 12 symptoms. The symptoms were: pain, tiredness 
(fatigue), drowsiness (sleepiness), depression, anxiety, nausea, anorexia, shortness of 
breath, secretions, constipation, unable to respond and delirium.  
 
4.13 Completion of the research study 
At the end of the nine month data collection, either the researcher or research assistant 
visited the care home and collected any completed forms and the research study box. 
At the same time, information posters were removed and new posters (Appendix xiii) 
were provided to each care home to let all staff know that the data collection was over 
and to thank them. A letter of thanks (Appendix xiv) was sent to each manager with a 
short descriptive summary of the data from the first deaths from their care home, once 
100 deaths in total had been achieved, once the information was collated. A more 
detailed summary of findings (from the first 100 deaths) from all care homes 





4.14 Ethical issues  
Ethical norms in research have an important role. They not only promote the practice 
of effective and respectable research, but act to consider and protect those involved in 
the process. When conducting research with human beings, research ethics considers 
the minimisation of harm and the maximisation of benefits a key requirement 
(Shamoo, 2009). Two points of reference are used to guide and discuss the ethical 
decision making within this study. These are the four principles of ethics (Beauchamp, 
2013) and the Economic and Social Research Council (ESRC) Framework for 
Research Ethics (ESRC, 2015). By applying the principles addressed in the two 
frameworks, all aspects in relation to this study will be addressed.  
 
4.14.1 Ethical approval 
The study went through a full process to gain ethics approval. Applications were made 
to the local Primary Care Trust REC and the regional NHS National Research Ethics 
Service (NHS NRES) committee with both responding that an ethical review was not 
required for this study. An application was made to the Division of Health Research 
Ethics Committee at Lancaster University, which received full approval in February 
2009. Table 4.6 lists the process and decisions and provides links to the documents 
located within the appendices. 
 
 
Table 4.6 - Ethics approval processes 
Description/Appendix no Notes 
Letter of ethics approval from Lancaster 
University. Issued 28 January 2009 
(Appendix xv) 
Full ethics approval was granted following 
IHR Ethics Committee meeting on 11 
December 2008.  
Letter of ethics approval from Lancaster 
University. Issued 20 February 2009 
(Appendix xvi) 
A request was made to the IHR Ethics 
Committee on 20 February 2009 to increase 
the number of participating care homes from 
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10 to 11. This letter confirmed that it was a 
minor amendment and the research still met 
the requirements for ethical approval.  
Letter of ethics approval exemption from 
NHS RES. Issued 29 September 2009 
(Appendix xvii) 
The project outline (similar to the outline 
provided to the IHR Ethics Committee) was 
submitted. The Chair advised that it was 
considered to be an audit so did not require 
ethical review by the NHS REC.  
Letter of ethics approval exemption from 
local PCT14. Issued 27 August 2008 
(Appendix xviii) 
The project outline (similar to the outline 
provided to the IHR Ethics Committee) was 
submitted. The study did not require PCT 
Research and Audit approval because the 
study did not involve PCT staff or patients. 
 
 
Collecting data on people at the end of life requires additional consideration, 
particularly around the nature and type of the information. The nurses were reporting 
on information that was usually collected as part of normal care and was thus classified 
as ‘existing data’ by the National Research Ethics Service at the time when the 
proposal was considered (NHS, NRES 2008). It must also be noted that when the 
research proposal was approved in 2009, much of the current ethical guidance and 
requirements for research was predominantly for clinical trials and non-therapeutic 
medical research (Smith, 2008) and ethics approval for studies such as this one were 
less frequent and therefore this did not always readily align with guidance. However, 
reviewing the study by current guidance, it would still not be considered research by 
the NHS because: the participants in the study are not randomised to different groups, 
the study protocol does not change treatment or care from the accepted standards and 




                                                          
14 PCTs (Primary Care Trusts) were part of the NHS and responsible for commissioning primary, 
community and secondary health services from providers from 2001 to 2013. They were superseded 
by Clinical Commissioning Groups. 
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4.14.2 Ethical issues arising in the study 
When considering the frameworks of Beauchamp and the ESRC Framework for 
Research Ethics, the following aspects are relevant to this study, and will be now 
discussed in more detail: autonomy, beneficence, avoiding harm (non-maleficence), 
confidentiality, independence and justice. The approach to consent will be discussed 
further in the next section, but this study utilises ‘existing data’ and has not been 
required to adopt the usual ‘default’ position of fully informed consent. (Boddy, 2010). 
However, to maintain the integrity of the study, participants were fully informed of the 
study with the option to either opt out or withdraw at any time during data collection 
and this will be discussed in relation to ethical principles. The section will conclude 
with a consideration of the principles specifically in relation to closed institutions. 
 
4.14.3 Autonomy 
Respect for autonomy is the first of the four principles of bioethics (Beauchamp, 2013) 
and calls for a respectful conduct when disclosing information. To make an 
autonomous decision, requires information giving and a freely given decision (without 
coercion) to take part in research. Information was provided in all of the care home 
sites and was openly displayed in public areas as well as featuring in resident and 
family meetings and newsletters. The researcher was available to meet with residents 
and families who required further information or clarification. 
 
Consent is a foundation principle of research and is linked closely to the concept of 
autonomy. It refers to the participation of an individual within a research project 
(Miller & Wertheimer, 2010). As consent is a procedure, rather than a simple yes or 
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no, the whole process of the study needs to be considered and the rationale for the way 
in which consent is obtained needs to be carefully weighed up. The issue of consent 
within this study needed to be sensitively tailored to the practical, emotional and 
psychological needs of those involved (Bradburn & Maher, 2005). Due to the nature 
of the study it was exempt from full informed consent procedures and individual 
informed consent was not required. This approach to consent has been utilised in 
several other studies involving similar populations in care home settings (Brandt et al., 
2005; Brandt et al., 2006; Brechtl et al., 2006; Solloway et al., 2005). Other studies in 
similar settings (Lichter & Hunt, 1990; Morita, Ichiki, Tsunoda, Inoue, & Chihara, 
1998; Nauck, 2001) have not indicated if or how consent was gained which may 
indicate some of the challenges involved. A wider example of a similar approach can 
be seen in a study conducted by Macleod et al. (2000). This required identification of 
cases through the cancer registry, and then death register and NHS record review. It 
was done without seeking individual informed consent for data collection, although 
patients had to be made aware, through leaflets and explanation, that data collection 
for this purpose was taking place and were invited to comment upon it. The study for 
this thesis was considered minimal risk (as discussed in section 4.14.2) which 
supported the decision to not require full informed consent. Firstly, the demographic 
information collected was non-identifiable, and neither care homes nor participants 
would be identified within any external reports or publications. Secondly, the 
observations were non-invasive and formed part of the usual care routine carried out 
by staff. 
  
Despite the above instruction that fully informed consent was not necessary, the 
researcher believed that it was important to adhere to the principles that informed 
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consent obliges i.e. respect for the person, not deceiving or exploiting nor shaming or 
harming in any way (Boddy, 2010). 
 
4.14.4 Beneficence and avoiding harm (non-maleficence) 
Leading on from the discussion of consent above, this was guided by a balance 
between beneficence and non-maleficence. As this study was prospective in nature, it 
was not known who would be participating (i.e. dying during the study) until the 
resident started on their dying trajectory. It would have created a greater risk to consent 
every person in the care home, as there was a high chance that they would not become 
a participant but would have had a potentially upsetting discussion if they were to have 
been individually consented into the study. Given that the situation around imminent 
death provokes a very personal reaction, it was more appropriate that the information 
was provided generally and each person had the opportunity (either through the care 
home staff or the researcher) to gain more knowledge about the study. This was carried 
out with a degree of caution as some studies have reported findings that professionals 
believe that research in dying patients is never appropriate (de Raeve, 1994; Hughes, 
Preston, & Payne, 2013; Preston, Payne, & Todd, 2009). However, also reported is 
that involvement in research can provide a sense of empowerment, of value and 
contribution (Bradburn & Maher, 2005). 
  
Within this study it was agreed that participants would not face any harm – that it was 
considered ‘minimal risk research’ for a number of reasons. Observations are non-
invasive. The 2am observation was not carried to avoid unnecessary disturbance to 
residents. The only potential impact was that an increased and more thorough symptom 
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measurement could improve care. While no research that is harmful should be 
undertaken (Cowan, 2009), being prohibited by gatekeepers may be unethical in itself, 
in that it denies the residents the best possible care (Parahoo, 2006). This study did not 
face these challenges (it has already been discussed how the care homes were engaged 
with which supported this) and as a result no-one chose not to take part in the study or 
opted out during the data collection. 
 
4.14.5 Confidentiality 
Confidentiality was maintained in a number of ways. Study codes were used for both 
care homes and participants on all completed data forms. The staff completing forms 
used a unique code for each resident/form completed. The staff kept a separate master 
document that links the study code to subjects’ identifying information locked in an 
office. Identifying information of the participants was not shared with the researcher. 
The care homes in the study were dispersed across a wide geographical area meaning 
it was not possible to identify the individual homes.  
 
All research study data were kept secure at all times. All paper records were kept in a 
locked cupboard and all computerised records had security codes assigned to them. 
Data will be destroyed in line with the Lancaster University's Research Data 
Management Policy which currently states "that all research data will be stored in 
either electronic or paper form for a minimum of 10 years after the end of a project, 
unless ethical considerations, participant confidentiality, FOI requirements or external 





There were no conflicts of interest identified prior to this research. The researcher was 
known professionally to the care homes who took part in the study, but was not directly 
associated with any care home. This raises questions about researcher positionality in 
a positivist study, however (Jafar, 2018) argues that positionality does not undermine 
the truth of the research, but rather it marks the boundaries of the research. It is the 
intention of the researcher to be open and transparent about their involvement and how 
this may have added to the value of the research.  
 
4.14.7 Justice  
Justice is being fair to research participants and although a potentially subjective 
principle (Pieper & Thomson, 2013), the researcher recognised that a greater evidence 
base in end of life is needed. Research could only take place in this population as the 
distinctiveness around end of life care is normally not generalisable to research with 
people who have curable conditions, therefore if people at the end of life are to be 
offered the best levels of care, research needs to be conducted within this group 
(Perkins, Barclay, & Booth, 2007; Seymour & Skilbeck, 2002). Despite some 
concerns, Gysels, Evans, and Higginson (2012) found, through a systematic review, 
that the majority of patients would be willing to take part in end of life research.  
 
4.14.8 The principles of ethics in closed institutions  
Gatekeeping is when health professionals or families prevent participants from being 
asked to become involved in research studies in the belief that they are protecting them. 
(Preston et al., 2009). Gatekeepers are usually health professionals (Alexander, 2010) 
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and can be potentially paternalistic and tokenistic preventing potential participants 
from speaking for themselves (Walker & Read, 2011). In this study, there was a risk 
that care home staff would block the researcher from having access, by either not 
involving them or failing to comply with data collection. The emphasis on end of life 
care makes this a greater risk. Knowing the care homes in a professional context is 
more likely to create a supportive approach (Walker & Read, 2011), however the 
researcher needs to be aware of the potential influence leading to bias. There needs to 
be a balance of remaining independent while being able to use the professional 
relationship to ensure good research outcomes. 
 
Gatekeepers can both facilitate access to participants and bar the way (Emmel, Hughes, 
Greenhalgh, & Sales, 2007). The research was conducted with care, respect and regard 
which helped to support a high level of participation with minimal missing data 
(Gysels et al., 2012). Individual support and supervision optimised the participants’ 
contributions  (Beaver, Bogg, & Luker, 1999).  
 
4.15 Reliability and validity 
Due to the nature of the study, one feature requiring particular deliberation concerned 
rigour. Rigour in research normally refers to the way in which integrity and 
competence are confirmed to enhance the quality of the research (Coryn, 2007; Heale 
& Twycross, 2015). In quantitative research, this is attained through measurement of 
reliability and validity. Although these are often treated separately, they are inter-




Reliability refers to the consistency and dependability of a measurement, or to the 
degree to which an instrument measures when repeated in a population of groups or 
individuals (Bruce et al., 2008). Although reliability cannot be calculated exactly, 
reliability estimation can be exercised. The main categories of reliability to be 
discussed are equivalence, stability and internal consistency (Cohen, 2011; Trochim, 
2008; Twycross & Shields, 2004).  
 
Firstly, to demonstrate reliability between the pre-test and post-test data, a t-test can 
applied to demonstrate if the equivalent forms of a test yields consistent results if 
applied to matched samples (Cohen, 2011). In this study, matched samples using 
demographic data were shown through a high correlation coefficient and through the 
means and standard deviations between the two groups.  
 
Secondly, to achieve a level of agreement between the care home staff, who were the 
observers, a process was identified (Heale & Twycross, 2015). These involved 
ensuring consistency of interpretation through training and support; and minimising 
external sources of variation by having agreement symptom definition. Although these 
second actions were not an estimate of reliability, they would help to improve the 
reliability between raters. 
 
All of the qualified staff within the care home were provided with an information sheet 
regarding the study (Appendix x). A pro-forma was provided to each care home to 
record when the information was given to the member of staff and the member of staff 
would sign to confirm they had received and understood it (Appendix xi).  
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All care homes were offered training sessions to support qualified nursing staff with 
the use of the ESAS using case studies and sample ESAS forms to sustain internal 
reliability and rigour (Potter et al., 2003). A general overview of the project was 
provided with the opportunity for questions and feedback. The ESAS was introduced 
to staff and a facilitated case study based on a fictional resident called ‘Maud’ 
demonstrated the use of the scale. This allowed staff to see the ESAS ‘in action’ and 
increased inter-relater reliability by checking that raters agreed with the rating scores 
of the ESAS  (Hearn & Higginson, 1999; Zimmermann et al., 2010), but also agreed 
with each other over the values to be applied. This supported a standardisation of 
measurement through different conditions. The ‘crib sheet’ used by the researcher to 
lead the training sessions can be seen in Appendix xii. The use of a single assessment 
form enabled staff to become more familiar with its use. The ESAS form was kept 
with the resident’s usual monitoring paperwork and used by staff at the bedside to 
enable them to make assessments in the same way regardless of  the staff member 
carrying out the assessment (Bruera & Portenoy, 2001).  
 
During the sessions, feedback from staff identified that there was a lack of clarity of 
the terminology used for labelling symptoms so in response, a process to standardise 
the definitions was employed. The lack of clarity of the terminology may have arisen 
due to the origins of the ESAS from the United States as some of the language, 
although English, felt unfamiliar to the care home staff. The staff needed a greater 
understanding of the vocabulary used in the ESAS to promote consistency, 
applicability and to increase inter-rater reliability. The use of a global description was 
a method adopted by Bisgaard et al. (2011) who recognised that diagnosis and 
monitoring (in the case of asthma) was confounded by “second-hand description with 
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inaccurate terminology” (p.1155). Unable to change the second hand reporting, they 
set about standardising the terminology. Adding extra definitions to the ESAS is 
supported by Watanabe et al. (2011), who also found that some terms in the ESAS 
were perceived as confusing. Inconsistency in definitions does matter in gaining a form 
of consensus for meaningful clinical or research comparisons (Russell, 2015) 
 
As a solution, but to prevent modifying the ESAS beyond its original format, a list of 
definitions were obtained from NHS choices (www.nhs.uk) and printed on the reverse 
of every ESAS form. Staff subsequently reported that it clarified the terminology used 
and helped them to be more consistent in the application of the instrument. The 
definitions that were used are presented in Table 4.7 
 
Table 4.7 - Definition of terms used in the Edmonton Symptom Assessment 
Scale (ESAS) 
Symptom Definition 
Pain Pain is an unpleasant physical or emotional feeling. If a person cannot 
report pain, they may show it in a number of other ways, such as 
restlessness, agitation, grimacing or groaning 
Fatigue 
(Tiredness) 
Fatigue is extreme tiredness and lack of energy, which makes even 
minor tasks difficult 
Drowsiness 
(Sleepiness) 
Drowsiness is when someone feels extremely tired and uncontrollably 
near to sleep 
Depression Depression is when someone has feelings of extreme sadness, despair 
or inadequacy that last for a long time 
Anxiety Anxiety is an unpleasant feeling when someone feels worried, uneasy 
or distressed about something that may or may not be about to happen 
Nausea Nausea is when a person feels like they are going to be sick 
Anorexia Anorexia is a loss of appetite is when a person does not feel hungry or 
wants to eat 
Shortness of 
Breath 
A person may be short of breath, unable to take a deep breath, gasping 
for air, or feel like they are not getting enough air 
Secretions (Y/N) An excess and/or thickening of respiratory secretions 
Constipation 
(Y/N) 
Constipation is when a person passes stools less often than usual, or 
when they are having difficulty going to the toilet because their stools 
are hard and small 
Unable to 
respond (Y/N) 
When a person becomes increasingly difficult to rouse or in a sleep like 
state and will be unresponsive 
Delirium (Y/N) Delirium is a severe state of mental confusion and anxiety that may or 




The purpose of reliability in this form is to measure consistency over time and with 
similar samples. In this study, this has been achieved through two measures. Firstly, 
the study used a prospective data collection method. Prospective data sets are usually 
more complete and are less reliant on memory as they are recorded at the time. Each 
measurement is made ‘in time’ which means being able to detect anomalies as they 
occur, therefore promoting consistency across samples. The study also utilised the 
ESAS, which has been shown to have reliability in similar populations. The time span 
of data collection improves stability as a reliable instrument used in similar research 
will yield similar data from similar participants over time (Cohen, 2011). 
 
Researcher (observer) consistency was improved by the use of triangulation within the 
methods (Adami & Kiger, 2005). Due to the nature of the data collection period, there 
were a number of observers. The observers were based in different locations/care 
homes. In addition, there was an increased number of occasions when the observations 
were made. These were assessed using a test/retest correlation coefficient such as 
Spearman, Pearson or t-test (Trochim, 2008).  
 
Internal consistency refers to an agreement of the results for different items for the 
same construct within the measure. A common way of calculating correlation values 
is by the use of Cronbach's Alpha (Heale & Twycross, 2015). The study ran this test 
through SPSS 19 to measure the consistency amongst the items by calculating all split-





While reliability is about the consistency and dependability of a measurement, validity 
involves the degree to which empirical evidence supports the suitability and relevance 
of the interpretations of scores, or more simply, the accuracy of the measurement 
(Kaplan, 2008; Trochim, 2008; Twycross & Shields, 2004). The main types of validity 
that will be discussed are content validity, criterion validity and construct validity and 
will be regarded in relation to internal and external validity. 
 
Face validity is the weakest type of content validity, but it does has value in that it 
helps shape the instrument and helps shape the construct into a strategy (Trochim, 
2008). There were a number of elements that gave this study face validity. The 
instrument had been introduced to the observers, i.e. the registered nurses who were 
involved with collecting data prior to the study period. As the data that were collected 
during the study was the same that they would usually collect as part of normal care, 
they were considered to be a good judge of the suitability of the instrument. Had this 
been rejected by the observers, it may well have been considered to not have face 
validity. A more rigorous way to assess content validity was carried out during the 
selection of the instrument when previous validation studies were reviewed. Key areas 
to consider were that an appropriate range of end of life symptoms were included as 
this was a key domain within the research question and that the instrument was able to 
be used ‘over time’ due to the longitudinal nature of the research. Although the 
instrument was not validated in the care homes setting, it was not believed to signify 




Construct validity links the measure and the theory, although there has been a shift 
from thinking about the validity of the test to the validity of the outcomes (Colliver, 
Conlee, & Verhulst, 2012). Constructs can be concerning causes, effects and the cause-
effect relationship. If the construct is not valid then a test on which it is established 
will not be valid either (Trochim, 2008). Within this study, the construct may be seen 
as measurable symptoms; however, within positivism, it is more common to define 
constructs by their relationship with other constructs (Colliver et al., 2012). Applied 
to this study, it means that evidence for the construct comes from evidence for the 
instrument through the wider validation of the ESAS. In addition, construct validity 
within this study was increased by virtually eliminating selection bias as all 
participants who died over the study period would be included unless they chose for 
their data not to be included or they died away from the care home. Another method 
to increase construct validity is to reduce the risk of type I and type II errors within the 
results – type I can be addressed by setting levels of significance, type II by reducing 
the level of significance. 
 
Criterion-related validity is similar to construct validity, but links the test to external 
criteria such as another test (Heale & Twycross, 2015). Within this study there was a 
risk of choosing an instrument based on convenience rather than being fit for purpose, 
thus increasing the risk of criterion errors. However, comparing instruments against 
each other enabled the best fit for the criterion as well as the most convenient 





4.15.3 Other considerations in relation to reliability and validity within the study 
The impact of the involvement of participants through the use of ‘inappropriate’ 
consent methods as highlighted by  Smith (2008) and  Cassell and Young (2002) can 
impact upon both the reliability and validity of the findings. By excluding difficult to 
research groups, such as dying patients or those that are unable to give fully informed 
consent can result in a limited subset of the potential population and may give a false 
legitimacy to ‘successful’ studies (Cassell & Young, 2002). 
 
4.16 Managing the data 
At the time of data collection, the data were entered into SPSS 19 by an administrative 
assistant. At the time of input, the data were cross-checked for accuracy against the 
original data collection forms by the researcher. The data were entered into SPSS 19 
by an administration assistant, so the researcher would conduct the data cleaning. A 
small sample of the data (n = 8, 5%) will be re-entered into an empty database and 
compared with full data set. If any errors are detected, they will be traced back and 
compared with the original data forms, and fully corrected. Full details of the 
adjustments will be expanded upon in the results chapter. 
 
4.16.1 Data transformation 
Data often requires transformation to enable a data set to resemble a normal 
distribution by making it fit a normal distribution curve or when the variance of the 
data is not homogenous. This is done not only to bring it to normality, but to try to 
meet the assumptions prior to using any type of a general linear model, such as t-test, 
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ANOVA, regression etc. However this process can also fundamentally transform the 
nature of the variable making interpretation more complex due to the nature of the 
transformations (Osbourne, 2002). It is the intention of this research study to utilise 
non-normal data if necessary and exhaust all analytical options prior to making a 
decision to transform. A specific section regarding any data transformation required 
and an explanation for the inclusion of valid non-normal data will be provided at the 
beginning of chapter five. 
 
4.16.2 Missing data 
Depending on the type of missing data, the following options will be considered to 
determine how to handle the missing values (MacFarlane, Veach, & LeRoy, 2014). 
Although excluding cases with missing data are common in some disciplines such as 
psychology and education (Baraldi & Enders, 2010), the software package used in the 
research study (SPSS 19) has a default option to implement the generation of 
replacement values. However, the nature of this process needs to be considered in 
relation to the type and purpose of the missing data. The following methods will be 
utilised in the event of missing data. If data are ‘missing at random’, these are likely 
to be less problematic and not bias the available data. In this case the missing data will 
be disregarded, with the available data analysed; however, this would depend upon the 
number of missing data compared to the size of the dataset (Denis, 2015; Higgins & 
Green, 2008). If data are ‘not missing at random’ and the reason they are missing is 
related to the specific characteristics of the participants, then the missing data will 
become non-ignorable and publishing the available data alone will lead to bias. In this 
case, the missing data will be imputed with a mean value, and will be treated as if it 
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had been observed (Denis, 2015; Higgins & Green, 2008). Last Observation Carried 
Forward (LOCF) is alternative method. In LOCF, the last captured value is carried 
forward and assumed not to alter over time. This is a popular method but requires that 
outcomes do not vary when data become missing and that a single data point can be 
used to approximate the distribution of potential values (Molnar, Hutton, & Fergusson, 
2008). Specific details regarding the treatment of any missing data will be provided at 
the beginning of chapter five. 
 
4.16.3 Statistical methods 
Descriptive statistics will be used to describe the study population demographics (both 
the care homes and the participants/residents), with the results reported as Mean, 
Standard Deviation (SD), Median and Range. Twelve symptoms will be systematically 
measured and recorded using the Modified Edmonton Symptom Assessment Scale 
(ESAS) at four hourly time points during the data collection period (see Appendix xiv). 
Monitoring will take place five times per 24 hours at 06.00 hrs, 10.00 hrs, 14.00 hrs, 
18.00 hrs, 22.00 hrs. A measurement of the symptoms at 02.00 hrs was intentionally 
not included to avoid residents being unnecessarily disturbed at night.  
 
To test the hypotheses, the following methods will be used 
Hypothesis one and three: ‘there will be an increase in the presence and intensity of 
the total symptom load between 48 hours, 24 hours and 4 hours prior to death’ and 
‘there will be an increase in the presence and intensity of each individual symptom 
between 48 hours, 24 hours and 4 hours prior to death’.  
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To provide an overview of the presence and intensity of symptoms at three time points 
prior to death (4 hours, 24 hours and 48 hours), descriptive statistics will be used. This 
will result in four groups: a) total symptom presence load, b) total symptom intensity 
load, c) individual symptom presence and d) individual symptom intensity. This 
process is described in Table 4.8. 
 
Table 4.8 The calculation of the presence and intensity of symptoms 
Group Description Method of calculation 
 
 
A and B 
 
Total symptom 




The mean score of the presence or intensity of 
each individual participant at a given time point 
(4 hours, 24 hours, 48 hours) were added 
together and then divided by the total number of 
participants – this resulted in a total symptom 
load score for each time point for both presence 
and intensity 
C Individual symptom 
presence 
The number of symptoms per participant were 
calculated by totalling the number of symptoms 
at each time point (4 hours, 24 hours, 48 hours). 
D Individual symptom 
intensity 
The total intensity score was calculated by 
totalling the intensity score of symptoms at each 
time point (4 hours, 24 hours, 48 hours). 
 
These symptom scores will be analysed in the following ways: 
1) For the total symptom load scores for presence and intensity (a & b) and the 
individual symptom score for intensity (d), a one-way repeated measures analysis of 
variance (ANOVA) will be conducted on the participants for whom there are data 
available over the three time points (N = 61). In this instance ANOVA is used to 
determine whether there are any statistically significant differences between the means 
of two or more measures for the same participants. . These will be reported as the F 
value, degrees of freedom (df), p value and partial theta (η) (an estimation of effect 
size). Next, post hoc comparisons will be performed. The total symptom load (presence 
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and intensity) and individual symptom intensity will undergo a pairwise comparison 
to look for significant differences between the three time points. ANOVA can be used 
for these data because there are three or more groups and the data are continuous. The 
distribution of the data must be normal, and standards deviations must be similar for 
each group (homogeneity of variance). Data will be observed against Maunchly’s Test 
of Sphericity to ensure that the data demonstrate compound symmetry. If the 
significance value is p < 0.05, this assumption is violated. Due to the nature of the data 
collection instrument, only eight symptoms will be included in the individual symptom 
intensity, because four of the symptoms (secretions, constipation, unable to respond 
and delirium) were recorded in the data collection as ‘present’ or ‘not present’, so do 
not have an intensity score. 
 
2) The individual symptom presence score (c) is categorical data because a symptom 
can only be present or not, so this will need to be treated differently. Cochran’s Q test 
will be used because this is a non-parametric way to find differences in matched sets 
of three or more groups. These will be reported as the Q value. As previous, post hoc 
comparisons, in the form of pairwise comparisons will be performed on any that have 
a significant Q value (p < .05) (SPSS does not perform multiple comparisons when the 
overall test does not show significant differences across samples). Cochran’s Q test 
can be used because there is one dependent dichotomous variable (presence or 
absence). 
 
All of the scores for a, b, c & d will be reported as uncorrected. A Bonferroni test is 
the most commonly used test to correct for multiple comparisons however its use needs 
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to be considered and it should not be used routinely. Consideration needs to be made 
as to whether (1) a single test of the universal null hypothesis that all tests are not 
significant is required, (2) it is essential to avoid type I error, and (3) a large number 
of tests are carried out without pre-planned hypotheses (Armstrong (2014a).  
 
Hypothesis two and four: ‘there will be an association between the total presence and 
intensity of the total symptom load and the key characteristics of residents at 48 hours, 
24 hours and 4 hours prior to death” and “there will be an association between the total 
presence and intensity of individual symptoms and the key characteristics of residents 
at the time closest to death (within 4 hours)”.  The presence and intensity of symptoms 
will positively correlate with older age, a higher number of diagnoses, a longer length 
of stay and a male gender’. 
 
An inferential analysis will performed to test the hypothesis, and to observe for 
associations between the symptoms and the participant characteristics. Depending on 
the distribution, it is planned to use a parametric test of bivariate correlation, Pearson’s 
correlation coefficient, to measure the strength and direction of linear relationships 
between the variables. To use Pearson’s, correlation data are required to be continuous, 
have an absence of outliers and be normally distributed. The Kolmogorov–Smirnov 
test will examine if variables are normally distributed. When observing for statistical 
significance, a significant p value will be reported with the level of significance set at 
p > .05, although smaller values have been reported on where appropriate. However 
the effect size (in this case the product moment correlation co-efficient) will also be 
reported to see the strength of the association. It can be argued that a more clinically 
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useful approach is promoted by the emphasis of the size of effect as unlike, 
significance tests, effect size is independent of sample size (McLeod, 2019). 
 
4.17 Storage of data and information, data protection 
The completed demographical information and the ESAS forms, once completed by 
staff, were stored in a central point in the home prior to collection by the researcher or 
administration support person. This was agreed with each home individually, but 
needed to be in a secure place in the care home. A stock of the research study 
documents were stored in each home in a brightly coloured box and contained all the 
documents. The boxes were kept secure in the staff office and easily located for staff 
completing forms and acted as a ‘reminder’. Envelopes were provided for each 
completed form, which were sealed before placing in the central storage point. All the 
paper information was kept in a locked filing cabinet in a locked research office at 
Cheshire Hospices Education (based at St Luke’s (Cheshire) Hospice, Winsford). The 
paper copies will be destroyed at the end of the research study on completion of the 
thesis. All electronic data were saved on a password-only accessible drive on the 
network of computers belonging to Cheshire Hospices Education. This system 
complied with the Data Protection Act, registration number Z6557193. 
 
4.18 Conclusion 
This chapter presents the ontological positioning of this study within the positivist 
worldview, chosen to answer the specific aims and objectives of this study as identified 
at the beginning of the chapter. The characteristics of this position are identified and 
how this shaped the study design. Taking a positivist stance to measure symptoms may 
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require no further discussion as it aligns to a dominant worldview; however, this 
chapter has demonstrated that this was the most appropriate choice of epistemology. 
But due to the nature of the study, particularly in relation to the aspects around end of 
life and the inability of the population to be able to ‘experience’ symptoms, a positivist 
approach was the appropriate one to take.  
 
A positivist approach has subsequently influenced the choice of methods in order to 
measure the incidence and prevalence of symptoms, while gaining that knowledge in 



























This research aims to study the presence and intensity of physical symptoms of 
residents in the dying phase in care homes and explore whether there are changes in 
symptoms over time and how they relate to specific demographics and other 
characteristics. 
 
The objectives of the research are: 
1. To measure the presence and intensity of total physical symptoms, and test the 
associations between key characteristics (age, gender, number of diagnoses and 
length of stay), during the final 48 hours of life in people who are resident in a 
care home.  
2. To measure the presence and intensity of individual physical symptoms, during 
the final 48 hours of life in people who are resident in a care home and test the 
associations between key characteristics (age, gender, number and type of 
diagnoses and length of stay) during the final 4 hours of life in people who are 
resident in a care home.  
3. To propose a typology of symptoms associated with the dying phase derived 





To be able to test research objectives one and two, the following hypotheses were 
developed: 
1. There will be an increase in the presence and intensity of the total symptom load 
from 48 hours, to 24 hours and 4 hours prior to death (Research Objective 1). 
2. There will be an association between both the total presence and intensity of the 
total symptom load and the hypothesised characteristics of residents at 48 hours, 24 
hours and 4 hours prior to death. The presence and intensity of symptoms will 
positively correlate with older age, a higher number of diagnoses, a longer length of 
stay and a male gender (Research Objective 1). 
3. There will be an increase in the presence and intensity of individual symptoms 
between 48 hours, 24 hours and 4 hours prior to death (Research Objective 2). 
4. There will be an association between the total presence and intensity of individual 
symptoms and the key characteristics of residents at the time closest to death (within 
4 hours). The presence and intensity of symptoms will positively correlate with older 
age, a higher number of diagnoses, a longer length of stay and a male gender (Research 
Objective 2). 
 
This chapter presents the findings from the research. First, the sample will be described 
through the presentation of the organisational and participant characteristics. The data 
are complex in parts, due to the cumulative nature of recruitment to the study, so these 




The first and third hypotheses will be addressed and met through descriptive and 
inferential analyses of the data. A descriptive analysis of the occurrence of individual 
symptoms will be presented and the total presence and intensity of symptoms will be 
addressed through an inferential analysis of the data utilising a one way repeated 
measure ANOVA and pairwise comparisons at 4 hrs, 24 hrs and 48 hrs prior to death. 
 
The second and fourth hypotheses will consider the association between the total 
symptom load and individual symptom presence and intensity and the characteristics 
of age, gender, number of diagnoses and length of stay in care home at 4 hours, 24 
hours and 48 hours prior to death. 
 
5.2 Description of the sample 
5.2.1 Organisational characteristics 
Data were collected from 11 care homes with a mean bed capacity of 60 (SD = 31, 
range 30 - 137). All of the care homes were registered to provide care for both older 
people and older people with dementia. Fifty-one per cent (n = 334) of the total beds 
(N = 656) in the homes were designated for older people and 43% (n = 282) for older 
people with dementia. One care home had a third registration category for mental 
disorder (6%: n = 40 of the total beds). Seventy-three percent (n = 8) of the homes 
were purpose built and 27% (n = 3) had converted residential properties for use as a 
care home. The care homes were located mainly in town or semi-rural locations. Sixty-
four per cent (n = 7) of the care homes were ‘for profit’ organisations (see Table 5.1 




                                                          
15 Up to 2010, the Care Quality Commission (CQC) used star ratings as part of their quality assessment 
(0=Poor, 1=Adequate, 2=Good, 3=Excellent). These were replaced by the current system of 
‘inadequate’, ‘requires improvement’, ‘good’ and ‘outstanding’. 



















A 137 30 67 40 3 Star Part of a not for profit 
healthcare provider 
with over 300 care 
homes nationally 
A purpose built home, 
comprising of five 
single storey units, 
located on the outskirts 
of a city 
B 90 39 51 0 2 Star Part of an 
independent 
healthcare provider 
with three local care 
homes 
A purpose built two 
storied home with three 
units, located on the 
edge of a town 
C 69 30 39 0 3 Star Part of an 
independent 
healthcare provider 
with over 50 care 
homes nationally 
A purpose built single 
storied home with two 
units, located on the 
edge of a small town 
D 60 30 30 0 2 Star Part of a not for profit 
healthcare provider 
with 22 care homes 
regionally 
A purpose built two 
storied home 
comprising of three 
units, located on the 
outskirts of a town 
E 55 45 10 0 2 Star Part of an 
independent 
healthcare provider 
with four local homes 
A converted two storied 
house, with two units, 
located approximately 
three miles from a small 
town 
F 49 25 24 0 2 Star Independent family 
run care home 
A converted two storied 
country home, located 
in the countryside, close 
to three towns 
G 48 48 0 0 2 Star Part of an 
independent 
healthcare provider 
with 730 care homes 
nationally 
A purpose built two 
storied home, located 
within a residential area 
of a town 
H 40 20 20 0 3 Star Part of a not for profit 
healthcare provider 
with 22 care homes 
regionally 
A purpose built single 
story home, comprising 
of two units, located on 
the outskirts of a town 
I 40 21 
 
19 0 3 Star Part of a not for profit 
healthcare provider 
with 22 care homes 
regionally 
A purpose built two 
storied home, located in 
a village 
J 38 23 15 0 2 Star Independent owner 
managed care home 
A converted three 
storied home, located in 
a village 
        
K 30 25 5 0 2 Star Part of an 
independent 
healthcare provider 
with four local homes 
A purpose built two 
storied home in a 
residential area on the 
outskirts of a town  
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5.2.2 Participant characteristics 
The sample (the individuals identified as being in the last phase of life whose data were 
collected) was composed of 157 participants. The mean age of the sample was 84.80 
years (SD = 7.67, Range = 58 - 105). Just over two-thirds of the participants (69.4%, 
n = 109) were female. The mean length of stay in the care home prior to death was 111 
weeks (SD = 146 weeks), with a minimum stay of 2 days and a maximum stay of 707 
weeks. The number of medical diagnoses recorded at entry to the study ranged from 
one to nine per participant, with a mean number of diagnoses of 3.3 (SD = 1.68). Forty-
eight percent (n = 76) of participants had a diagnosis of dementia, 39% (n = 61) had 
cardiovascular disorders, 27% (n = 43) had cancer, 20% (n = 31) had had a previous 
stroke and 10% (n = 15) had respiratory disorders (see Table 5.2). Two participants 
were excluded from the study as they made a recovery, resulting in a total of 157 
participants. 
 




Age (years)  
      Mean ± SD 84.80 ± 7.67 
      Median 85 
      Range 58 – 105 
 
Gender, female, n (%) 109 (69.40) 
 
Length of stay (weeks/days)  
      Mean ± SD 111 ± 146 (weeks), 775 ± 1020 (days) 
      Median 61 (weeks), 427 (days) 
      Range 0.30 – 707 (weeks), 2 – 4946 (days) 
 
Number of diagnoses  
      Mean ± SD 3.3 ± 1.7  
      Median 3 
      Range 1 – 9 
 




5.3 Defining the complexity of the data 
Due to the uncertain nature of recognising impending death, commencing data 
collection for a participant approaching the end of life presented challenges in 
recognising the point at which to start data collection. In accordance with the research 
study protocol, participants were entered into the study at the point impending death 
was recognised by the multi-disciplinary team using criteria defined by the Liverpool 
Care Pathway16. The longest period of data collection prior to death for a participant 
was 24 days (relevant for one participant) and the shortest period was within four hours 
of death occurring (n = 23). The difficulties in recognising dying in order to recruit 
participants resulted in an unbalanced design. This meant participants ‘joined’ the 
study at varying stages yielding data of a cumulative nature, but of varying lengths of 
time. For consistency, all of the time series data charts are shown with the nearest point 
to time of death at the intersection of the y-axis at the left hand side. Figure 5.1 shows 




                                                          
16 The LCP was an Integrated Care Pathway intended to provide a method of recording and measuring 
outcomes of end of life care. Two of the following four symptoms had to be present, and all other 
reversible causes ruled out. The patient is: 1) bed bound, 2) semi-comatose, 3) only able to take sips of 
fluids, 4) no longer able to take tablets  (Ellershaw et al, 2001) 
      Dementia 75 (48) 
      Cardiovascular 61 (39) 
      Cancer 43 (27) 
      Stroke 31 (20) 























Figure 5.1 - Number of participants recruited to the study at each time point 
 
 
The nature of the challenge of recognising impending death to recruit to the study is 
illustrated in Figure 5.2, which shows the cumulative number of participants, and 









Figure 5.2 - Cumulative total of participants recruited to the study by time point 
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The data incorporate a range of individual trajectories. These can be described in two 
ways: firstly, each individual presents a unique set of symptoms where symptoms can 
be present or not present; when present, they can vary in intensity. Secondly, and 
importantly, the symptoms can be combined to represent the full research population 
and this will be addressed as this chapter develops. 
 
5.3.1 Individual participants’ trajectories 
In order to give a more detailed illustration as part of this descriptive section, the 
following figures demonstrate the individuality of participants’ trajectories by 
depicting the symptom profiles of five participants recruited to the study. To 
demonstrate this, figures 5.3 – 5.7 show 10 consecutive time points of data collection 
(i.e. the data collected within 48 hours of death) for five participants. The purpose of 
these charts are to demonstrate the differences across individual residents. These five 
participants include the first and penultimate participants in the order that the data were 
collected, plus three other randomly selected participants to represent each quintile. 
For ease of viewing, the data for each participant are shown in two separate charts. 
The left hand side chart presents eight symptoms which were assessed as 0 (absent), 1 
(mild), 2 (moderate) or 3 (severe) and indicated on the y-axis. The right hand side chart 
indicates four symptoms, which were assessed as 0 (absent) or 4 (present) and 
indicated on the y-axis. Each time point is shown as a figure (0 to -9) on the x-axis 
with zero (0) being the point nearest to death (within four hours of death) and 
decreasing incrementally in four-hour periods (-1, -2, -3, -4, -5, -6, -7, -8) with -9 being 





















































































Figure 5.7 Individual trajectory - Participant 156 
 
 
Using the first two participants as examples (Figures 5.3 and 5.4), they show notably 
different symptom profiles. Participant one (Figure 5.3) had data collected over the 
full 48 hour period (or ten different time points). In the left hand figure, regarding the 
eight symptoms (assessed as 0 - 3), these show that the participant did not have nausea 
present, they had depression, fatigue and anorexia present at a consistent level, their 
levels of drowsiness and shortness of breath both increased towards the time of death, 
their anxiety initially fluctuated and decreased, while their pain levels fluctuated 
throughout the final period of life. In the right hand figure, regarding the four 
symptoms (assessed as absent/present), these indicated neither the presence of 
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constipation nor delirium throughout the final days, a constant presence of secretions 
and a shift from the absence to the presence of the ability to respond within the final 
few hours of life.  
 
Participant two (Figure 5.4) presents with only a single time period of data captured, 
meaning that death was not assessed as imminent until within four hours prior to the 
participant dying. Six symptoms, namely depression, shortness of breath, drowsiness, 
fatigue, unable to respond and secretions were all assessed as present at four hours 
prior to death. The remaining six symptoms were assessed as not present.  
 
While this section has emphasised the variations within individual trajectories, and 
these have been illustrated above, the aim of this research is to present the symptoms 
across the population as a whole, and this will be discussed in the following section. 
 
5.3.2 Managing the data 
All data were entered into SPSS 19 by an administrative assistant. All data were cross-
checked at the time of input by the researcher for accuracy of inputting. Minor errors 
were detected and corrected. At the time of checking, the assistant’s understanding of 
the data were clarified to reduce the risk of inputting errors. The data were entered into 
SPSS 19 by an administration assistant, so the researcher conducted the data cleaning. 
A small sample of the data (n = 8, 5%) was re-entered into an empty database and 
compared with full data set. A very small number of errors were discovered, well 
within the permissible margin of error of 1.5%. The errors were traced and compared 
back with the original data collection forms and corrected. 
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5.3.3 Data transformation 
There were no requirements for the need for data transformation as the data met the 
normality requirements for the tests being performed.  
 
5.3.4 Missing data 
The levels of missing data required for the analyses were very low. Of all the variables 
recorded, there was missing data regarding the length of stay in 1% of participants (n 
= 2) which had not been completed by the staff collecting the data. These two data 
points, given that they comprised of much less than 10% of the total possible number 
(Cohen, Cohen, West, & Aiken, 2003), were replaced by mean imputation. 
Consequently the analysis was carried out on a complete dataset. 
 
5.4 A descriptive analysis of the data 
5.4.1 The presence and intensity of symptoms at 4, 24 and 48 hours prior to death 
As discussed in the methods chapter, 12 symptoms were systematically monitored and 
recorded using the Edmonton Symptom Assessment Scale (ESAS) at four hourly 
periods (see Appendix xiv). Monitoring took place five times per 24 hours, as 
assessing the resident at 2am was not appropriate to ensure they were not unnecessarily 
disturbed at night. The next section describes the presentation of symptoms, firstly as 
an overview of all symptoms and then as a sum of total presence and total intensity to 
show the overall symptom load on the resident. Overall presence and intensity by 




5.4.2 The presence and intensity of individual symptoms – an overview 
Due to the difficulty of predicting impending death, the incremental enrolment of 
participants to the study meant that the number of participants varied between each 
time period. The period within four hours of death included all 157 participants, the 
period within 24 hours prior to death included 100 participants and the period within 
48 hours included 61 participants. Within the latter analyses, the participants who had 
data had across all three time points over the final 48 hours of life are included (N = 
61) so to start the section with a broad overview, the presence and intensity of each 
individual symptom within the final four, 24 and 48 hour periods prior to death are 
presented in Table 5.3. An example to demonstrate how the data have been calculated 







Figure 5.8 An explanation of the data found in Table 5.3  
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Table 5.3 - Occurrence of symptoms by percentage, within four, 24 and 48 hours of death (symptoms are presented ranked by intensity as 




Within four hours of death, n = 157 Within 24 hours of death, n = 100 Within 48 hours of death, n = 61 
Yes 
 n (%) 








Intensity n (%) Mean 
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(69) 
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21   
(21) 
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(8) 
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(9) 

























19   
(19) 
10   
(10) 
5      
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11   
(7) 
4    
(2.5) 




14   
(14) 
5      
(5) 
6      
(6) 















Nausea 12  
(7.6) 
4   
(2.5) 
6    
(3.8) 




4       
(4) 
3      
(3) 



















n/a n/a n/a 2.45 
1.96 
50   
(50) 









Note:  Symptoms were scored as 0 (absent) or 1 - 3 (the higher score = the more intense the symptom).  *These four symptoms were scored either 
as absent or present. 
Secretions* 37 
(23.6) 
n/a n/a n/a .94 
1.70 
17   
(17) 




n/a n/a n/a .52 
1.36 
 
Constipation* 11     
(7) 
n/a n/a n/a .28 
1.03 
8       
(8) 




n/a n/a n/a .33 
1.11 
 
Delirium* 11     
(7) 
n/a n/a n/a .28 
1.03 
8       
(8) 








Table 5.3 highlights that there were common features across the three time periods, 
despite the differing numbers of participants (157 participants at 4 hours, 100 
participants at 24 hours and 61 participants at 48 hours). The five most commonly 
occurring symptoms in the final four hours prior to death were drowsiness, fatigue, 
anorexia, unable to respond and shortness of breath and this pattern was repeated 
across all of the three time periods.  The most common symptom was drowsiness (the 
range across the three time points was between 86 - 88%), followed by fatigue (80 - 
84%), anorexia (64 - 69%), unable to respond (38 - 61%) and shortness of breath (18 
- 48%). For the symptoms that had the widest ranges of presentation (unable to respond 
and shortness of breath), the percentage of participants experiencing the symptoms 
was at its lowest in the time periods furthest away from death and increased towards 
the time of death. The least reported symptoms (nausea, constipation and delirium) 
varied in their frequency across the three time periods: nausea (range 0 - 8%), 
constipation (range 7 - 8%), and delirium (range 7 - 8%).   
 
In addition to looking at the occurrence of the individual symptoms at the different 
time points, the total number of symptoms across the three time points appears to 








5.4.3 The total presence and total intensity of symptoms 
When reviewing the data in Table 5.3, patterns in changes in symptoms towards the 
time of death start to become apparent. However to test this more rigorously, further 
analysis is required. The analysis will be presented from two different aspects. Firstly, 
the total symptom load in terms of presence and intensity will be explored. The total 
symptom load scores were computed by calculating the mean score of the presence or 
intensity of each participant at the given time point (4 hours, 24 hours, 48 hours), then 
divided by the total number of participants which resulted in a mean score for each 
time point of presence or intensity. This led on to an examination of each individual 
symptom for the level of presence and intensity to understand which symptoms present 
with greater frequency and intensity. Each individual symptom score was calculated 
by totalling the number of symptoms or the mean intensity of symptoms per 
participant.  Table 5.4 presents the total presence of all symptoms prior to death (Mean, 
Standard Deviation, Median and Range), and Table 5.5 presents the total intensity of 
all symptoms prior to death (Mean, Standard Deviation, Median and Range). 
 
Table 5.4 – Total presence of symptoms at 4 hrs, 24 hrs and 48 hrs prior to 
death 
 Time before death (N = 61) 






0 - 8 
3.97 (1.61) 
4 
0 - 7 
3.62 (1.46) 
4 
0 - 7 
 
Table 5.5 Total intensity of eight symptoms^ at 4 hrs, 24 hrs and 48 hrs prior 
to death  
 Time before death (N = 61) 






0 – 2.13 
.89 (.42) 
1 
0 – 1.75 
.82 (.40) 
.88 
0 – 1.63 
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* Four symptoms (secretions, constipation, unable to respond and delirium) were 
recorded as ‘present’ or ‘not present’, so do not have an intensity score 
^ The potential range of the intensity of symptoms is between 0 - 3 
 
Tables 5.4 and 5.5 show an increase in the mean of both the total presence and intensity 
of symptoms between the 48-hour period and the 4-hour period, with a greater 
presence and intensity at 4 hours, i.e., the time closest to death. The next section will 
compare these means using a one-way repeated measure ANOVA to determine 
whether any statistically significantly differences are present across the analysis.  
 
5.4.4 The total presence of symptoms at 4 hrs, 24 hrs and 48 hrs prior to death 
In order to test the hypothesis that the total presence of symptoms would increase over 
the three time periods (for those participants for whom these data were available, n = 
61), a one-way repeated measure ANOVA was conducted using the data displayed as 
means in Table 5.4. This indicated (F = 13.82, df = 2, 59, p < .001, partial η = .32) a 
significant difference in the mean number of symptoms reported over the three time 
points. While the p value is significant at < .001, the effect size of partial η at .32 is 
considered to be of a large magnitude (University of Cambridge, 2019)17 making this 
an important difference. As the analysis involved three levels, post hoc comparisons 
were performed; these indicated significant (uncorrected) differences between all of 




                                                          




Table 5.6 Pairwise comparisons of total presence of all twelve symptoms at 4 hrs, 
24 hrs and 48 hrs prior to death (N = 61)  











symptoms at 4  
hours 
24 hours .48*** .13 .22 .73 
48 hours .82*** .16 .50 1.14 
Presence of 
symptoms at 24 
hours 
4 hours -.48*** .13 -.73 -.22 
48 hours .34* .15 .04 .65 
Presence of 
symptoms at 48 
hours 
4 hours -.82*** .16 -1.14 -.50 
24 hours -.34* .15 -.65 -.04 
Note: * p < .05, ** p < .01, *** p < .001 
 
Table 5.6 shows that there was a significant increase in the total presence of all twelve 
symptoms between 4 hours, 24 hours and 48 hours prior to death with a higher 
presence of symptoms occurring between 4 hours and 24 hours compared to between 
24 hours and 48 hours. This confirmed an increasing presence of the total symptoms 
towards the time of death, with greater significance between the two final time points 
(4 hours and 24 hours). 
  
5.4.5 The total intensity of eight symptoms at 4 hrs, 24 hrs and 48 hrs prior to 
death 
The same analysis was applied to test the hypothesis that the total intensity of 
symptoms would increase over the three time periods (Table 5.5). Again, a one way 
repeated measure ANOVA was conducted. This indicated (F = 9.76, df = 2, 59, p < 
001, partial η = .25), a significant difference in the mean intensity of symptoms 
reported over the three time points. While the p value is significant, the effect size of 
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partial η is regarded as large (University of Cambridge, 2019)18 meaning this is a 
worthy distinction. The analysis involved three levels, therefore post hoc comparisons 
were performed; these indicated significant (uncorrected) differences between two of 
the three time points when compared pairwise (all p  < .01) (See Table 5.7). 
 
Table 5.7 Pairwise comparisons of total intensity of eight symptoms^ at 4 hrs, 24 
hrs and 48 hrs prior to death (N = 61) 











symptoms at 4  
hours 
24 hours .11*** .03 .06 .17 
48 hours .18*** .04 .09 .27 
Presence of 
symptoms at 24 
hours 
4 hours -.11*** .03 -.17 -.06 
48 hours .07 .04 -.002 .14 
Presence of 
symptoms at 48 
hours 
4 hours -.18*** .04 -.27 -.09 
24 hours -.07 .04 -.14 .002 
Note: * p < .05, ** p < .01, *** p < .001 
^ Four symptoms (secretions, constipation, unable to respond and delirium) were 
recorded as ‘present’ or ‘not present’, so were not allocated an intensity score 
 
Table 5.7 shows that there was a significant increase in the intensity of symptoms 
between 4 hours and 48 hours prior to death with a higher presence of symptoms 
between 4 hours and 24 hours compared to between 24 hours and 48 hours, 
demonstrating that symptoms became more intense nearer the time of death.  
 
 
                                                          




5.4.6 The presence and intensity of individual symptoms 
When referring back to Table 5.3, the patterns in changes in the individual symptoms 
towards the time of death were observed. The last section reviewed the changes in total 
presence and intensity of symptoms, but further analysis to understand how individual 
symptoms changed over time is required. Table 5.8 presents the presence and intensity 
of individual symptoms prior to death at the same time points as previous, 4 hours, 24 
hours and 48 hours. The presence is reported as the number of participants 
experiencing a symptom at the given time point, while the intensity is reported by the 
Mean, Standard Deviation, Median and Range. Due to the nature of the data collection 
instrument, only eight symptoms are included in the individual symptom intensity, 
because four of the symptoms (secretions, constipation, unable to respond and 
delirium) were recorded in the data collection as ‘present’ or ‘not present’, so do not 
have a score allocated for intensity. 
Table 5.8 – Presence and intensity of individual symptoms at 4 hrs, 24 hrs and 
48 hrs prior to death  
  Time before death (N = 61) 
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* Four symptoms (secretions, constipation, unable to respond and delirium) were 
recorded as ‘present’ or ‘not present’, so do not have an intensity score 
^ The potential range of the intensity of symptoms is between 0 - 3 
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Table 5.8 shows a range of changes across the individual symptoms. Drowsiness, 
fatigue, anxiety, nausea, anorexia and shortness of breath all increased in both presence 
and intensity towards the time of death. The presence of secretions, unable to respond 
and delirium all increased towards the time of death. In contrast, pain and depression 
reduced towards the time of death, although pain had increased between 48 and 24 
hours, but decreased at the fours hour time point. To understand these further, the next 
section will analyse whether these changes were statistically significant. 
 
5.4.7 Pairwise comparisons of the presence of individual symptoms at 4 hrs, 24 
hrs and 48 hrs prior to death 
 
In order to test the hypothesis that the presence of individual symptoms (the number 
of participants having a symptom) would increase over the three time periods (n = 61 
as 61 participants had data collected at all three time points). Due to the categorical 
nature of the data (present or not present) and the measurement of the symptoms over 
three time points with the same participants, a standardised Cochran’s test was 
conducted using the data from Table 5.8 (see Table 5.9 for these). The Q values are 
reported in Table 5.9. As the analysis involved three levels, post hoc pairwise 
comparisons were performed on those that had a significant Q test (p < .05) (SPSS 
does not perform multiple comparisons when the overall test does not show significant 
differences across samples); these indicated significant (uncorrected) differences in 






Table 5.9 Results of Cochran’s Q test of the presence of individual symptoms (N 
= 61) 
























Shortness of breath 
Secretions 
Constipation 
Unable to respond 
Delirium 
Note: * p < .05, ** p < .01, *** p < .001 
 
The following table (5.10) provides an example of the data on which the Cochran’s Q 
test was run for the symptom of unable to respond at the three different time points. 
This shows an increasing number of participants had unable to respond recorded as a 
symptom towards the time of death. 
 
Table 5.10 Unable to respond – a sample of the data 
Time point Present (1) Not present (0) 
4 hour 39 22 
24 hour 31 30 
48 hour 23 38 
 
The pairwise comparisons tables (see Appendix xv) show that there was a significant 
(estimated at p < .05) increase in the presence of four of the twelve symptoms in the 
participants, which were anorexia, shortness of breath, secretions and unable to 
respond towards the time of death. The presence of anorexia increased significantly 
closer to death between the 48 hour and 4 hour time period and the 48 hour and 24 
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hour time period, but not between the 24 hour and 4 hour time period. The presence of 
shortness of breath increased significantly between the time periods of 24 hours to 4 
hours and 48 hours to 4 hours, again closer towards the time of death. The presence of 
secretions increased significantly between the 48 hour and 4 hour time points and 
between the 24 hour and 4 hour time points. Finally, being unable to respond increased 
significantly between all of the three time points (The full data can be found in 
Appendix xvi). 
 
5.4.8 Pairwise comparisons of the intensity of individual symptoms at 4 hrs, 24 
hrs and 48 hrs prior to death  
 
To be able to test the hypothesis that the intensity of individual symptoms would 
increase over the three time periods (for those participants for whom these data were 
available, n = 61), a one-way repeated measure ANOVA was conducted using the data 
from Table 5.8. Due to the number of symptoms being analysed the F value, F, degrees 
of freedom, df, and partial theta, partial η are reported in table 5.10 below. As the 
analysis involved three levels, post hoc comparisons were performed; these indicated 
significant (uncorrected) differences between all of the time points when compared 
pairwise (all p < .05) (see Appendix xv for full data tables).  
 
 
Table 5.11 Results of a one-way repeated measure ANOVA of the intensity of 
eight individual symptoms^ (N = 61) 
 F value 
 
df partial η 
Symptom    
Pain .85 2, 59 .29 
Fatigue 6.03** 2, 59 .17 
Drowsiness 9.04*** 2, 59 .24 
Depression 1 2, 59 .04 
Anxiety .08 2, 59 .003 
Nausea 2 2, 59 .07 
Anorexia 6.36** 2, 59 .18 
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Shortness of breath 11.53*** 2, 59 .28 
Note: * p < .05, ** p < .01, *** p < .001 
^ Four symptoms (secretions, constipation, unable to respond and delirium) were 
recorded as ‘present’ or ‘not present’, so do not have an intensity score 
 
 
The pairwise comparisons tables (see Appendix xvi) show that there was a significant 
increase in the intensity towards the time of death in four of the eight symptoms that 
had intensity levels measured, fatigue, drowsiness, anorexia and shortness of breath. 
The intensity of fatigue, drowsiness and shortness of breath significantly increased 
between the time points of 4 hours to 24 hours and 4 hours to 48 hours. The intensity 
of anorexia increased between all of the time points towards the time of death. (The 
full set of comparisons can be found in Appendix xvi). 
 
5.5 Inferential analysis  
5.5.1 The associations between total presence and intensity of symptoms and 
certain demographic and clinical characteristics 
 
The next section will look at the relationships between specific variables to test the 
hypothesis that there will be positive correlations between age, gender, number of 
diagnoses and length of stay and the two symptoms variables – presence and intensity 
– over the three time points prior to the time of death.  
 
5.5.2 The associations between the total presence of symptoms and the 
characteristics of age, gender, number of diagnoses and length of stay in care 




Table 5.12 Associations between total presence of symptoms and characteristics 
(N = 61) 
 Time before death 
 4 hours 24 hours 48 hours 
Age  -.10 -.03 .06 
Gender .07 -.04 .00 
No. of diagnoses .09 .06 .05 
Length of stay (in 
days) 
-.12 -.27** -.29* 
Note: * p < .05, ** p < .01, *** p < .001 
 
As can be seen in the correlation matrix in Table 5.11, the only significant correlation 
was in the predicted (negative) direction which related to a shorter length of stay being 
correlated to the presence of a higher number of symptoms at the 24 hour and 48 hour 
time points (r = -.27 (24 hours) to r = -.29 (48 hours), but not at the four hour time 
point prior to death. These, however, were of a small to medium effect sizes. 
 
5.5.3 The associations between the total intensity of symptoms and the 
characteristics of age, gender, number of diagnoses and length of stay in care 










Table 5.13 Associations between total intensity of eight symptoms^ and 
characteristics (N = 61) 
 Time before death 
 4 hours 24 hours 48 hours 
Age  -.04 .02 .08 
Gender -.02 -.05 .01 
No. of diagnoses .07 .01 -.04 
Length of stay (in 
days) 
-.16* -.23* -.29*  
Note: * p < .05, ** p < .01, *** p < .001 
^ Four symptoms (secretions, constipation, unable to respond and delirium) were 
recorded as ‘present’ or ‘not present’, so do not have an intensity score 
 
As can be seen in the correlation matrix in Table 5.12, the only positive correlation is 
in the predicted direction (a shorter length of stay, higher intensity of symptoms) over 
all three time points (r = -.16 (4 hours) to r = -.29 (48 hours), however these were of a 
small effect size giving a relatively consistent pattern here across intensity and 
presence. 
 
The next section will look at the presence of the individual symptoms (all 12 symptoms 
can be included while looking at presence) at the time closest to death (four hours) as 
this can include the data from all 157 participants. The mean presence of individual 
symptoms will be correlated with the demographics of age, gender, number of 
diagnoses and length of stay in the table (5.13) and with the five most common 
diagnoses in table 5.14. 
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5.5.4 The associations between demographics and the presence of individual 
symptoms at the time closest to death (within the final four hours)  
 
Table 5.14 Associations between demographics and individual symptoms at the 
time closest to death (within the final four hours) (N = 157) 
          Symptom 
 































































































-.03 .06 .14 -.06 -.03 -.06 .10 -.16* .14 -.04 .04 -.04 
Gender 
 
-.05 -.05 .04 -.03 -.13 -.03 -.03 .04 .19* .09 .08 .09 
No. of 
diagnoses 
.21** .01 -.08 .09 .19* .04 .01 .18* -.02 .14 -.22** .04 
Length of 
stay  
-.16* -.18* .02 -.21* -.08 -.02 -.14 .05 .06 -.04 .10 -.08 
Note: * p < .05, ** p <. 01, *** p <. 001 
 
In relation to the number of diagnoses a participant had, the total was significantly 
correlated with a number of symptoms, those with a higher number of diagnoses were 
less likely to be unresponsive (r = -.22) while they were more likely to have pain (r = 
.21), anxiety (r = .19) and shortness of breath (r = .18), all of which were of a small 
effect size. 
There is an association of small effect between the length of time a person had been in 
a care home and the three symptoms of pain, fatigue and depression. These were all 
negatively correlated (r = -.16, r = -.18 and r = -.21) meaning the longer a person spent 




5.5.5 A post hoc analysis - The associations between the diagnosis of dementia and 
symptom presence at the time closest to death (within the final four hours) 
This final section leads on from the analysis in section 5.5.4 and will consider a specific 
diagnosis in more depth. The diagnosis of dementia has already been discussed in 
previous chapters as a diagnosis of specific interest, therefore, it has been decided to 
include this symptom in a post hoc analysis as it links closely with research objective 
2 although was not specified in the original hypotheses. Of the 157 participants with 
data at the time point closest to death, 75 participants had a diagnosis of dementia, 
while 82 did not. The analysis will involve the application of multivariate analysis of 
variance (MANOVA). MANOVA is similar to an ANOVA (as applied earlier in this 
chapter) but enables the inclusion of several dependent variables. MANOVA permits 
the testing of the effect of one or more independent variables on two or more dependent 
variables. The key assumptions to conducting a MANOVA are that the observations 
are randomly and independently sampled from the population and that each dependent 
variable has an interval measurement and is normally distributed.  
 
The result of the MANOVA indicated that there was a statistically significant 
difference in the presence of symptoms between those participants with a diagnosis of 
dementia and those without, F (12, 144) = 2.48, p < .01; Wilk’s Λ = 0.829, partial η2 
= .17). On examining the individual symptoms, the diagnosis of dementia had a 
significant effect on three symptoms: fatigue (F (1, 155) = 12.76, p < .001, partial η2 
= .08); depression (F (1, 155) = 8.19, p < .01, partial η2 = .05); and anorexia (F (1, 
155) = 6.87, p < .01, partial η2 = .04). This means that having a diagnosis of dementia 
increased the likelihood of having fatigue, depression and anorexia, but was not linked 
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to any of the other symptoms. The relationship between fatigue and dementia was 
highly significant, (p < .001) with a large effect size, while the relationship between 
the symptoms of depression and anorexia were both significant (p < .01) with small to 
medium effect sizes. 
 
As this final set of analyses were performed as a post-hoc test, these results would need 
replication in further studies but can provide an indication of the relationship between 
the presence of symptoms in the final few hours of life and a diagnosis of dementia. 
 
5.6 Conclusion 
The data were complex due to the cumulative nature of recruitment to the study. 
Participants were recruited when it could be identified that they were dying: the 
difficulties with this meant that recruitment to the study ranged from between four 
hours up to 24 days prior to death highlighting the uncertainty of recognising 
impending death. Data were collected on 12 individual symptoms (the modified ESAS 
comprised of eight ordinal and four categorical responses). 
 
Through an initial simple descriptive analysis, the five most commonly occurring 
symptoms were found to be drowsiness, fatigue, anorexia, unable to respond and 
shortness of breath and the least reported symptoms were nausea, constipation and 
delirium. However, to examine this pattern further and address the objectives, a set of 
hypotheses were developed and a more detailed programme of analysis carried out to 
test the hypotheses. The total symptom load was first investigated in relation to 
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presence and intensity and this was followed by an exploration of the presence and 
intensity of individual symptoms.  
 
When considering the total presence and intensity of all symptoms, there was an 
increase in the mean of both, showing an increase towards the time of death. 
Subsequent pairwise comparison testing between 4 hours, 24 hours and 48 hours 
resulted in statistically significance differences across all of the time periods in relation 
to presence and in all but one (48 hours to 24 hours showed a mean change, but not a 
significant change) in relation to intensity. This demonstrated that the total presence 
of symptoms increased and became more intense the nearer to the time of death. 
Taking a similar approach to the previous analysis, but by examining the presence and 
intensity of individual symptoms, there was found to be a significant increase in the 
presence of four of the twelve symptoms towards the time of death which were 
drowsiness, shortness of breath, secretions and unable to respond. The main increases 
were found in the periods between 24 and 4 hours and 48 and 4 hours. It was only 
possible to study the change in intensity of eight symptoms (due to the binary nature 
of the measuring of four of the symptoms) and this disclosed a significant increase in 
the intensity towards the time of death in four of the eight symptoms; fatigue, 
drowsiness, anorexia and shortness of breath. Similarly to presence, the main increases 
were found in the periods between 24 and 4hours and 48 and 4 hours. 
 
Next, associations between the symptoms and demographic variables were tested for 
in order to look for correlations. The total presence and intensity of symptoms and the 
characteristics of age, gender, number of diagnoses and length of stay in care home 
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were tested at 4 hours, 24 hours and 48 hours prior to death. In relation to presence, 
the only significant correlation was related to a shorter length of stay being correlated 
to the presence of an increased number of symptoms at the 24 hour and 48 hour time 
points. This was also the only significant correlation in relation to intensity, when a 
shorter length of stay was found to relate to a high intensity of symptoms, although 
only at the 24 hour and 48 hour time points.   
 
Finally, associations between demographics, diagnoses and symptoms were tested for, 
these were limited and mainly of small effect (r< 0.30). Some key associations were 
observed including the relationships between the length of stay and different types of 
diagnoses, and the increased likelihood of having specific symptoms when certain 
diseases were present. 
 
Summary of the hypotheses in relation to the findings 
1. There will be an increase in the presence and intensity of the total symptom load 
between 48 hours, 24 hours and 4 hours prior to death. The null hypothesis was rejected 
and the hypothesis was accepted. 
2. There will be an association between the total presence and intensity of the total 
symptom load and the key characteristics of residents at 48 hours, 24 hours and 4 hours 
prior to death. The presence and intensity of symptoms will positively correlate with 
older age, a higher number of diagnoses, a longer length of stay and a male gender. 
The null hypothesis was upheld as there were very few correlations between symptom 
presence and intensity and the key characteristics. Of the few relationships, all were 
of small effect.  
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3. There will be an increase in the presence and intensity of individual symptoms 
between 48 hours, 24 hours and 4 hours prior to death. The null hypothesis was rejected 
and the hypothesis was accepted. 
4. There will be an association between the total presence and intensity of individual 
symptoms and the key characteristics of residents at the time closest to death (within 
4 hours). The presence and intensity of symptoms will positively correlate with older 
age, a higher number of diagnoses, a longer length of stay and a male gender. The null 
hypothesis was upheld as there were very few correlations between symptom presence 
and intensity and the key characteristics. Of the few relationships, all were of small 
effect. 
 
The results from a descriptive analysis and an inferential analysis of the data have been 
presented in this chapter. The following chapter will interpret and explain these 
findings in light of what is already known about symptoms at the end of life in care 









Chapter 6 – Discussion 
6.1 Introduction 
The focus of this study has been the presence of symptoms, because symptom 
measurement, leading to its subsequent management is a core element of end of life 
care (Sepúlveda, Marlin, Yoshida, & Ullrich, 2002). Estabrooks et al. (2015) identified 
that assessing symptoms that lead to managing them is a foundational component, 
stressing the very active elements of treatment, management and control. The literature 
review identified five gaps in the research in symptom prevalence in care home 
residents at the end of life: 
1) The lack of prospectively collected data 
2) The data were typically collected without using any form of instrument or data 
collection tool, or if instruments were used, there was no consistency of their 
use   
3) Studies did not capture symptoms relevant for the care home population 
4) The temporal aspects of symptom prevalence have received little attention 
5) Only one study was carried out in the UK (Knight & Jordan, 2007) 
 
To address these gaps, the research objectives and hypotheses set out to explore the 
presence and intensity of end of life symptoms at key time points towards the very end 
of life. This discussion chapter will critically consider the findings, focusing on the 
presence and intensity of symptoms and the changes over time, and in consideration 
to certain characteristic and demographics, and outlining a new symptom typology 
associated with the dying phase in care home residents. This will lead into a discussion 
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involving the recognition of the dying phase for residents dying in care homes. Finally, 
the strengths and limitations of the study will be identified, and concluding with the 
implications for practice, policy and research. 
 
6.2 An overview of the characteristics of symptoms of a resident dying in a care 
home 
The sample was composed of 157 participants from 11 different care homes. The mean 
age was 84.80 years and comprised of two-thirds females. The length of stay in the 
care home ranged from two days to over 13 years.  
 
The first part of the simple descriptive analysis found the five most commonly 
occurring symptoms at the end of life were drowsiness, fatigue, anorexia, unable to 
respond and shortness of breath and the least reported symptoms were nausea, 
constipation and delirium. Drowsiness and fatigue were the most common with similar 
rates of prevalence (drowsiness, range 86 - 88% and fatigue, range 80 - 84%) 
increasing in intensity closer to the time of death. Other studies in end of life symptoms 
in care homes residents show similar findings (Brechtl et al., 2006; Hendriks et al., 
2014; Sandvik et al., 2016). Although fatigue and drowsiness are often used 
interchangeably, fatigue is different from drowsiness. Drowsiness is feeling the need 
to sleep, while fatigue is a lack of energy and motivation (Chamberlain, Houghton, & 
Gray, 2010). However, a proxy observer may be unable to differentiate between the 
two, which lead to them being categorised together, particularly at the end of life. This 
could explain why many studies had considered one or the other (Brechtl et al., 2006; 
Van Lancker et al., 2013), while only a few studies had used both (Hui, Dev, et al., 
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2015).  A commonality between the work of Hui et al (2015) and this study was the 
use of the Edmonton Symptom Assessment Scale (ESAS) which includes both fatigue 
and drowsiness. As discussed earlier in the literature review, the use of so many 
different instruments made it very difficult to compare results, thus impacting upon 
consistency. 
 
As found within this study, drowsiness and/or fatigue were the most common 
symptoms at end of life, however, this may have been predicted, given the expectation 
that people will increasingly sleep more within the terminal phase and while this did 
appear to occur in many studies, as identified above, it did not occur with all. Studies 
that have been carried out at the end of life with other populations again rank 
drowsiness and/or fatigue as highly prevalent symptoms (Cheung, Le, & 
Zimmermann, 2009; Doorenbos, Given, Given, & Verbitsky, 2006; Hui, Santos, et al., 
2015; Nauck, 2001). Drageset, Corbett, Selbaek, and Husebo (2014) found that pain 
was the highest occurring symptom although their study compared cancer related 
symptoms between residents with and without cancer, rather than focussing 
specifically on end of life symptoms. This concurs with the work from Ritchie et al. 
(2013) who found pain to have the highest rate of symptom occurrence in age group 
60 – 65 years but when compared with older age groups, they reported that a lack of 
energy had a higher occurrence than pain. This suggested that there was an age related 





As well as considering presence of individual symptoms, this study set out to take a 
temporal view of changes in the presence and intensity of symptoms, both in terms of 
overall total symptoms and within individual symptoms. 
 
6.3 The total presence and total intensity of symptoms and changes over time 
When considering the total presence and intensity of all symptoms, there was an 
increase in the mean of both, showing an increase towards the time of death. 
Subsequent pairwise comparison testing between the 4 hour, 24 hour and 48 hour time 
periods resulted in statistically significance differences across all of the three time 
periods in relation to presence and in all but one in relation to intensity. The time period 
between 48 hours to 24 hours revealed a shift in the mean towards the time of death, 
but not a significant change. This means that total presence of symptoms increased 
towards the time of death, so that a participant had more symptoms, and those 
symptoms became more intense the nearer to the time of death.  
 
6.4 The presence and intensity of individual symptoms and changes over time 
Taking a similar approach to the total symptom load, it was necessary to understand 
whether all symptoms were increasing at equal levels or whether it was individual 
symptoms that were increasing the total load. Expanding on the analysis further by 
examining the presence and intensity of individual symptoms, there was found to be 
an increase in the presence of seven of the symptoms between the three different time 
points towards the time of death; of these, four were statistically significant, which 
were drowsiness, shortness of breath, secretions and unable to respond. The main 
increases were found in the periods between 4 and 24 hours and 4 and 48 hours. There 
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were a few anomalies within presence; for example, the presence of both depression 
and pain decreased, which given an increase in the presence of drowsiness may have 
led to these symptoms being more difficult to assess.  
 
When considering the changes in levels of intensity within the individual symptoms, 
it was only possible to study the change in intensity in eight symptoms (due to the 
binary nature of the measuring of four of the symptoms).  This disclosed a significant 
increase in the intensity towards the time of death in four of the eight symptoms, 
fatigue, drowsiness, anorexia and shortness of breath. Similarly to presence, the main 
increases were found in the periods between 4 and 24 hours and 4 and 48 hours. These 
temporal aspects of combined symptom load have not been studied previously in 
relation to residents in care homes; however, this presentation has a very similar 
pattern to Seow et al. (2011) who documented the intensity of nine ESAS symptoms 
in the last six months of life with patients with cancer. They reported that fatigue, poor 
appetite, drowsiness, shortness of breath, and well-being worsened over time, whereas 
nausea, depression, anxiety, and pain remained mostly stable. 
 
When looking at groups of signs and how the signs co-occur, there are patterns that 
begin to emerge when reviewed over time. There were a group of five symptoms 
(drowsiness, fatigue, anorexia, unable to respond and shortness of breath) that were 
present at three key points during the final two days of life (at 4 hours, 24 hours and 
48 hours). They were ranked in the same order at each of the three different time points 
prior to death. However, even beyond these three time points, the symptoms were also 
present in the study population and were the most frequently occurring across the data 
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collection period across all participants. There was, however, a difference in the 
intensity to which these symptoms were observed. The intensity of symptoms 
increased towards the time to death.  
 
All symptoms except pain increased towards the time of death in intensity (although 
pain reduced very slightly and was not statistically significant). A general decline (one 
that is with less presence and intensity of acute symptoms) can be seen within this 
cohort.  These are very similar to the findings of Estabrooks et al. (2015)  and Echteld, 
Deliens, van der Wal, Ooms, and Ribbe (2004) who carried out studies in similar 
populations. However in their studies, the level of pain was reported to have decreased, 
but this could be due to a lack of ability to express it either due to proxy reporting or 
could have been masked by other symptoms such as drowsiness.  
 
6.5 A typology of symptoms associated with the dying phase in care home 
residents 
The background for categorisation of symptoms in end of life care primarily comes 
from the Liverpool Care Pathway (LCP) (Chapman & Ellershaw, 2011; Coackley & 
Ellershaw, 2008; Ellershaw, Smith, Overill, Walker, & Aldridge, 2001). The LCP 
included five symptoms and were identified as “key symptoms” and described as the 
“commonest symptoms in the dying phase”. It is not explained why the four 
“commonest” symptoms (plus one “other problem”) were included within the LCP, 
yet it went on to become a highly influential document to support symptom control 
through assessment and measurement in end of life care. This was further evidenced 
by the increasing number of published studies around symptoms that aim to improve 
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their management. Fewer studies had been carried out to understand the impact of the 
symptoms without an ‘end-goal’ in sight. Some symptoms appeared to have been 
given more value than others. For example, there were large numbers of studies 
focussing specifically on pain, shortness of breath, and secretions and nausea were 
included regularly in studies, while symptoms such as fatigue remained relatively 
under researched and less understood (Judge, Schnitzer, & White, 2015). A type of 
categorisation was considered by Treusch et al. (2015), who studied behavioural 
symptoms in dementia and discussed apathy as a ‘passive’ symptom as opposed to 
other symptoms such as agitation and aggression. The authors did not discuss why they 
labelled apathy as ‘passive’, although they did consider that apathy can be easily 
overlooked by staff, possibly because it is a quieter or less obvious symptom, in that it 
usually presents in a low key manner, but its very nature can lead to be less disruptive 
to staff with less burden to treat and manage. Looking at the symptoms from this study, 
drowsiness, fatigue, anorexia and being unable to respond all fell into a similar 
category, in that they were quieter symptoms. As a result, from the findings within this 
study, a typology of symptoms is proposed that addresses three different dimensions. 
1) the classification of symptoms into two principal categories; 2) the prevalence of a 
range of symptoms taking into account their presence and intensity and; 3) the 
temporal characteristics of symptoms. Although these will be presented in a systematic 
manner, the three aspects interconnected with each other and this will be referred to as 












Figure 6.1 A visual representation of the symptom typology 
 
6.6 The classification of symptoms into two principal categories 
The implications of the presence and intensity of symptoms will be discussed further 
on in this chapter, however a key finding of this study concerned the symptoms that 
were the most prevalent and how they were interpreted. It is proposed that the 
symptoms can be divided into two principal categories aligning to the symptoms with 
the highest levels of frequency and intensity. While literature that discussed symptom 
groupings or clusters or reporting about different levels or intensities is very common, 
there was a paucity of literature about symptoms themselves being classified. A 
classification that is used internationally is the ICD-16 (version 16) (World Health 
Organization, 2016), but this is a disease categorisation codes for reporting diseases 
and health conditions. It does not describe the symptoms. (Meads & McLemore, 1974) 
use a similar coding to classify patients symptoms. Stanton, Downham, Oakley, 
Emery, and Knowelden (1978) identified two different categories of symptoms: major 
and minor, during a study of terminal illnesses in children. They proposed that major 
symptoms were those that usually needed a medical opinion on the same day, while 
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minor did not and observed that many children had non-specific symptoms rather than 
the physical signs of life-threatening illness that are of major concern to health care 
professionals. Wilson, Downham, and Forster (1984) expanded upon the work of 
Stanton in relation to major vs. minor illnesses in children and although they argued 
that major and minor symptom categories were not sufficiently discriminating enough 
to use in practice, they still used the same division in relation to those needing same 
day medical opinions. There are a number of problems with this classification. It is a 
very medically emphasised classification, which is linked wholly to its degree of life-
threatening threat. It does not allow for any individual interpretation as what is major 
for one person is minor for another. 
 
While searching for any evidence that this had been addressed previously, a forum 
member on the website/forum Researchgate posted a question in 2014 to ask “Is there 
any universal symptom classification”? (https://www.researchgate.net/post/Is_there_ 
any_universal_symptom_classification)  It was asked whether there were any universal 
approaches to classify symptoms according to their features. He received several 
replies to provide him with disease specification classification, but nothing else. 
 
Using the modified Edmonton Symptom Assessment Scale (modified ESAS), this 
study measured 12 different symptoms: anorexia, anxiety, constipation, delirium, 
depression, drowsiness, fatigue, nausea, pain, secretions, shortness of breath, and 
being unable to respond. These symptoms, especially when experienced at the end of 
life would be difficult to categorise as major or minor, yet when viewed in their 
ascending order (of most prevalent first), a different classification appears 
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6.6.1 Silent symptoms 
This study had identified that the symptoms that occurred with the highest frequency 
and intensity were drowsiness, fatigue, anorexia and unable to respond. It is proposed 
that these symptoms fall under the classification of ‘silent’.  
 
End of life care education often places a strong emphasis on teaching health care 
professionals how to manage symptoms, particularly around symptoms as reported in 
the literature review, such as pain, dyspnoea, nausea and secretions. However, many 
of the symptoms experienced at the end of life, such as the most common ones 
identified in this study, i.e., drowsiness, fatigue, anorexia and unable to respond, do 
not require active treatment but rather require recognition of their being part of the 
dying process. Some symptoms at the end of life may be viewed as ‘inevitable’ or 
‘acceptable’. Health professionals may be so attuned to symptoms that must be treated 
that they do not view these as symptoms. During professional training, there was an 
emphasis on active symptom treatment, so that the more subtle symptoms received 
less attention. Fatigue was one such symptom that had traditionally received less 
attention than others (Haas, Kallen, & Escalante, 2012). It can also be affirmed by the 
literature review in chapter three, where pain was included in 23 studies, yet fatigue 
with its high prevalence only in nine. This in turn reduces the symptoms’ value in the 
eyes of those caring for residents with symptoms like fatigue, making certain 
symptoms appear or seem ‘silent’. This invisibility can also be linked to the tenet of 
treating what can be seen which can be related to the above about viewing them as 
inevitable. The impact upon moral distress as a result of witnessing symptoms, and 
ignoring them may have made it easier to bear as human beings which can result in 
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professionals into thinking that they are not a problem. Every person has an ‘internal 
frame of reference’ (Rosendal, Jarbol, Pedersen, & Andersen, 2013), which interprets 
bodily sensations as either ‘normal’ or ‘threatening’ and was moderated by an internal 
frame of reference based on previous bodily experiences. When caring for older 
people/dying people the internal frame of reference of the professional may broaden 
the perception of ‘normality’ so it becomes accepted without question. The analysis of 
professionals’ practice in palliative care shows how the ‘end of life’ was constructed 
in two ways: as a stage of psychological preparation for patients and families (and 
therefore an object of professional intervention), and as a gradual process culminating 
in death (Alonso, 2012).  
 
Recognising the worth of silent symptoms could support the earlier identification of 
dying. Within this study, the silent symptoms increased towards death at the highest 
rate. This was supported by other studies (Sandvik et al., 2016) who found that 
increased fatigue and poor appetite were significantly associated with being able to 
identify the day a person was imminently dying. 
 
6.6.2 Strident symptoms 
This study had identified that the symptoms that occurred with the least frequency and 
intensity were shortness of breath, secretions, pain, anxiety, depression, constipation 





Strident symptoms are those that are treated in an active way. Considering the main 
symptoms that were originally identified in the Liverpool Care Pathway and now are 
included in individualised care plans19, they were all symptoms that had a solution or 
a way of reducing them. In many ways, these are the opposite of silent symptoms 
because they require attention. While silent symptoms are quiet and insidious, strident 
symptoms can be more apparent and noisy. They can be less difficult to ignore and can 
be more demanding of the professional.  
 
There is a risk in taking too much notice of these symptoms at the cost of ignoring 
silent symptoms. While they do need to and can be managed and can also indicate the 
end of life, this study found that they did not occur with the same frequency and 
intensity as the silent ones and they are not as reliable in being used to recognise the 
very end of life. They may, however, distract the professional from having recognised 
impending death and shift the focus to acute symptom management, which is when the 
risk of inappropriate hospital admissions can occur. As professionals who strive to 
provide good care, especially at the end of life when it may feel like the last chance to 
get it right, there is often a desire to ‘do’ something; yet ‘being with’ someone which 
is a very real humane response, is often perceived as something more uncomfortable 
and challenging to do (Speakman, 2018). 
 
The identification of these two categories of symptoms within this study appeared to 
be novel and has not been identified in any other published work to date. Although 
                                                          
19 Individualised care plans are identified in the NICE Guidance document ‘Care of dying adults in the 
last days of life’ (March 2017). It was part of the process that superseded the Liverpool Care Pathway 
 188 
 
similar rankings of symptoms have been found in other studies, and will be discussed 
later in this chapter, this previously unrecognised categorisation of silent and strident 
symptoms is unique. 
 
6.7 Symptoms and different individual characteristics 
The purpose of this section of the analysis was to look for symptom modulators; these 
are variables that are consistently associated with the expression of one or more 
symptoms. The main variables that were tested for associations were: 
Age was included because the average age of residents is increasing, but it is also likely 
to continue to increase as this proportion of the population are increasing, leading to 
the oldest people requiring care.  
Gender was included as a variable in view of the increasing number of men living in 
care homes compared to women. 
Length of stay was included because of the decreasing length of stay in care homes. 
Number of diagnoses were included due to the increasing complexity of residents 
second to multiple morbidities. 
Finally, the five most frequent diagnoses were included: one area of topical interest is 
dementia, prevalence is increasing generally but also within the literature review, three 






6.7.1 Associations between total presence and intensity of symptoms and 
characteristics 
Associations between age, gender, number of diagnoses and length of stay and the total 
symptom presence and intensity were tested for. The main association that was 
observed was a relationship between the length of stay and total symptom presence 
and intensity. Regarding total presence, there was a negative association, which meant 
that the less time spent in the care home, the participant would have a higher number 
of symptoms, and however this was only statistically significant at 24 and 48 hours. 
There was a greater association between the total symptom intensity over time and the 
length of stay, as this was significant at all three time periods, although only with a 
small effect size. There was no association between any other variables in this study 
which starts to illustrate a portrayal of more similarities than differences in the dying 
phase of residents. 
 
6.7.2 The associations between demographics and the presence of individual 
symptoms at the time closest to death (within the final four hours) 
To narrow the focus down on the final four hours prior to death, all twelve symptoms 
were tested for associations with age, gender, number of diagnoses and length of stay 
These were found to have overall little associations with the symptoms, with mainly 
small effect sizes. The most notable association was that of the number of the number 
of diagnoses and four symptoms (pain, anxiety, shortness of breath and unable to 
respond), although again, with small effect sizes (r = -.18 to -.22) indicating an 




Finally, associations between symptoms and five different diagnoses were tested for. 
Again, there were some correlations, but these were all of small effect size (r = -.18 to 
-.23), making it difficult to show clear relationships between these variables. 
 
Sometimes, it is more important to consider what the data does not demonstrate rather 
than what is present.  When considering the associations between total presence and 
intensity of symptoms and characteristics, as well as individual symptoms and 
characteristics, the study population has very few differences, despite their different 
characteristics resulting in a very homogeneous cohort of people. 
 
6.8 Recognition of the dying phase 
In line with many other studies, this study identified a slow response of staff in 
anticipating or recognising dying. As discussed in the background chapter 2, end of 
life care is care that has a very broad application and can apply to a person who has 
many weeks or months to live. However as this study is focussing on the final days of 
life, end of life care here is used to apply to that period of time immediately prior to a 
resident’s death (this would have previously be known as ‘terminal care, although that 
term is little used now). The mean time from recognition of death to the point of death 
in this study was 2.3 days (median 4.5 days), but within a very large range of time 
(four hours – 24 days). Most deaths, however, occurred shortly after data collection 
started (when recognition of death took place). Twenty three participants only had a 
single set of data recorded, so having died within four hours of being identified as 
dying. Yet their symptoms were only minimally different to those who had longer data 
collections of a few days. Barclay et al. (2014) identified that while there is a gradual 
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deterioration or ‘dwindling’ of older frail people, this is commonly recognised in 
retrospect. Their study proposed this, having identified four trajectories to death: 
‘anticipated dying’, ‘unexpected dying’, ‘uncertain dying’ and ‘unpredictable dying’, 
however it was a small study with 23 deaths. As it appeared that all deaths in the 
participating care homes were captured within this study, it would rule out unexpected 
dying, so leaves a very fine line between anticipated dying: and unexpected and 
uncertain dying. As most deaths occurred within a relatively short time of recognition, 
this study supports the conclusion that most deaths are either uncertain or unexpected, 
yet the reality is that with the right knowledge and support, care home staff would be 
able to observe for anticipated dying in many cases. This may also be explained by the 
work of Cable‐Williams and Wilson (2014) who noted that the trajectories of decline 
associated with chronic progressive diseases in advanced old age have few prognostic 
markers making it difficult to determine when to start end of life care. Covinsky, Eng, 
Lui, Sands, and Yaffe (2003) also found a link between frailty and functional decline 
stating that it was not likely for any of the four measures of frailty to identify a time 
point prior to death when there was an abrupt decline in function that would signal 
impending death.  
 
Despite a general awareness in the care homes that death occurs naturally at the end of 
a long life and/or long illness (Cable‐Williams & Wilson, 2014), this serious decline 
towards death was not noticed or acknowledged until an average of 2.3 days (and much 
less in many cases) in this study, thus limiting end of life care to very late stages and 
potentially resulting in reactive rather than pro-active care and subsequently reactive 
rather than pro-active decisions, which may aid understanding as to why some 
‘unavoidable’ hospital admissions occur. Presence of a symptom does not solely 
 192 
 
indicate death within the last 48 hours: participants were more likely to have increased 
unresponsiveness (but not significantly so) (Pollock, Caswell, Harwood, & Porock, 
2014). 
 
6.9 The strengths of the study 
6.9.1 A unique approach 
This was the first known research study to observe and report a typology of dying and 
characterise the symptoms into two types. The research aim and objectives were based 
on a clinically relevant question, so as a result, the findings had meaning about the 
population that they involved. The study set out purposively to observe and report a 
range of common end of life symptoms experienced at the very end of life, using 
prospective methods and direct and consistent measurement procedures. 
 
6.9.2 The use of a systematic measurement tool 
The study utilised the Modified Edmonton Symptom Assessment System to assess and 
measure symptoms. While there was no perfect tool following a comprehensive review 
of the available tools, the modified ESAS met specific criteria. It fulfilled the 
requirement of being both a clinical tool, but also met the requirements for being used 
within clinical audit or research (Nekolaichuk et al., 2008). It enabled a consistent 
approach to the assessment and measurement of symptoms within a single document, 
while also allowing a repeated administration over the period of data collection. The 
goal of the ESAS has been described as simply practical: to identify a few active 
symptoms using a consistent listing and scoring system across patients (Richardson & 
Jones, 2009). It was easy to administer and was reported to be easily integrated into 
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the nurse’s daily routines, so much so that several of the care homes continued with its 
use after the data collection had been completed. 
 
6.9.3 A comprehensive data set 
The sample of care homes were purposive due to ensuring that the homes were willing 
to be involved with the study and stayed engaged throughout the research process. 
However this purposive sample was a representation of a mix of types and sizes of 
care homes and a representative sample when comparing the characteristics with other 
care homes across the area. They were, however, spread across a broad geographical 
area which meant a significant amount of travelling for the researcher when collecting 
data sheets. 
 
This study had a relatively small sample size (N = 157), although this was comparable 
and often favourable in line with the other studies in the literature review. The real 
strength however, came from the richness of the data that were achieved due to the 
number of time points and residents that were incorporated. This resulted in almost 
two thousand observations collected through the course of the study. There was very 
little missing data which meant that missing data computations were not required. 
Despite the fact that the participants were all at the end of life and that it is a very 
sensitive time for the residents, families and staff, there were no requests for 
participants not to take part in the study nor for any withdrawals once data collection 
was underway. Even though the very end of life phase is very difficult to predict, there 
were no reports from care homes of not collecting at least one data point from residents 
who were dying, adding to the comprehensiveness of the data set. 
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6.9.4 Supportive relationships with care homes 
The strengths noted above were supported by the full data set that were achieved 
during this study. The researcher was known to the care homes professionally through 
previous professional support (mainly through the provision of education) and this 
enabled the researcher to be able to work closely with the homes while maintaining a 
professional boundary. The relationships that developed with the homes (and with the 
care home manager and senior staff) were key. The relationship was supportive but 
realistic with its expectations and the requests made of the care homes. It resulted in 
high quality data and despite the length of the data collection period, there were little 
missing data. 
 
It has been reported that care home staff, health professionals or family may all act as 
gatekeepers to ensure that residents do not participate in research that may be 
burdensome or detrimental to their health and wellbeing (Moore and Hanratty, 2013). 
Being invited and able to speak with care home staff and with families at family 
meetings meant there were no residents’ families who requested their family member 
not be involved with the research. 
 
6.10 The limitations of the study 
6.10.1 The choice of a systematic measurement tool 
At the time of data collection, there was no validated measurement tool currently used 
in this population to report the end of life symptoms; however, the use of the modified 
ESAS was the best available for data collection with staff reporting on its ease of use 
and clarity. The completeness of the data collected also indicates that this instrument 
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was not burdensome for in use in practice, an aspect that could have seriously impacted 
upon the study if it had been. The modified ESAS was selected as it provided the best 
match to the research requirements. However, it comprised of 12 symptoms, and 
although these were appropriate when selecting the instrument, it limited the range of 
symptoms to be studied, although having a pre-defined set of symptoms is seem as 
preferable to having no guide. The modified ESAS also had an anomaly in that eight 
symptoms were continuous variables with a scale of 0-4 and four symptoms were 
recorded as categorical (present or absent). This resulted in not being able to measure 
intensity of these four symptoms as they could only be present or not, and had not been 
assessed with an intensity score. To overcome this, an option may have been to use an 
alternative version of the ESAS, for example, one with all symptoms having the ability 
to be measured as continuous. Staff from the care homes could have been involved in 
the original choice of tool as their experience of end of life care would have been 
valuable to inform the decision process. A representative from each of the care homes 
could have been invited to provide feedback regarding the potential use of the modified 
ESAS. However, a balance between the utility of a tool and the purpose for data 
collection for a research project would need to be kept at the forefront. It was also 
fortunate that the researcher worked within a different care home as a bank nurse and 
had experience of end of life care at first hand. 
 
Since the study has been carried out, there have been further changes and subsequent 
studies involving the ESAS to increase reliability and validity. The ESAS-revised 
retains core elements of the ESAS, with improved interpretation and clarity of 
symptom intensity assessment. It represents the next generation of  development, with 
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further validation recommended for drowsiness, appetite, and well-being (Watanabe 
et al., 2011). 
 
At the time the study was carried out, another instrument, the Palliative Outcome Scale 
(POS) was reviewed and rejected as it did not meet the criteria as well as the ESAS. It 
now has undergone major changes (now renamed integrated Palliative Care Outcome 
Scale or iPOS). There are multiple versions for use with different types of diseases and 
care settings (including proxy-rating) and it has demonstrated construct validity 
acceptable test/re-test reliability for seven items, and good internal consistency 
(Collins et al., 2015). However, the iPOS is being primarily used as part of a set of 
Patient Reported Outcome Measures (PROMS) to capture changes in health status. 
With this in mind, the advice on using the iPOS is to understand how the symptoms 
are affecting the individual rather than capturing its presence or intensity. This 
highlights the challenge of finding an appropriate measurement tool that meets the 
needs of the patient while being suitable for use in research. 
 
A single tool was used to collect data; as discussed earlier, this was a considered 
decision to reduce the burden on the qualified nurses in collecting the data. It also 
enabled consistency with use of the instrument in that staff could become familiar with 
the instrument and not have a risk of competing instruments causing confusion. 
However, there is a risk when measuring the prevalence and intensity of symptoms for 
patients at the very end of life. A single tool may not be sensitive enough to measure 
psychological symptoms such as depression, especially if they consist of 
multidimensional aspects affected by emotional, social, and various other elements 
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(Kajiwara, Kako, & Miyashita, 2019). This will be discussed in more depth in section 
6.10.4. In addition, the use of this may have also caused some limitations such as floor 
or ceiling effects, due to the measurement limitation that occurs when the highest 
possible score or close to the highest score on a test or measurement instrument is 
reached, thereby decreasing the likelihood that the testing instrument has accurately 
measured the intended variable (Denzin & Lincoln, 2011). The four point scale of the 
ESAS may have contributed to this and using the ten point scale would have widened 
the floor and ceiling effect. 
 
6.10.2 The use of a systematic measurement tool 
Although the use of a systematic measurement tool can be considered a strength, 
conversely this can also be seen as a limitation. There is a need to ensure full reliability 
and to use the tool properly. The staff completing the assessment were all qualified 
nurses. As discussed earlier, all staff had undergone training to understand the rationale 
for the study and the use of the modified ESAS. A case study was presented to enable 
discussion to support consistent completion, and definitions of the symptoms were 
added to the back of the modified ESAS form following feedback from the staff to 
ensure the use of a consistent definition of the symptoms. Inter-rater reliability 
between different staff members could have been further enhanced by obtaining 
information on the staff collecting data, for example, type of qualification 
(RGN/RMN), how long they had been qualified, what was their first language. This 
could have been checked against other completed data to see if it was a factor. The 
modified ESAS form incorporates a space at the bottom for the nurses’ initials, so it 
would have been a straight forward process to add in this extra level. Reliability could 
 198 
 
have been further checked by the use of focus groups with staff to promote discussion 
about the assessment (and if any problems arose). A second method would have 
involved gaining ethical approval at the beginning of the study to gain access to 
resident notes or their drug charts which would further acted as a review process. 
 
On reflection, a follow up evaluation could have been carried out to understand what 
the staff thought of the modified ESAS tool. Informal feedback was gathered 
throughout the process, but this was done to support the staff, i.e., to be able to pick 
up on any problems during data collection, but was not done within a rigorous process. 
The feedback could have been gained by holding a small focus group with 
representatives from the care homes. Their views on the design, applicability, ease of 
use and the nature and types of symptoms included would have been of benefit to 
increase learning about the use of tools at the end of life in care homes, especially as 
this is very new territory to be exploring. 
 
6.10.3 Lack of missing data 
Missing data is another provocative matter. While having minimal missing data is a 
positive factor, especially with the need to carry out statistical analyses, it also raises 
the need to consider any consequences that this may have. As discussed above, the 
data were collected by qualified staff and the completed forms were collected by the 
researcher or the business administrator. All forms were scanned on collection for 
gaps, but forms (apart from a few omissions) were complete. Each time point was 
initialled for verification by the member of staff completing that assessment. While it 
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is possible that all forms were authentically completed, the initials could have been 
double checked with the member of staff to ensure this.  
 
A further question to be asked is whether the tool changed the behaviour of the staff? 
Where there patterns of reporting, i.e., staff following previous assessment rather than 
looking at the resident? This would have been more difficult to overcome, but holding 
a focus group with staff following the data collection period could have led to 
discussion. An alternative way to assess this would be to gather a random sample of 
completed modified ESAS forms and analyse for patterns, particularly if the staff 
initials on the forms were used as a comparator. 
 
6.10.4 Proxy data collection and symptom assessment 
There was a potential that compliance of the use of proxies to collect data could have 
limited the completeness of data collection; however, given the ontological approach 
and the nature of end of life, it has proved to be a very beneficial way to collect data, 
resulting in a complete set of data. The modified ESAS had been validated for the use 
of proxy data collection and staff were fully prepared for this role; however, the 
subjective nature of symptoms still creates challenges during proxy data collection and 
these have been discussed earlier in the thesis. One aspect that can prove difficult is 
that of assessment of psychological symptoms. In particular, one of the symptoms 
included on the modified ESAS is depression. When reviewing the results of the 
analysis, it was seen that depression was less prevalent towards the time of death. This 
raises the question as to whether it had reduced, whether it had become less apparent 
because other symptoms such as drowsiness had increased and masked depression, or 
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whether the staff assessing were able to adequately measure the symptom. There are 
specific tools available, e.g., The Hospital Anxiety and Depression Scale (Zigmond & 
Snaith, 1983), however, the challenge is finding suitable tools for multi-dimensional 
assessment rather than having to use several uni-dimensional tools for each 
assessment. Preparation for integrating assessment of multiple symptoms, as well as 
having the knowledge of individual symptoms is important. In relation to depression 
this could mean having a knowledge of how to assess, but also self-awareness of staff 
own beliefs on depression as their views of patient suffering, especially at the very end 
of life, are relevant given the major role they play. For symptoms such as depression; 
advice to staff can include to assume the same unless notable changes were observed 
that could be attributed to the symptom. However, depression is an important symptom 
and should continue to be assessed. Any form of psychological distress impairs the 
person’s capacity for pleasure, and meaning, erodes quality of life and intensifies pain 
and other symptoms (Block, 2000) and while pharmacological management may not 
be appropriate, support and care of the person is paramount. 
 
6.10.5 The challenges in recognising dying 
Although the total number of participants was estimated prior to the study and 
subsequently achieved, the challenge was the care home staff recognising when a 
resident entered their final days of life. This meant that many residents did not ‘join’ 
the study until the final day or hours of life. It resulted in a very complex and large set 
of data which took a considerable amount of time for data input and the subsequent 
analysis. By using pairwise comparisons, it enabled the recognition of death as a 
 201 
 
variable to be incorporated in the analysis, but longer periods of data collection for 
individual participants would have further strengthened the analysis.  
 
6.11 The implications on policy and practice 
Care homes often operate in isolation from other services and from each other, even 
when part of a larger corporation, so their position in the wider care provision needs 
to be considered. To consider this, a typology identified by Froggatt et al. (2017) can 
be drawn upon. The typology incorporated three levels that need to be considered to 
be able to implement palliative care delivery and practice in care homes: 1) macro 
(national/regional/local policy, legislation, regulatory drivers); 2) meso (actions to 
support development, such as research, education and practice model); 3) micro (the 
recognition of the very end of life phase and the delivery of palliative care). It could 
be seen how a cascade effect from the macro level to the meso level would have an 
effect on the micro level. This typology has similarities with the Organizational 
Culture Model developed by Edgar Schein (Schein, 2004), who described a series of 
three layers or sub-cultures, each one affecting and being affected by the next one. 
Applying this process to the care homes, it becomes apparent that if inappropriate 
hospital admissions are to be avoided for residents who are dying, the meso level needs 
to include actions such as education and training, but that there is a macro level that 
must be addressed to support care homes to be able to put the meso actions in place in 
order to influence the micro level, or the delivery of palliative care. Wider policy 
development and implementation can help to shape this. The framework for enhanced 
health care in care homes (National Health Service, 2016) is attempting to pull together 
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care homes and services to improve care, while providing much needed support for the 
care homes. 
 
6.12 The macro level – Policy and planning 
There are growing challenges associated with ageing globally and so there is an urgent 
need to build a robust international comparative evidence base that can inform the 
development of policies with the goal to improve end of life care in care homes (Van 
den Block et al., 2016). From the literature review in chapter three, it was noted that 
there was a lack of published research from the UK around end of life symptoms in 
care homes, so support is needed to develop research skills to lead these, plus ways of 
increasing engagement with care homes. In today’s climate of staff shortages and 
financial cut-backs this may be difficult, so the development of regional 
teaching/research-based care homes that become centres for practice-based research 
could be one solution (Hockley, Harrison, Watson, Randall, & Murray, 2017). There 
is a risk, however, that the good quality care and learning and development that has 
the potential to take place does not come out of these homes/centres but remains in-
situ. Another policy implication that has been identified from this study will now be 
addressed. 
 
6.12.1 Avoiding inappropriate hospital admissions 
Although this is could also be considered a meso/practice issue, it is appropriate to 
position this under the implications for the policy section as it is often a bigger issue 




The correct recognition and identification of the symptoms that signified the very end 
of life could prevent residents being admitted into hospital when supportive or comfort 
care provided in the care home would be the best option. It highlights the importance 
of assessment and measurement, improving pro-active care which can stop things 
getting out of control. It would also help those people that are not at end of life receive 
the appropriate medical care they need at a time when care homes are fearful of 
admitting residents for what could be a very appropriate and timely admission.  
 
6.13 The meso level - supporting development through education and practice 
model/frameworks 
6.13.1 Developing a curriculum for staff working with care home residents at the 
end of life 
The education and support of staff is an important area of development to enhance the 
care of residents at the end of life. Bone et al. (2018) stressed the importance of 
education for staff in driving the current increase in care home deaths, and said that if 
there is no end of life care training and release for training for staff in care homes, the 
trend in declining hospital deaths will likely reverse as a result by 2023.  There are a 
wide range of professionals who support care homes, beyond the care home staff 
themselves, and so education and support would be needed for them as well. Based on 
the findings from this study, it is proposed that it would include the following three 
key areas: 1. Identification of all types of symptoms (including silent and strident); 2. 
Recognising the significance of symptoms; and 3., Managing the consequences of 1 
and 2. The following table (6.1) describes how these three areas relate to the emerging 




Table 6.1 A curriculum for care home staff based on the findings of the study 
Key area Emerging finding Application of findings to a 
curriculum  
1.Identification 





The most prevalent symptoms may 
not need ‘treatment’ but care of the 
resident is still crucial 
 
There is little difference in 
symptoms at very end of life 
regardless of diagnosis 
 
 
Not all symptoms need 
management, but they do require 
acknowledgement 
 
Recognising and addressing pre-







The four key ‘silent’ symptoms 
increase in severity towards death 
 
This study has shown that accurate 
measurement provides relevant 
information 
 
Recently, several studies have 
examined the ESAS predictive 
validity, although not currently in 
the care home setting (Hui & 
Bruera, 2017) 
 
Silent symptoms may not be 
recognised by families as part of 
the dying process so their 
significance may need highlighting 
 
Spotting the ‘trigger’ change 
points of the dying process 
 




Use of an appropriate symptom 





Communication with families and 




This study has shown there are no 
certainties, but there some 
indicators that can help with early 
recognition of impending death 
Strident symptoms will still be 
present in some residents and 
require management 
 
This study has shown a range of 
different symptoms can present 










Complex symptoms require 
specialist advice or support 
 
Recognition of needing to work 
with uncertainty but indicators can 
alleviate some uncertainty and 





All round general symptom 
management knowledge is 
required but also need to know 
when to refer on 
 
Holistic care planning. End of life 
care is not just about drugs and 
syringe drivers (but might be 
needed) but keeping the person 
comfortable is the goal 
 
How to access to support network 
of other professionals 
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6.14 The micro level - recognising dying and the delivery of end of life care 
6.14.1 The recognition of imminent death 
Symptoms can be monitored in order to manage and treat to promote quality of life 
and subsequently support a good death, but they can also be observed and monitored 
for an indication of approaching death. Following this study, it has been shown that 
both purposes of symptoms can support the provision of good end of life care (Sandvik 
et al., 2016). This study established that many symptoms are related to a general 
deteriorative condition, that they generally increase in presence and intensity towards 
the time of death, and that residents dying in nursing homes have similar symptoms 
despite different characteristics. The symptoms are less acute than reported in other 
populations and these symptoms can be divided between 2 different types – silent and 
strident.  
 
To apply the findings from this study, care home staff can be made more aware of the 
type and nature of symptoms (as in the curriculum in Table 6.1) and that an increase 
of symptoms may be an indicator of approaching death (specifically when the silent 
symptoms are increasing in presence and increasing in intensity). They also need to be 
aware that the diagnosis of the resident is largely irrelevant to this process but the less 
time the resident has been in the care home may mean that if they are presenting with 
more and increasing symptoms, they are more likely to be moving into the dying phase. 
Residents in care homes have a slow gradual decline (Barclay et al., 2014) which may 
not be picked up by staff (or relatives) who see the person each day.  Adding in an 
additional assessment, such as the Karnofsky Performance Scale (KPS) (Oken et al., 
1982), which is a measure of the patient's overall performance status or ability to 
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perform their activities of daily living, can help to see decline and make sense of 
changes in symptoms. The combination of these two approaches, when carried out 
regularly, may assist staff when making decisions about hospital admission and help 
to prevent inappropriate and unwanted (on the part of the resident) admissions. This 
will also help to support Advance Care Planning (ACP):  
“Advance care planning offers people the opportunity to plan their future care 
and support, including medical treatment, while they have the capacity to do 
so” (Happ et al., 2002): p.829) 
 
Although ACP should ideally be completed as early as possible, for example, on 
admission to the care home or soon after. However it often does not get addressed due 
to apprehension about upsetting the patient or their family, or that patients were not 
ready for these conversations with only 16% of staff discussing advance care planning 
at least sometimes (Ottoboni et al., 2019). Patients and families prefer health 
professionals to initiate the conversation, but professionals often defer the discussion 
until it is deemed clinically relevant (Hall, Rowland, & Grande, 2019) but can miss 
the opportunity as the patient deteriorates. By identifying the increasing presence and 
intensity of symptoms, along with an increasing KPS, may provide a trigger to have 
conversations about care and hospital admissions before it gets too late. 
 
6.14.2 Targeting the right type of care to the right people 
Different models of care are required for people with different illness trajectories 
(Murray, Dawson, Thomas, & Cebul, 2005), but what this study has shown is that there 
is a ‘type’ of trajectory of a slow decline that is common to residents in care homes in 
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the final few days, meaning it could be possible to identify an appropriate approach to 
care. Specialist and generalist palliative care are the terms mainly applied, but having 
an approach that sits somewhere between the two may be more appropriate for 
residents in care homes. While the specialist skills of a Clinical Nurse Specialist (i.e. 
Macmillan Nurse) may not be necessary, end of life care does require specific skills to 
meet the challenges of recognising, and specifically interpreting, end of life symptoms. 
Within the UK there is a medicalisation of end of life care in older people in care 
homes that may be unnecessary (Lievesley et al., 2011). Resources may be being 
invested in the wrong ways. In addition, a clear rationale of what is the role and 
boundaries of specialist palliative care is required – it does have a role, but it needs a 
more clearly defined role. This links into the next section regarding the care home 
culture. 
 
6.14.3 The impact of care home culture 
The culture of institutions providing care for older people is increasingly recognised 
as influential in the quality and nature of the care provided (Killett et al., 2016). As 
already discussed, (Schein, 2004) describes culture as a dynamic relationship between 
three levels, with artifacts being the most shallow, espoused values in the middle and 
assumptions lying at the deepest level. Culture in any setting does not just involve 
bringing in a ‘good’ manager or putting a policy on the wall. It is about working with 
practice issues and aligning them with espoused values. From that practice, 




The findings from this study will not necessarily be able to affect assumptions directly, 
but it can influence practice and support staff to change culture through changing 
values which could ultimately shift assumptions. For example, by having a model built 
on the knowledge, skills and confidence to identify end of life through the recognition 
of decline and the presentation of silent symptoms, staff may be able to have 
conversations with residents and their families about end of life wishes and from that, 
build the confidence to have these conversations earlier (maybe on admission). The 
willingness to discuss these difficult issues and the resulting openness between staff 
and residents and families influences values and ultimately can change assumptions. 
It only needs small steps to do this which leads to an accumulative and much bigger 
effect. 
 
6.15 Implications for research 
Symptom research is a fertile field (Kroenke & Harris, 2001) and there are a lack of 
studies at end of life, particularly in certain groups such as older people or with certain 
symptoms such as the silent ones identified in this study. There needs to be consistent 
ways of researching symptoms utilising best practice guidance. A higher priority 
should be given to exploring symptoms as a phenomenon in its own right rather than 
focus on symptoms as part of diagnostic constructs only (Rosendal et al., 2013). This 
would prevent the focus on a ‘fix-it’ solution only and place symptom assessment and 
measurement as a way of understanding how symptoms are utilised more broadly. 





6.15.1 Standardisation of approaches 
The philosophy behind the UK Medical Research Council (MRC) and National 
Institutes of Health Research (NIHR) funded ‘MORECare’ was to recognise that 
firstly, end of life care is neglected by medicine, and secondly, that end of life care 
research is complex and hard to conduct with no common standards (Higginson et al., 
2013). As a result, they have produced a guidance statement on the best methods to 
research end of life care. This study has found that it had aligned itself with several of 
the MORECare criteria, such as focusing on a period of time, using a number of time 
points to gain longitudinal information and attempted to support proxy reporting. The 
MORECare statement offers a practice guide, rather than a model or theory, so the 
next implication is for the use of a conceptual model. 
 
6.15.2 Use of a symptom research model 
Brant’s model (Brant et al., 2010) was introduced in the background/context chapter. 
On reviewing the model further, it becomes apparent that there are some components 
that are more appropriate to include than others, especially if this model is to be used 
with a population at the end of life or any other group where self-reporting is not 
appropriate or possible, and that symptom management is not in question, for example, 
in symptom research. To isolate the components that are required from the New 
Symptom Management Model the following steps have been taken. This process has 
been explained in a set of images and tables and will be described after the process 




Step 1. The wider model is presented and the components that will be carried forward 
are identified (Figure 6.2) 
Step 2. The evaluation component, the current criteria and the adaptations that will be 
applied to operationalise the model for current use are listed (Table 6.2) 
Step 3. The components have been transferred to a visual representation of the model 
that includes the key components from supported by concepts arising from the criteria 
for a model and have been colour coded to show the relationship to Brant’s et al 
original model. (Figure 6.2) 
 
Step 1 









Figure 6.2 Part of the New Symptom Management Model (Brant et al, 2010) 






Step 2.  
The evaluation component, the current criteria and the adaptations that will be applied 
to operationalise the model for current use are listed below in Table 6.2. 
 
 
Table 6.2 – The key components within symptom research in older people in 
nursing care homes (based on Brant et al criteria) 
Evaluation 
component 
Criteria Using the criteria to operationalise 






Demographics (age, gender), 
performance status, disease type, 




Number and type of 
diagnoses/diseases 
Length of residence in care home 
Symptom 
appraisal 
Symptom assessment and 
evaluation, type, common 
symptoms, timing, 
intensity/severity, frequency, 
interactions with others, 
situational factors, assessment 
instruments for measurement 
Symptom assessment and 
evaluation, type, common 
symptoms, timing, 
intensity/severity, frequency, 
interactions with others, situational 





Symptom multiplicity, symptom 
interactions 
Symptoms occurring together 
Outcomes or 
consequences 
Cognitive performance, mortality 
(recognising end of life), 
morbidity and co-mortalities 
Symptoms at point of recognition 
of impending death/time to death 
Temporal 
components 
Temporal patterns, change over 
time, rate of change, progression 
of symptoms and disease state 
Rate of change 
Change over time 
Intervention 
components 
Different interventions, clinician 
influences 
Objective assessment 
Concepts Identified, well defined  
Relationships Clearly delineated  




Step 3.  
The components have been transferred to a visual representation of the model that 
includes the key components from supported by concepts arising from the criteria for 
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a model and have been colour coded to show the relationship to Brant’s et al original 




















Figure 6.3 – A revised model of Brant et al (2010) model for symptom research 
(at end of life) 
 
The key features of this application are the temporal aspects, and looking for changes 
in symptoms over time. The antecedents are the areas of interest, such as specific 
demographics or diseases. In the very middle is the measurement or appraisal of 
symptoms and the multiplicity of symptoms. This model helps to inform a 
conceptualization of symptoms to develop an understanding how they appear, 
particularly in relation to temporal aspects and their relationships with each other. It 
also recognises that symptoms may be more or less visible, such as the silent and 
strident ones categorised within this study, and that all symptoms are equally 
important. The model identifies the key components within symptom research in older 
people in nursing care homes, rather than the nature of the symptoms themselves, so 
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addition of silent/strident definitions to this particular model is not appropriate (until 
further work is undertaken) 
 
6.15.3 The use of appropriate measurement tools 
A further implication of this study is the choice and use of instruments for end of life 
symptom research. Generally, if an instrument is intended for research purposes alone, 
there may be a drive to develop complex multi-dimensional instruments that have less 
practical applications, especially with populations at the end of life. If the instrument 
is for practical and/or clinical assessment, utility becomes a key factor in the choice of 
instrument. The main requirements of an instrument are that it has to be 
comprehensible to diverse groups of staff and fairly quick to apply. It also needs to be 
considered how it can be used when measuring by proxy due to the likely incapacity 
of the population to be able to self-report.  It will also depend on who will be informing 
the assessments. If staff are using it for a practical aspect, i.e., measuring, monitoring 
or improving care, potential training implications need to be considered to ensure 
reliability as well as validity. A further useful addition to the criteria would be to 
include the ability to assess multiple symptoms. This is supported by Van Lancker et 
al. (2013), who, following a systematic review found that many validated instruments 
existed to assess single symptoms, but none for multiple symptoms. The ESAS was 
reliable, but it had restricted validity due to the lack of application in the care home 
setting. In addition, there have been frequent modification of the ESAS raising some 






The main findings have been that symptoms tended to relate to a general deteriorative 
condition suggesting that dying in nursing homes represents a gradual decline towards 
death. The limited associations between demographics such as disease, age and gender 
indicate that those dying in nursing homes have similar symptoms despite different 
characteristics. There are less symptoms than reported in other populations and these 
symptoms can be divided between two different kinds – silent and strident, concluding 
in a typology that has not been previously identified in symptom research in this 
population.  
Although many symptom research studies do not explicitly utilise a framework or 












Chapter 7 – Conclusion and Recommendations 
7.1 Introduction 
This chapter will summarise the findings from the research. First it will outline the 
importance of the research and why it was important to carry out in this population. 
Then, it will consider the major contributions of this research. Each finding will be 
summarised and the implications of these discussed. The contributions of the research 
are in some places unique, and in others they add to or build on existing knowledge. 
The implications will be aligned to practical, organisational or policy related domains. 
 
7.2 The importance of this research 
This subject of this research was of importance because it was recognised that the 
number of residents who are dying in care homes is increasing. This population 
consists of some of the frailest people in society: they live with high levels of disability, 
they often have multi-comorbidities and they are usually in their final months or years 
of life. Despite this, there is relatively little understood about the final days of this 
population’s life, so this work was important to be able to contribute to the knowledge 
of how end of life care can best be provided, as everyone has the right to die with 
comfort and dignity, in the place of their choosing with appropriate support. It was also 
important to carry out the research in this setting as staff working in care homes are 
facing increasing pressures to provide good care, while working in challenging 
situations with high work-loads, high staff turn-over, reduced funding and often a lack 
of managerial stability. Working ‘with’ care homes in the field rather than ‘on’ care 
homes can be one way of valuing staff and recognising their expertise, as well as 
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improving research participation. A key driver for this study was to support and 
improve the quality of dying for residents in care homes. Improving the quality of 
dying for residents can improve the experience of the families and loved ones of 
residents as the perception of a ‘bad death’ has been linked with a complicated 
bereavement process (Wilson, MacLeod, & Houttekier, 2015). Furthermore, 
satisfaction for the care staff providing care can sustain their well-being and lead to 
increased staff retention (Marcella & Kelley, 2015). 
 
7.3 What has this research contributed? 
This research has made a number of contributions to the wider body of knowledge; 
some are new while there are other findings that add support to what is already known.  
 
Key finding number one was the knowledge that dying was different in this 
population compared to people dying in other settings. This study has shown that dying 
in a care homes is a slow and gradual process, but relatively free of acute type 
symptoms. Residents admitted to care homes are most likely going to die in the care 
home after an average of a 11.9 month stay (Forder & Fernandez, 2011). This 
compares with an average hospital length of stay of 5.9 days (Stewart, 2019) and an 
average hospice length of stay of 15 days (Hospice UK, 2016). Both care settings are 
for acute care with a very short length of stay.  This suggested that care needs to be 
focused on supporting residents who are becoming increasingly fatigued and drowsy, 
eating less and drinking less and ultimately becoming unresponsive. Although other 
causative factors of deterioration need to be excluded, care home staff (and those 
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working with care homes) should be educated and supported to recognise impending 
death in residents. These findings were of value on a number of different levels. For 
professionals, they provided information that has not been previously widely available 
to influence the way in which care is given. It will confirm what many care home staff 
have known for a number of years; that is that the residents in their care often ‘slip 
away’ peacefully (Fleming et al., 2017). Hospices have cared for dying people for 
many years and have a very low hospital admission rate at the end of life. Care homes, 
who have a different demographic, but essentially the same cohort of dying people as 
hospices, do not always recognise the need not to admit to hospital. 
 
Despite Key finding one recognising that dying in care homes is different from other 
populations, Key finding two identified that there were very few differences in 
symptoms between the different population demographics within the cohort, meaning 
that dying is also quite similar across different residents. Variables of interest such as 
age, gender, diagnosis and length of stay in the care home showed little difference in 
symptoms within the cohort. Although there were some differences in individuals, 
when looking at this group as a cohort there were mainly similarities. The similarities 
present within this cohort, regardless of diagnosis, age, gender and length of stay at 
this very late stage of life, had not been reported on before making this seem to be a 
unique finding. As the diagnosis of dementia was included in the modelling process, 
this implies that people with dementia do not seem to have a different death trajectory 




The symptoms were able to be categorised into two different types which creates Key 
finding three. The symptoms that were the most frequently occurring/most intense 
have been characterised as being ‘silent’. Silent symptoms are gradual in their onset, 
have an observable pattern and increase towards the time of death. The group of four 
symptoms of increasing drowsiness, fatigue, anorexia and being unable to respond had 
not been previously specifically identified as being important in relation to impending 
death. The categorisation of the ‘silence’ of them had also not been noted in previous 
literature. This is often because many studies had focused on the reporting of ‘strident’ 
symptoms, particularly pain, which was evident in nearly all of the studies that were 
reviewed in the literature review; pain had also been a solo study outcome in two 
studies. This suggests that ‘silent symptoms’ do have value and could be 
acknowledged for what they demonstrate. It needs to be recognised that not all 
symptoms have to be ‘managed’ through medical/pharmacological interventions, but 
that they are useful signs for the professionals caring for people at the end of life. It 
matters because it can influence where the emphasis of end of life care in care homes 
is placed. Teaching care home staff to identify and become familiar and comfortable 
with these symptoms could be more beneficial to teaching management of a set of 
acute symptoms that are less likely to arise.  
 
Key finding four showed that residents dying in care homes did not have significantly 
high numbers of symptoms that required acute symptom management. These 
symptoms also fell into the silent symptom classification whereas the symptoms that 
usually required acute management fell into the strident classification. The 
implications of this is similar to Key finding three, although in addition, when 
 219 
 
‘strident’ symptoms arise, care home staff should know where to go and whom to ask 
for support. 
 
This study showed that recognising death is very challenging (Key finding five). 
Although this finding was not unique to this study, as it has been described previously, 
it had often not been reported upon as part of a symptom research study. In this 
research, it was detected because participants needed to be recruited at the point of 
recognition of entering the dying phase and 23 out of the 157 were not recruited until 
less than four hours prior to death. It is worthy of note that no resident died (in the care 
home) without having at least one assessment using the ESAS so although death may 
have been reported as ‘unexpected’, there were warnings in many cases even if it was 
less than four hours prior to death. The implications are that although professionals 
may feel concerned at not being able to forecast dying with any degree of accuracy, 
the lack of certainty can be used to benefit care. Professionals who work with residents 
in care homes need to be supported to use approaches to pre-empt this uncertainty. If 
the care homes engage in thorough Advance Care Planning processes, this can promote 
choice and decision making for residents and families, one of the things that can help 
to improve quality of life. To do this, staff need to have excellent communication skills 
of the type that are often provided to acute clinical staff as they will need to be able to 
support open, honest and sensitive discussions with residents and their families. If 
residents are not identified as dying until very late in the dying trajectory, the result 
can lead to inappropriate care such as hospital admissions or emergency response calls 




The findings are important when it comes to developing and implementing policy. 
There is a contradiction in current directives. On one hand, there is a national drive to 
reduce ‘inappropriate’ admissions from care homes to hospital, so a resident who is 
identified as being at the end of life gives a rational decision not to admit. However, 
there is a fear from care homes that they are not providing essential care if they fail to 
admit, and fear that they put themselves in line for scrutiny from their regulatory body 
or managers (National Institute For Health And Care Excellence, 2015b). 
  
7.4 How the research met the study aim and objectives 
These have been identified throughout this thesis and are hereby presented as a 
summary within table 7.1.  
 
Table 7.1 Achievement of the research aims and objectives 
Aim How were these achieved? 
Describe the presence and intensity of 
physical symptoms of residents in the 
dying phase in care homes, and explore 
whether there are changes in symptoms 
over time and how they relate to 
specific demographics and other 
characteristics. 
Twelve symptoms were assessed: ‘Is it 
there’, ‘How often is it there for’ and 
‘What level did it occur at’ meeting the 
requirements for presence and intensity. 
Their common characteristics were 
explored. 
Objectives How were these achieved? 
To measure the presence and intensity 
of total physical symptoms, and test the 
associations between key characteristics 
(age, gender, number of diagnoses and 
length of stay), during the final 48 hours 
of life in people who are resident in a 
care home. 
The presence and intensity of the total 
physical symptoms were tested for 
significance by pairwise comparison and 
showed an increase in both presence and 
intensity towards the time of death. There 
were very few significant associations. 
 
To measure the presence and intensity 
of individual physical symptoms, during 
 
The presence and intensity of individual 
physical symptoms were tested for 
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the final 48 hours of life in people who 
are resident in a care home and test the 
associations between key characteristics 
(age, gender, number and type of 
diagnoses and length of stay) during the 
final 4 hours of life in people who are 
resident in a care home. 
significance by pairwise comparison and 
showed an increase of several symptoms 
in both presence and intensity towards 
the time of death. There were very few 
significant associations. 
 
To propose a typology of symptoms 
associated with the dying phase derived 
from the population characteristics and 
the longitudinal changes over time. 
 
The typology comprises of two elements: 
Firstly, it identified a slow gradual 
deterioration towards death, and 
secondly, documented a classification of 
silent and strident symptoms. 
 
7.5 Methodological findings 
Although symptoms at the end of life in care home residents was not an area that has 
attracted extensive research, the range of variations within the reporting of the 
presence of symptoms across the different studies was considerable. There was little 
consensus between the reporting of symptoms, although drowsiness was a very 
commonly reported symptom. Throughout the different studies, there was a very wide 
range of different ways of obtaining data from observation through to extracting data 
from residents’ records. While the majority of studies used retrospective data, there 
were far fewer that collect data prospectively. The studies that involved prospective 
data often did not involve the staff caring for them and, given that the nature of data 
collection will normally be by proxy, it could be a weakness of any potential study by 
not involving the staff who know the resident and by utilising records that may not 
have been fit for purpose when written. Understanding the temporal aspects is a less-
researched area. It was not easy to identify when a person is dying, so hence made it 




The value of prospective cohort studies need to be recognised. Collecting data for the 
direct purpose of a study was beneficial as retrospective data were much more open to 
misinterpretation. Prospective studies do have challenges, but they provided a key 
method to obtain specific data. The methods of collecting data (by assessing 
symptoms) and using a standardised instrument could be a lesson learnt from this 
study, although there were challenges in identifying an appropriate instrument for this 
study too. The literature review demonstrated that research on symptoms could be 
more rigorous, more standardised and more joined-up. As studies like this often 
involve small numbers, having studies that can be consolidated into meta-analyses 
would be very advantageous. There is a need to have processes for regular and 
comparative assessment and monitoring of significant symptoms and a way to find a 
more global description/ assessment of symptoms instead of a qualitative assessment 
(Bisgaard et al., 2011).  
 
There needs to be a consensus on what are the significant symptoms at end of life. This 
would lead to a more consistent approach in symptom management. Future research 
could focus on defining key symptoms to be able to develop consistent data sets going 
forward. Once core symptoms are agreed and explored, future research could be 
focussed on other broader issues. Studies that consider the management of symptoms 
in care homes would add to the knowledge base, and one that is not currently well 
researched. Some of the symptoms that have been grouped as ‘strident’, such as 
shortness of breath, secretions and pain, could be monitored along with their 
management, providing valuable information to support future symptom management. 
This study highlighted a group of symptoms which have been grouped as ‘silent’. They 
often receive little attention within research studies, yet are the most prolific within 
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this cohort. Further understanding of the impact of these symptoms upon residents is 
required, but also there is also a need to consider why these symptoms remain 
unacknowledged in some cases.   
 
7.6 Recommendations 
7.6.1 Recommendations for future practice 
1. All staff working in care homes and with care homes are educated to recognise 
the signs of impending death and understand the nature of symptoms, 
particularly in relation to ‘silent’ and ‘strident’ symptoms.  
2. Care homes are supported to carry out consistent assessment and measurement 
of symptoms for residents who are at the very end of life. 
3. Guidelines that support symptom management are aligned with the new 
knowledge about the prevalence of symptoms in this population. 
 
7.6.2 Recommendations for future policy 
1. Care homes need to be recognised for their contribution to end of life care and 
involved when policies and guidelines are being developed. 
2. More knowledge is required about the influence of culture within care homes 
and the impact that has upon implementation of practice or delivery systems in 






7.6.3 Recommendations for future research 
1. Guidance from the MORECare statement is taken into account when planning 
research in care homes.  
2. Temporal aspects of symptoms are a requirement to understand the changes 
that occur over a given period of time. 
3. A matched study looking for silent and strident symptoms in other populations 
or care contexts 
4. Proxy reporting measures are strengthened and developed further. 
5. There is a development of a symptom research model that will provide a lens 
through which to view symptom research and provide the consistency needed 
to produce studies suitable for cross analysis. 
6. A reliable and valid instrument is available for use with a care home population 
that captures the appropriate symptoms over a series of time points with the 
ability to be used by a proxy-rater. The instrument needs to be straightforward 
in use and is practical and functional for care home staff as well as researchers.  
 
7.7 Conclusion 
To conclude this thesis, this positivist study has met the aims and outcomes that it set 
out to achieve. The importance of understanding the symptoms is not only important 
from a symptom management perspective, but demonstrates that the effect of not 
understanding symptoms (and the broader impact of them) can be very wide-reaching. 
This study, through its findings, will help to improve care for older people dying in 
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Appendix i - Characteristics of an Ideal Model or Theory for Symptom 








Demographic and sociocultural characteristics 
Age, gender, marital status, sexual preference, race, culture, role, education, 
socioeconomic status, developmental stage 
Psychological characteristics 
Attitude, motivation, mental ability, mental illness 
Physiological characteristics 
Disease type and state, types of treatments, co-morbid conditions, clinical 
factors 
Individual health and illness factors 
Health knowledge, values, attitudes, past experiences, sense of coherence, self-
efficacy, motivation, resiliency, risk factors, personal definition of wellness, 
substance abuse issues 
Symptom 
appraisal 
Symptom assessment: location, timing, intensity, quality, exacerbating factors, 
alleviating factors 
Symptom meaning: distress, impact, existential meaning 
Symptom evaluation and response to self-care, pharmacologic, and non-
pharmacological interventions 





Multiple underlying mechanisms 












Quality of life 





Change over time 
Onset and rate of change 




Exacerbation of symptoms 




Health seeking behaviours 






Concepts Identified, well-defined, discussed 
Relationships Clearly delineated 
Utility Model is useful, generalizable and parsimonious 
Brant, J. M., Beck, S., & Miaskowski, C. (2010). Building dynamic models and theories to advance 
the science of symptom management research. Journal of Advanced Nursing, 66(1), 228. 
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Appendix ii - Assessment form for data extraction and scoring 
 
 
Hawker, S., Payne, S., Kerr, C., Hardey, M., Powell, J. (2002) Appraising the 




Author(s): Date of Publication: 
 






(  )  Quantitative 
(  )  Qualitative 
(  ) Combination 
Location of Study: 
 
Sample – Size: 




Research Questions / Hypothesis (If Any): 
 
 
Method and Analysis: 
 
 











                                                                          Good             Fair             Poor             Very Poor                Comments 
1. Abstract and title 
 
     
2. Introduction and aims 
 
     
3. Method and data 
 
     
4. Sampling 
 
     
5. Data analysis 
 
     
6. Ethics and bias 
 
     
7. Findings/results 
 
     
8. Transferability/generalizability      
9. Implications and usefulness      
 
Total 
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Appendix iii - Protocol for scoring for methodological rigour 
 
 
1. Abstract and title: Did they provide a clear description of the study? 
Good   Structured abstract with full information and clear title 
Fair   Abstract with most of the information 
Poor   Inadequate abstract 
Very Poor  No abstract 
 
2. Introduction and aims: Was there a good background and clear statement 
of the aims of the research? 
Good  Full but concise background to discussion/study containing 
up- to date literature review and highlighting gaps in 
knowledge 
Clear statement of aim AND objectives including research 
questions 
Fair   Some background and literature review 
Research questions outlined 
Poor   Some background but no aim/objectives/questions, OR 
Aims/objectives but inadequate background 
Very Poor  No mention of aims/objectives 
No background or literature review. 
 
3. Method and data: Is the method appropriate and clearly explained? 
Good  Method is appropriate and described clearly (e.g. 
questionnaires included) 
Clear details of the data collection and recording 
Fair   Method appropriate, description could be better 
Data described 
Poor   Questionable whether method is appropriate 
Method described inadequately 
Little description of data 
Very Poor  No mention of method, AND/OR 
Method inappropriate, AND/OR 
No details of data 
 
4. Sampling: Was the sampling strategy appropriate to address the aims? 
Good  Details (age/gender/race/context) of who was studied and 
how they were recruited 
Why this group was targeted 
The sample size was justified for the study 
Response rates shown and explained 
Fair   Sample size justified 
Most information given, but some missing 
Poor  Sampling mentioned but few descriptive details 
Very Poor  No details of sample 
 
5. Data analysis: Was the description of the data analysis sufficiently 
rigorous? 
Good   Clear description of how analysis was done 
Qualitative studies: Description of how themes 
derived/respondent validation or triangulation 
Quantitative studies: Reasons for tests selected hypothesis 
driven/ numbers add up/statistical significance discussed 
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Fair   Qualitative: Descriptive discussion of analysis 
Quantitative. 
Poor   Minimal details about analysis 
Very Poor  No discussion of analysis 
 
6. Ethics and bias: Have ethical issues been addressed, and what has 
necessary ethical approval gained? Has the relationship between researchers 
and participants been adequately considered? 
Good  Ethics: Where necessary issues of confidentiality, sensitivity, 
and consent were addressed 
Bias: Researcher was reflexive and/or aware of own bias 
Fair   Lip service was paid to above (i.e., these issues were 
acknowledged) 
Poor   Brief mention of issues 
Very Poor  No mention of issues 
 
7. Results: Is there a clear statement of the findings? 
Good   Findings explicit, easy to understand, and in logical 
progression 
Tables, if present, are explained in text 
Results relate directly to aims 
Sufficient data are presented to support findings 
Fair   Findings mentioned but more explanation could be given 
Data presented relate directly to results 
Poor  Findings presented haphazardly, not explained, and do not 
progress logically from results 
Very Poor  Findings not mentioned or do not relate to aims 
 
8. Transferability or generalizability: Are the findings of this study transferable 
(generalizable) to a wider population? 
Good Context and setting of the study is described sufficiently to 
allow comparison with other contexts and settings, plus high 
score in 
Question 4 (sampling) 
Fair Some context and setting described, but more needed to 
replicate or compare the study with others, PLUS fair score or 
higher in 
Question 4 
Poor   Minimal description of context/setting 
Very Poor  No description of context/setting 
 
9. Implications and usefulness: How important are these findings to policy 
and practice? 
Good Contributes something new and/or different in terms of 
understanding/insight or perspective 
Suggests ideas for further research 
Suggests implications for policy and/or practice 
Fair   Two of the above (state what is missing in comments) 
Poor   Only one of the above 
Very Poor None of the above 
 
Hawker, S., Payne, S., Kerr, C., Hardey, M., Powell, J. (2002) Appraising the 














End of life in Care Homes: 
Research project on symptoms experienced by residents at end of 
life 
 
THIS INFORMATION LEAFLET IS FOR CARE HOME MANAGERS 
 
 
Why is this research being done? 
Care homes are caring for an increasing number of people at the end of life 
and generally use symptom management guidance from a range of sources. 
This can include the Liverpool Care Pathway flow charts or information from 
the local specialist palliative care teams. It is extremely useful to have this 
guidance, but much of the current guidance has come from research with 
people with cancer and there has been little research done looking at the 
symptoms experienced by residents living in care homes. It would be very 
useful to be able to get an up to date picture of what is happening with residents 
at this stage of their life. This would ensure that appropriate symptom 
management guidance can be provided for residents living in care homes and 
the staff caring for them.  
 
Who can take part? 
A number of homes across the CECPCT/WCPCT area are being asked to take 
part in a research project 
The criteria for inclusion in the research project are:  
 There is managerial support and/or organisational support (depending 
on care homes’ policy) for the project to go ahead within the care home. 
 There is current use of an Integrated Care Pathway/Liverpool Care 
Pathway or equivalent and/or ways of identifying dying residents. 
 At least one member of staff has undergone additional palliative care 
training/education within the last 12 months.  
 
What would you be asked to do? 
All qualified staff would be asked to record the symptoms experienced by 
residents (at the end of life – i.e. within the final 48 - 72 hours) on a special 
form called an ESAS. The ESAS is a recognised tool that has been used in 
many care settings to monitor the symptoms experienced by people near the 
end of life. The ESAS will be attached to the Liverpool Care Pathway and the 
resident’s symptoms will be observed and documented at the same time that 
the care pathway documentation is normally completed. There will be more 
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information available about the ESAS and I am happy to speak to staff either 
individually or as a team about the ESAS and how it is completed.  
The project will also be collecting some demographic information about the 
resident, so the (qualified) staff would be asked to complete another form with 
some basic information such as age, gender, diagnosis, length spent in care 
home. This form will be completed at the same time as the pathway is 
commenced.  We do not wish to collect any information that could identify the 
residents, so will not be asking for names, previous addresses, names of GPs 
etc. 
Both of the collection forms will have codes on the top right hand corner. The 
forms will come as a ‘pair’ – i.e. the ESAS and the demographic information 
sheet. Please ensure that the codes on both forms match so the data can be 
collated at a later date. 
All completed forms need to be placed in a sealed envelope (blank envelopes 
will be provided) and kept in an agreed place, probably the nurses or, if more 
suitable, your own office. Forms will be collected once a week by one of the 
research team. Staff will have the opportunity to ask questions or have 
anything clarified during this visit. The date of next collection/visit will be posted 
on a note at the collection point. 
 
What will we do with the information you give us? 
The data that you provide (i.e., all the information on the forms) will be inserted 
into a computer, which will enable us to see the occurrence of specific 
symptoms and any relationship to each other. The data will not be identified to 
any individual (it will be anonymous) but will build up to provide a bigger picture 
of what sort of things happen to residents at the end of life. 
The completed forms will be always be stored in a safe locked place and the 
data on the computer will only be able to be accessed with a special password. 
At the end of the research project, the completed forms will be destroyed. 
 
Consent from residents and families 
Although the research project will involve a number of residents, there will be 
many more that do not get involved with the research project. However, it is 
important to inform residents and families that a research project is taking 
place. An information poster has been produced so it can be placed on a notice 
board for residents and their families to read. Depending on the 
communication structure of the home, the information may also be discussed 
at residents meetings or an item placed in the home newsletter. I would be 
very happy to speak to any resident/family member or member of staff if more 
information is required.  
An extra booklet with more details about the research project will be available 
for any residents or families who require additional information. Copies of this 
booklet will be kept in the box where you will place the completed forms. 
Finally, I would be very happy to speak to any resident/family member or 
member of staff if more information is required and can be contacted directly 
by the resident/family or you are welcome to get directly in touch with me.  
Any resident or their family can request for their information not to be included 
in the research project. If a resident or their family member requests not to be 
involved, there will be some (colour to be inserted once agreed with individual 
homes) coloured stickers in the collection box. Staff will be requested to stick 
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one of these on top of the resident’s kardex/notes so all staff will know that this 
data should not be collected. If a resident is involved in the research project 
and a family member requests that the data is withdrawn, the ESAS and the 
demographics sheet should be destroyed and a note of the code number put 
in the collection box. Once the data has been collected (after the death of the 
resident), it would not be possible for the data to be withdrawn as it will have 
been anonymised, therefore not identifiable for removal. 
 
What if you change your mind about taking part? 
If you say that you want to take part in this project and then you change your 
mind about it, that is fine – just let us know! You are welcome to change your 
mind at any time and we will not put pressure on you to continue.  
 
Who are we and how can you contact us? 
My name is Lynne Partington and I am a researcher working at St Luke’s 
Hospice. I also work as a Lecturer in Palliative Care at Cheshire Hospices 
Education. 
Nichola Noden (who is an administrator working at Cheshire Hospices 
Education) will be working with me for one day a week. 
I have an honorary contract with Lancaster University for the duration of this 
project and am being supported by Dr Katherine Froggatt, who is a researcher 




We can be contacted at Cheshire Hospices Education on 01606 559292 or by 








































Title of project: Research on symptoms experienced by residents at 





I.……………………………………………. agree to 
involve……………………….     
(Subject’s full name)           (Care home name)  
to take part in the above named project, the details of which have been 







I…………………………………………….. certify that the details of this project 
(Investigator’s full name) 
have been provided and fully explained to the subject named above and 

















Appendix vii - A4 poster for care home notice boards 
 
 
Research project in (insert name) care home 
 
We are always looking for ways to improve the care provided to 
residents at all stages of their stay with us. So we are involved in a 
research project, which is looking at the experiences of people at 
the end of life. The research is particularly focussing on what sorts 
of symptoms (for example, pain or breathlessness) that people may 
experience at the end of their lives. 
  
Lynne Partington is a lecturer and 
researcher based at St Luke’s Hospice in 
Winsford.  She is particularly interested in 
care homes and also works part-time as a 
bank nurse in a care home in another area.  
 
The research involves Lynne collecting information from the staff at 
the home. The information will be collected from the forms that are 
usually completed when residents are very poorly so no extra effort 
is required. The information will be collected with the greatest of 
confidence and respect and all information will be anonymised so 
the resident will not be able to be identified in any way. The project 
has been granted ethical approval from Lancaster University. 
 
If you or your family do not wish your information to be involved in this 
project, please inform the manager, ** **, or nursing staff 
If you would like more information, please speak to the manger or staff, or 
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Please use this form if a resident or family wishes to withdraw from the 
research project AFTER data collection has begun. Please make a note of 






Date of withdrawal 
 

















































End of life in Care Homes: 
Research project on symptoms experienced by residents at end of 
life 
 




Why is this research being done? 
Care homes are caring for an increasing number of people at the end of life 
and generally use symptom management guidance from a range of sources. 
This can include the Liverpool Care Pathway flow charts or information from 
the local specialist palliative care teams. It is extremely useful to have this 
guidance, but much of the current guidance has come from research with 
people with cancer and there has been little research done looking at the 
symptoms experienced by residents living in care homes. It would be helpful 
to be able to get an up to date picture of what is happening with residents at 
this stage of their life to ensure that appropriate symptom management 
guidance can be provided for residents living in care homes. 
 
Who can take part? 
All qualified nurses working in (Name) Care Home are invited to be involved in 
this research project 
 
What would you be asked to do? 
You will be asked to record the symptoms experienced by residents (at the 
end of life – i.e. within the final 48 - 72 hours) on a special form called an ESAS. 
The ESAS is a recognised tool that has been used in many care settings to 
monitor the symptoms experienced by people near the end of life. The ESAS 
will be attached to the Liverpool Care Pathway and the symptom will be 
recorded at the same time that you usually complete the care pathway 
documentation. There will be more information available about the ESAS and 
I am happy to speak to you either individually or as a team about the ESAS 
and how it is completed.  
We will also be collecting some demographic information about the resident, 
so will ask you to complete another form with some basic information such as 
age, gender, diagnosis, length spent in care home. This form will be completed 
at the same time as the pathway is commenced.  We do not wish to collect any 
information that could identify the residents, so will not be asking for names, 
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previous addresses, names of GPs etc. to ensure that residents remain 
anonymous. 
Both of the collection forms will have codes on the top right hand corner. The 
forms will come as a ‘pair’ – i.e. the ESAS and the demographic information 
sheet. Please ensure that the codes on both forms match so the data can be 
collated at a later date. 
All completed forms need to be placed in a sealed envelope (blank envelopes 
will be provided) and kept in (a collection place to be agreed with the 
team/home manager). Forms will be collected once a week by one of the 
research team. Staff will have the opportunity to ask questions or have 
anything clarified during this visit. The date of next collection/visit will be 
available on a note at the collection point. 
 
What will we do with the information you give us? 
The data that you provide (i.e. all the information on the forms) will be input 
into a computer, which will enable us to see the occurrence of specific 
symptoms. The data will not be identified to any individual (it will be 
anonymous) but will build up to provide a bigger picture of what sort of things 
happen to residents at the end of life. 
The completed forms will be stored in a safe locked place and the data on the 
computer will only be able to be accessed with a special password. 
 
Consent from residents and families 
Although the research project will involve a number of residents, there will be 
many more that do not get involved with the research project. However, it is 
important to inform residents and families that a research project is taking 
place. An information poster has been produced so it can be placed on a notice 
board for residents and their families to read. Depending on the 
communication structure of the home, the information may also be discussed 
at residents meetings or an item placed in the home newsletter. An extra 
booklet with more details about the research project will be available for any 
residents or families who require additional information. Copies of this booklet 
will be kept in the box where you will place the completed forms. Finally, I 
would be very happy to speak to any resident/family member or member of 
staff if more information is required and can be contacted directly by the 
resident/family or you are welcome to get directly in touch with me.  
Any resident or their family can request for their information not to be included 
in the research project. If a resident or their family member requests not to be 
involved, there will be some (colour to be inserted once agreed with individual 
homes) coloured stickers in the collection box. Staff will be requested to stick 
one of these on top of the resident’s kardex/notes so all staff will know that this 
data should not be collected. If a resident is involved in the research project 
and a family member requests that the data is withdrawn, the ESAS and the 
demographics sheet should be destroyed and a note of the code number put 
in the collection box. Once the data has been collected (after the death of the 
resident), it would not be possible for the data to be withdrawn as it will have 
been anonymised, therefore not identifiable for removal. 
 
Who are we and how can you contact us? 
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My name is Lynne Partington and I am a researcher working at St Luke’s 
Hospice. I also work as a Lecturer in Palliative Care at Cheshire Hospices 
Education. 
Nichola Noden (who is an administrator working at Cheshire Hospices 
Education) will be working with me for one day a week. 
I have an honorary contract with Lancaster University for the duration of this 
research project and am being supported by Dr Katherine Froggatt, who is a 
researcher at the University. This research project has been given ethics 
approval by Lancaster University. 
 
We can be contacted at Cheshire Hospices Education on 01606 559292 or by 

















































Research project on symptoms experienced by residents at end of life 
 
Name of Care Home: 
Name of Unit: 
 
 
I agree that I have been provided with an information sheet regarding the 















   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 








Preparation session for care home staff for end of life 
symptom research project 
 
 
 Introduce self 
 
 Discuss background and rationale to research project 
 
 Discuss resident participation (family/resident meetings/posters/info 
booklets for families & residents) 
 
 Discuss the process (using the colour flow chart) 
 
 How to complete the first page (demographics – complete all boxes). 
Explain coding system 
 
 How to complete the ESAS – complete all boxes – decide severity of 
symptom – This is not about checking up on care but if you do have a 
challenging issue, please pass it on to me/Manager/Key link person  
 
 Presentation and practice of the use of the ESAS with ‘Maud’ – a case 
study 
 
 The first 2 weeks will be used as a trial and will then review any issues 
that have been identified 
 
 Discuss residents who withdraw (withdrawing sheet in box) or 
destroyed forms 
 
 LP and/or NN to visit weekly. Contact details available. ‘Next visit’ on 
top of box. 
 
 How does it fit with the use of the pathway – any questions about 
ICP/LCP? 
 
























We have now finished collecting information for the end of life research 
project that (care home) has been involved with for the last several 
months. 
Can we thank everyone at (care home) for collecting and passing on 
information for the research project undertaken by myself on behalf of 
St Luke’s Hospice and Cheshire Hospices Education. 
Some specific information from the findings will be provided through 
your Manager within a few weeks and there will be a more detailed 
report later on. If you need any information or have any questions, please 
contact Lynne or Nichola on 01606 559292. 
Thank you 
 
Lynne Partington & Nichola Noden 
 266 
 























Re: IHR Ethics Committee application for your research project titled “A 





Thank you for sending the revised paperwork relating to your research project. I can 
confirm, on behalf of the Ethics Committee, that your project has been approved. 







Dr Keren Cohen 

















Senior Lecturer and Researcher 










Re: “A prospective study to examine the incidences of end of life 
symptoms in care home residents” 
Many thanks for your letter of 20th February outlining a proposed extension of your 
project to include 11 rather than 10 care homes. This is a minor amendment and your 










































































































































Appendix xiv - Modified Edmonton Symptom Assessment Scale 
 
Modified Edmonton Symptom Assessment Scale (ESAS) for CARE HOMES 
Date     
Time 2am 6am 10am 2pm 6pm 10pm 2am 6am 10am 2pm 6pm 10pm 2am 6am 10am 2pm 6pm 10pm 2am 6am 10am 2pm 6pm 10pm 
Symptom         
Pain 
 
                        
Fatigue 
(Tiredness) 
                        
Drowsiness 
(Sleepiness) 
                        
Depression 
 
                        
Anxiety 
 
                        
Nausea 
 
                        
Anorexia 
 
                        
Shortness of 
breath 
                        
Delirium 
(Y/N) 
                        
Secretions  
(Y/N) 
                        
Unable to respond 
(Y/N) 
                        
Constipation 
(Y/N) 
                        
Initials of nurse 
completing 
assessment 
                        
 
Assessment Scale: None = 0               Mild = 1                        Moderate = 2*                  Severe* = 3           * requires daily follow-up plus 72 hour  
                                                                                                                                           follow-up 
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Appendix xv - Pairwise comparisons of the presence of individual symptoms at 4 
hrs, 24 hrs and 48 hrs prior to death 
Table Append xv (a) Pairwise comparisons of the presence of anorexia at 4 hrs, 
24 hrs and 48 hrs prior to death 
 
Factor 
Test Statistic Std. Error 
Presence of anorexia at 4 
hours v 24 hours 
.000 .023 
Presence of anorexia at 4 
hours v 48 hours 
.049* .023 
Presence of anorexia at 24 
hours v 48 hours 
.049* .023 
Note: * p < .05, ** p < .01, *** p < .001 
Table Append xv (b) Pairwise comparisons of the presence of shortness of breath 
at 4 hrs, 24 hrs and 48 hrs prior to death 
 
Factor 
Test Statistic Std. Error 
Presence of shortness of 
breath at 4 hours v 24 hours 
.197*** .055 
Presence of shortness of 
breath at 4 hours v 48 hours 
.246*** .055 
Presence of shortness of 
breath at 24 hours v 48 hours 
.049 .055 
Note: * p < .05, ** p < .01, *** p < .001 
Table Append xv (c) Pairwise comparisons of the presence of secretions at 4 hrs, 




Test Statistic Std. Error 
Presence of secretions at 4 
hours v 24 hours 
.131* .058 
Presence of secretions at 4 
hours v 48 hours 
.262*** .058 
Presence of secretions at 24 
hours v 48 hours 
.131* .058 
Note: * p < .05, ** p < .01, *** p < .001 
Table Append xv (d) Pairwise comparisons of the presence of unable to respond 
at 4 hrs, 24 hrs and 48 hrs prior to death 
 
Factor 
Test Statistic Std. Error 
Presence of unable to respond 




Presence of unable to respond 
at 4 hours v 48 hours 
.262*** .058 
Presence of unable to respond 
at 24 hours v 48 hours 
.131* .058 














































Appendix xvi - Pairwise comparisons of the intensity of individual symptoms at 4 
hrs, 24 hrs and 48 hrs prior to death 
 
Table Append xvi (a) Pairwise comparisons of pain at 4 hrs, 24 hrs and 48 hrs 
prior to death 
 95% Confidence 
Interval  
Factor Cross factor Mean 
difference 




Intensity of pain at 4 
hours 
24 hours -.098 .087 -.271 .075 
48 hours -.098 .098 -.295 .098 
Intensity of pain at 24 
hours 
4 hours .098 .087 -.075 .271 
48 hours .000 .107 -.214 .214 
Intensity of pain at 48 
hours 
4 hours .098 .098 -.098 .295 
24 hours .000 .107 -.214 .241 
Note: * p < .05, ** p < .01, *** p < .001 
Table Append xvi (b) Pairwise comparisons of fatigue at 4 hrs, 24 hrs and 48 hrs 
prior to death 
 95% Confidence 
Interval  
Factor Cross factor Mean 
difference 




Intensity of fatigue at 4 
hours 
24 hours .164* .067 .030 .298 
48 hours .295*** .085 .124 .466 
Intensity of fatigue at 24 
hours 
4 hours -.164* .067 -.298 -.030 
48 hours .131 .072 -.013 .275 
Intensity of fatigue at 48 
hours 
4 hours -.295*** .085 -.466 -.124 
24 hours -.131 .072 -.275 .013 
Note: * p < .05, ** p < .01, *** p < .001 
Table Append xvi (b) Pairwise comparisons of drowsiness at 4 hrs, 24 hrs and 48 
hrs prior to death 
 95% Confidence 
Interval  
Factor Cross factor Mean 
difference 




Intensity of drowsiness at 
4 hours 
24 hours .262** .084 .094 .430 
48 hours .410*** .097 .215 .605 
Intensity of drowsiness at 
24 hours 
4 hours -.262** .084 -.430 -.094 
48 hours .148 .084 -.020 .315 
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Intensity of drowsiness at 
48 hours 
4 hours -.410*** .097 -.605 -.215 
24 hours -.148 .084 -.315 .020 
Note: * p < .05, ** p < .01, *** p < .001 
Table Append xvi (c) Pairwise comparisons of depression at 4 hrs, 24 hrs and 48 
hrs prior to death 
 95% Confidence 
Interval  
Factor Cross factor Mean 
difference 




Intensity of depression at 
4 hours 
24 hours -.066 .057 -.179 .048 
48 hours -.098 .069 -.236 .040 
Intensity of depression at 
24 hours 
4 hours .066 .057 -.048 .179 
48 hours -.033 .040 -.113 .048 
Intensity of depression at 
48 hours 
4 hours .098 .069 -.040 .236 
24 hours .033 .040 -.048 .113 
Note: * p < .05, ** p < .01, *** p < .001 
Table Append xvi (d) Pairwise comparisons of anxiety at 4 hrs, 24 hrs and 48 hrs 
prior to death 
 95% Confidence 
Interval  
Factor Cross factor Mean 
difference 




Intensity of anxiety at 4 
hours 
24 hours .033 .096 -.160 .225 
48 hours .049 .125 -.200 .298 
Intensity of anxiety at 24 
hours 
4 hours -.033 .096 -.225 .160 
48 hours .016 .076 -.135 .168 
Intensity of anxiety at 48 
hours 
4 hours -.049 .125 -.298 .200 
24 hours -.106 .076 -.168 .136 
Note: * p < .05, ** p < .01, *** p < .001 
Table Append xvi (e) Pairwise comparisons of nausea at 4 hrs, 24 hrs and 48 hrs 
prior to death 
 
 95% Confidence 
Interval  
Factor Cross factor Mean 
difference 




24 hours .098 .069 -.040 .236 
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Intensity of nausea at 4 
hours 
48 hours .115 .067 -.018 .248 
Intensity of nausea at 24 
hours 
4 hours -.098 .069 -.236 .040 
48 hours .016 .016 -.016 .049 
Intensity of nausea at 48 
hours 
4 hours -.115 .067 -.248 .018 
24 hours -.016 .016 -.049 .016 
Note: * p < .05, ** p < .01, *** p < .001 
Table Append xvi (f) Pairwise comparisons of anorexia at 4 hrs, 24 hrs and 48 
hrs prior to death 
 95% Confidence 
Interval  
Factor Cross factor Mean 
difference 




Intensity of anorexia at 4 
hours 
24 hours .115** .041 .032 .197 
48 hours .295*** .082 .131 .459 
Intensity of anorexia at 
24 hours 
4 hours -.115** .041 -.197 -.032 
48 hours .180** .055 .071 .290 
Intensity of anorexia at 
48 hours 
4 hours -.295*** .082 -.459 -.131 
24 hours -.180** .055 -.290 -.071 
Note: * p < .05, ** p < .01, *** p < .001 
Table Append xvi (g) Pairwise comparisons of shortness of breath at 4 hrs, 24 hrs 
and 48 hrs prior to death 
 95% Confidence 
Interval  
Factor Cross factor Mean 
difference 




Intensity of shortness of 
breath at 4 hours 
24 hours .393*** .094 .205 .582 
48 hours .508*** .111 .286 .731 
Intensity of shortness of 
breath at 24 hours 
4 hours -.393*** .094 -.582 -.205 
48 hours .115 .088 -.061 .290 
Intensity of shortness of 
breath at 48 hours 
4 hours -.508*** .111 -.731 -.286 
24 hours -.115 .088 -.290 .061 
Note: * p < .05, ** p < .01, *** p < .001 
 
 
